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1 Collagen implant material in sterile syringe 6
ready for insertion into bony cavity.
2 Lateral view of normal adult rabbit 62
mandible.
3 Diagram to show site, size and shape of area 62
of operation on lower border of mandible.
4 (a) Undecalcified block (to demonstrate 81
fluorescent bone labelling) showing
bony defect and area of second molar
tooth before cutting.
(b) Similar block to Fig. 4a after cutting 81
at the level of the second molar tooth
in the area of operation. This provides
comparable areas for study.
5 Normal growing and dividing fibroblasts in 96
close relation to collagen implant material.
Phase contrast x 320.
6 Higher power view of implant material seen 96
in Fig. 5 with fibroblasts appearing to lie
inferiorly, superiorly or through the
matrix. Phase contrast x 640.
7 An area adjacent to Fig. 6 confirming the 96
intimate relationship shown in Fig. 2.
Phase contrast x 640.
8 Low magnification micrograph shows the 97
characteristic features of massed collagen
fibres seen lying in different orientations
and closely related to a fibroblasts. The
nuclear size and shape are normal but an
indentation is noted. There is a normal
distribution of chromatin. The cytoplasm
appears normal showing rough endoplasmic
reticulum, mitochondria electron dense
granules and empty spaces with no membranes
probably a fixation artetact possibly due
to loss of lipid material. Electron
micrograph x 2, 100.
9 Higher power view of area A confirming very 97
close relationship of fibroblasts with
collagen implant and confirming intact




10 Higher power view of area B showing nucleus 97
and nuclear membrane, mitochondrium and
several areas of intimate contact of
cellular membrane and collagen. Collagen
fibrils show characteristic cross-bonding.
Electron micrograph x 14,000.
11 Close relationship of normal fibroblast and 98
collagen fibrils. Electron micrograph x
3,500.
12 Higher power view of area C which shows the 98
cell appears to hold the collagen fibrils
in situ. Electron micrograph x 14,000.
13 5 days - collagen implant:
(a) Section shows implanted material (M) 108
associated with abundant granulation
tissue (G) and spicules of vital bone
(B). Trabeculae of woven bone (W) are
identified. H & E x 40.
(b) Section shows resorption of vital 108
mature bone by osteoclasts (arrowed)
and development of woven bone within
the granulation tissue. H & E x 144.
(c) Fibroblast rich granulation tissue. 108
H & E x 360.
14 5 days - control:
(a) Comparable field with Fig. 16 shows 109
cytologically similar granulation and
bone tissue. H & E x 144.
(b) High power view of area A in Fig. 14a 109
showing granulation tissue with no
significant difference from that seen in
Fig. 13c. H & E x 300.
15 10 days - collagen implant:
(a) Strands of cell rich fibrous tissue (F) 110
maturing from granulation tisssue
associated with implant material (M).
H & E x 40.
(b) Higher power view of fibrous tissue (F) 110
developing around implant material (M).
Note absence of inflammatory cells.
H & E x 360.
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16 10 days - control:
(a) Section shows fine trabeculation of bone 111
(B) within granulation tissue which
occupies the area of bone resection.
H & E x 40.
(b) Fast maturing fibrous tissue (F) within 111
the granulation tissue. A post surgical
spicule (S) of bone is identified as
well as advancing trabeculae of new
bone (B). H & E x 144.
17 14 days - collagen implant:
(a) Section shows fragmented implant - 112
material (M) partially replaced by
granulation tissue. H & E x 40.
(b) High power view shows early fibrocytes 112
(cf. fibroblasts) swarming over and
through fragmenting implant material.
(Note absence of foreign body giant cell
reaction.) H & E x 360.
18 14 days - control: 113
Comparable control shows much more mature
fibrous tissue (F) as demonstrated by cell
cohesion and regular orientation. H & E 40.
19 21 days - collagen implant: 114
Advancing bone front shows progression to
lamellar bone (B) and minimal bone
trabeculation but occlusion of surgical
defect by retained implant material (M).
H & E x 96.
20 21 days - control 114
Nearly complete occlusion of surgical defect
by granulation tissue (G) and plentiful
trabeculae of bone (B). H & E x 144.
21 21 days - control
(a) Regular advancing trabeculae of new 1 15
bone. x 144.
(b) High power view of advancing front of 115
osteoblasts, x 320.
(c) Lacunae of maturing bone showing 115




22 21 days - collagen implant
(a) Compared to Fig. 9a the advancing bone 1 16
is less well orientated and lacks the
fine trabeculation. Amorphous implant
material (M) is identified, x 144.
(b) Slower rate of replacement of implant 116
material by bone is evidenced by the
lack of fine trabeculation. Area A
Fig. 22a. x 300.
(c) Lacunae again show incremental pattern 1 16
of ossification demonstrating the
underlying process has not been
fundamentally altered only retarded.
x 500.
23 28 days - collagen implant 117
Surgical defect still present. H & E x 40.
24 28 days - control 1 17
Bone trabeculae now shown to extend
throughout the surgical defect. H & E x 40.
25 28 days - control 1 18
(a & b) Tetracycline only. High and low
power views show continuation of
more regular organised ossification
occluding the surgical defect,
a x 144: b x 560.
26 28 days - collagen implant 1 19
At 28 days the presence of the implant
material (M) still retards healing and the
pattern of ossification retains a more
disorganised pattern, x 144.
27 35 days - collagen implant 120
Low and higher power views (a) and (b) show
woven bone (B) still forming along within
fibrous granulation tissue (G). N.B.
Implant material is now no longer evident.
(a) H & E x 40: (b) H & E x 144.
28 35 days - control 121
Bony replacement of surgical defect.
H & E x 96.
X
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29 35 days - collagen implant 122
(a) and (b) confirm more disorganised and
localised (b) areas of ossification compared
with the more advanced and regular patterns
seen on the control side.
(a) x 40: (b) x 144.
30 35 days - control 123
In centre of original defect there is now an
organised and more regular pattern of
ossification with total replacement of the
surgical defect. x 144.
31 84 days - collagen implant 124
At 84 days a comparable bony trabecular
pattern to that seen in Fig. 16 (35 days)
on the control side is now evident.
(a) H & E x 60: (b) H & E x 144.
32 Flat bottomed polystyrene microtitration 127
plate showing colour change from colourless
to yellow (positive result) from which
absorbance is measured by Titertek Multiskan.
33 Antibody Response to Collagen Implant
(a) Reference sera 128
A set of values of optical densities
(O.D.) recorded for serial dilutions
of the combined reference sera using a
semi-log scale, is shown. Readings for
O.D. at dilutions of 1/27 and 1/81 are
marked.
The O.D. for these dilutions is given
an arbitrary value of 100 ELISA units.
(b) Antibody response 128
Each sample of rabbit serum, removed at
weekly intervals, is serially diluted.
O.D. readings for each sample at
dilutions of 1/27 and 1/81 are
recorded. With reference to the O.D.
of the combined reference sera above,
given a value of 100 units at these
dilutions a value is recorded for each
serum sample.
These values are plotted against time




34 5 days: No radiological changes, cut 131
margins still clear, defects still
radiolucent.
35 7 days: No radiological changes. 131
36 10 days: Cut margins now becoming less 131
distinct, especially the control (L) side,
with reduction in radiolucent area.
37 2 weeks: Control (L) side shows 132
opacification of the defect. The implanted
(R) side appears more radiolucent and the
margins are still quite distinct.
38 3 weeks: On the control (L) side there 132
appears to be calcification in the defect
with the lower border of the mandible almost
reconstituted. The (R) side shows increased
opacification, the cut margins being rounded
off but the defect is still obvious
radiographically.
39 4 weeks: Control (L) side shows new bone 132
deposited around the apices of the cut
teeth. The lower border of the mandible is
in continuity. The implanted side (R) shows
increased opacification with bone
regeneration but the defect is still visible
and the lower border of the mandible not yet
restored.
40 5 weeks: Control (L) side shows bony 133
regeneration at the apices of the cut teeth
but in this animal the lower border is not
yet reconstituted. On the implanted (R)
side, there is also bony regeneration in
the defect and the lower border of the
mandible is being reconstituted.
41 6 weeks: The control (L) side shows 133
recontour of the mandibular defect with good
bony deposition. Some "notching" in the
lower border is noted. The implanted (R)
side shows bone deposited around the cut
apices but the defect is still obvious and
the lower border is not reconstituted.
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42 12 weeks: Both sides show the defects have 133
now been filled with bone and the lower
borders reconstituted. The bone on the
control side (L) would appear to be denser
than the (R). There is "notching" in the
lower border on both sides but this is more
pronounced on the implanted (R) side.
43 Pig mandible to show density of defects with 137
and without collagen paste.
A Cavity full thickness of mandible +
collagen.
B Cavity full thickness of mandible.
C Cavity half mandibular thickness +
collagen.
D Cavity half mandibular thickness.
44 Healing of non-implanted cystic lesion of 138
the maxilla:
(a) Original well-circumscribed cystic
lesion.
(b) Six months post-cyst enucleation
showing radiating trabeculae of new
bone radiating in from periphery of
original area towards central zone.
Note also loss of well-circumscribed
margin.
(c) Original area now almost completely
replaced by radiating bone of repair.
45 Healing of cystic/granulomatous lesion of 138
the mandible with implant:
(a) Shows extent of original lesion.
(b) Three months post-operatively
demonstrating a peripheral radio-opaque
area with a more lucent central area and
margin of lesions still demonstrable.
(c) Six months post-operatively shows that
the peripheral zone is replaced by
radiating trabeculae of bone, the
original margin has become lost and a
small lucent area remains centrally.
Small fragments of amalgam used as an
apical seal are seen.




Radiographs to demonstrate classification of
lesion by size and show the healing process:
46 (a) S (small)'area <1 cm in diameter. 139
(b & c) Gradual replacement of the area with
trabeculated bone over one year.
Note small radiolucent area in C
adjacent to amalgam seal at root
apex. Probably this area remains as
a fibrous seal and does not calcify.
(Control group)
47 (a) M (medium) area 1-2 cm in diameter. 139
(b & c) Again demonstrate bony repair and
(c) shows again a small lucent area
at root apex two years after
surgery. (Control group)
48 (a) L (large) lesion 2 cm + in diameter. 139
(b) At one year shows radiating trabeculae
of new bone filling more than half the
original defect but a central lucent
area still remains. (Control group)
Radiographs show cases where clinically
healing has taken place, but radio-
graphically the area has not been fully
replaced by bone:
49 (a) Maxillary cyst removed from an area 140
where supporting bone has been lost
through the whole depth of the maxilla.
Bony repair has taken place,
(b) but a well demarcated area at apex of
root shows as a radiolucency. This
area where there has been loss of the
whole depth of the maxillary bone is
healed probably by fibrous tissue alone.
(Collagen implant group)
50 (a) Shows apical cystic granulomatous 140
lesion.
(b) Shows healed lesion with residual
radiolucent area around apices of




51 (a) Shows early peripheral radiopaque zone 140
progressing from original margin
(arrowed) three months post-surgery.
(b) At two years the original defect has
become replaced by bone but a small
lucent area related to the tooth apex is
noted. (Collagen implant group)
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ABSTRACT
The use of autografts and allografts to replace areas of bone
loss has found limited success. An ideal replacement for large
areas of bone loss is a vascularised bone graft; this may prove
impractical. An ideal allograft material has not been found; all
materials investigated so far have shown many disadvantages.
Non-biological materials may, at best, become encapsulated;
inorganic and organic biological preparations may result in poor
tissue healing, may induce an inflammatory immune response or be
eliminated. The properties of an ideal implant material are listed.
Bone consists of an organic matrix and inorganic salts as the
non-cellular elements and bone salts, in varying forms, have long
been used to act as biological space fillers. The current
literature suggests that collagen, which forms the major protein
mass in the bone, as a matrix of heterologous origin, is both
biocompatible and biodegradable and may also possess calcification
or ossification properties. It may also act as a biological space
maintainer and allow induction of and replacement of the area with
host bone. Opinion is divided with regard to the role of collagen
in this context.
A collagen preparation, specially formulated as a bone
dressing and found clinically to have suitable properties has been
the subject of investigation both _in_ vivo and jin_ vitro to determine
its effect on the healing of bony cavities.
xv i i i
Biocompatibility is shown by its effect on human fibroblasts
in tissue culture. The production of antibodies has been
investigated with an enzyme-linked immunosorbant assay (ELISA) and
has shown that heterologous collagen is an immunogen and produces a
specific antibody response. Bony cavities in the mandible of an
animal model have been used to show the effect of the implanted
collagen matrix on healing. The material acts as a very effective
haemostatic agent but although the healing process is comparable
with a control area, the implant retards the process and does not
show the uniform mode of bony replacement seen in the control area.
Several reasons are suggested for the difference. Healing in the
animal model is also shown radiographically and compared with a
human implantation study when the material is placed in
pathological bony cavities in either jaw. Similarly the human
study shows that healing will take place but is retarded in the
implant group.
Reports have shown that when collagen has been placed
subdermally a small proportion of patients developed chronic
granulomas. These findings have not been verified by this study:
no untoward reactions due to the implant were shown in any part of
this investigation.
Although the implant is both biocompatible and biodegradable,
it is questionable whether collagen has any osteoinductive
properties in its own right.
It is hoped that similar methods to those used in this work





A Angstrom units 10
ATP Adenosine triphosphate
B lymphocyte Bursa equivalent lymphocyte
°C Degrees Celsius
cm Centimetre
EDTA Disodium ethylene diamine tetracetate
ELISA Enzyme Linked Immunosorbant Assay
EM Electron microscope/microscopy
FFD Fixed focal distance
Glasgow's MEM Glasgow's minimal essential medium
KC1 Potassium chloride
Kg Kilogram









M solution Molar solution
p Micron 10 ^
pi Microlitre 10 ^
NaHCO^ Sodium bicarbonate
^2^2 Sodium carbonate
Na2HP0^ I2H2O Dibasic sodium phosphate





PBS Phosphate buffered saline
PBS tween Phosphate buffered saline-Tweeh 20 mixture
(R) Right
rpm Revolutions per minute
T lymphocyte Thymus dependent lymphocyte
ZnCL2 Zinc chloride
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GLOSSARY OF TRADE MARKS
Absele Absorbable Bone Sealant
Solubilised bovine collagen 17.5%: Stabilised bovine fibrin
17.5%: Dextran 70 8%: Glycol 30%: Water to 100%.
Ethicon Limited, P.O. Box 408, Bankhead Avenue, Edinburgh.
Achromycin
Tetracycline hydrochloride.
Lederle Laboratories, Fareham Road, Gosport, Hants.
Araldite Resin
Agar Aids, 66A Cambridge Road, Stanstead, Essex.
Avitene Microfibrillar Collagen
Avicon Inc., Fort Worth, Texas, U.S.A.
Dexon Sutures
Synthetic absorbable polyglycolic acid sutures.
Davis & Geek, Fareham Road, Gosport, Hants.
Dextran 70
Pharmacia Limited, Midsummer Boulevard, Milton Keynes.
Hypaque
Sodium diatrizoate.
Sterling-Winthrop, Onslow Street, Guildford, Surrey.
Hypnorm
Fentanyl citrate with Fluanisone.




Abbott Laboratories Limited, Queenborough, Kent.
Valium
Diazepam.
Roche Products Limited, P.O. Box 8, Welwyn Garden City, Herts.
Zenoderm Corium Implant
Porcine dermal collagen
Ethicon Limited, P.O. Box 408, Bankhead Avenue, Edinburgh.
Zyderm Collagen Implant
Bovine collagen dispensed in PBS with lignocaine.
Collagen Corporation, 2455 Faber Place, Palo Alto, California, U.S.A.
1.
INTRODUCTION
When tissue has been lost, the aim of a surgeon is to restore
the structure and integrity of that tissue wherever possible. When
normal form and function cannot be restored, the body will replace
the defect with fibrous tissue and such healing will often result
in a marked loss of tissue contour. Surgeons have tried to restore
aesthetic and functional defects with autograft and allograft
materials. The use of alloplastic materials to replace lost tissue
has frequently been unrewarding for patient and surgeon alike. New
materials are met with much enthusiasm initially, only later to be
condemned, as rejection and chronic inflammation ensue, with
subsequent tissue necrosis and fibrosis indicating that such
materials lacked biocompatibility.
Heterogenous materials have been used to replace areas of bone
which have been destroyed by disease. Osteomyelitic cavities were
common in the pre-antibiotic era and as early as 1889 decalcified
bovine cortical bone chips were used to fill such cavities
(Oikarinen & Korhonen 1979). Between the 1920's and 1960's plaster
of Paris was a popular material to fill bone cavities (Nystrom
1928; Nielson 1944; Bahn 1966). This material was partially
successful being resorbed concentrically and gradually replaced
with ossifying granulation tissue.
Hydroxyapatite forms a major portion of the inorganic salts in
bone and in various forms is used to fill bony defects and augment
lost areas of bone. The material is biocompatible but not bio¬
degradable (Taheri et_ a_l 1972 ). Certain corals appear to be
similar in structure to dried bone and it was hoped that these
2.
materials alone, or in conjunction with hydroxyapatite would be
better suited for bone replacement (Holmes 1979). Limited success
has been achieved. More recently much enthusiasm has been shown in
the use of ceramic materials to replace bone and joints (Driskell
et al 1972, 1973; Davis eit_ al 1972). Long term results of these
materials is awaited.
The use of a wide variety of materials indicates an ideal
alloplastic material has yet to be found. Such materials listed
above could at best be described as "minimally reactive", in other
words if placed within a biological system they would excite a
non-specific inflammatory or foreign body reaction of a chronic
nature and probably become walled off by a thin fibrous capsule
(Herch 1980). Until recently, little attention was given to the
other non-cellular organic component of bone, its collagen matrix.
It is known that collagen in connective tissues consists of rigid
triple helical molecules that provide structural integrity by
virtue of their staggered arrangement which depends on the covalent
intermolecular and intramolecular cross linkages (Nimmi 1973). When
the cross linking is increased by aldehydes or other methods, they
are said to excite a much reduced inflammatory reaction (Defalco
1970). Collagen can now be produced in a highly purified "pure"
form and such a heterologous collagen preparation could act as both
a biocompatible and biodegradable replacement scaffold in bony
defects. When collagen cross linking is increased, the rate of
breakdown of the material is prolonged so it is conceivable that if
the material remains _in situ while the area is calcified or
gradually replaced by bone, full restoration of the normal bony
contour could be achieved.
3.
The advantage of collagen over the inorganic allografts would
be complete degradation of the implant. If collagen is to be placed
in bony cavities it must remain _in situ while the area is healing to
provide the correct bulk and contour for complete tissue
restoration.
Several collagen preparations are available commercially.
Zyderm™ is a soluble collagen preparation used to replace lost
subcutaneous tissue. It is injected as a solution and would
therefore be unsuitable for bony implantation. Avitene™ is
prepared as a collagen 'powdered fleece' in small dry particles
which easily adhere to a bleeding surface. It is used as a
haemostatic agent (Hiat £t^ 1973) but is again not physically
suitable for filling bony cavities. A soluble collagen-fibrin
combination produced as a "putty" consistency was produced by
1 ™
Ethicon Ltd. as Absele . Such a material could have physical
properties better suited to bony implantation. Part of the
preceding work for this thesis involved the use of this material
and its assessment clinically as a bony dressing for a dry socket,
a common sequel to about 4% of all teeth extracted.
Dry socket, a term that was first used in the literature in
1896 (Crawford 1896) is believed to be the result of early or
excessive fibrinolysis of the blood clot in the post-extraction
socket (Birn 1973). The clot is fragmented and lost, leaving an
area of exposed alveolar bone. Pain and delayed healing result.
Many materials have been used to seal the exposed bone and act as
an antiseptic or obtundant. Some are said to have beneficial
1 Ethicon Ltd., Bankhead Avenue, Edinburgh, Scotland.
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effects in pain relief but all may have adverse effects on healing.
The author felt a more effective treatment may be provided by a
resorbable biological matrix and as collagen has been shown to be
compatible with human tissues, it could have a positive effect on
bone healing.
A small clinical study was undertaken using Absele™ but the
material proved unsuitable on many count's. It was felt that the
fibrin content may have caused an increased inflammatory reaction
and the material itself was too soluble in oral fluids.
From the experience gained and in consultation with the
manufacturer, it was felt that in theory a combination of the
soluble collagen component of Absele™ and an insoluble collagen
material would provide a more robust material that would remain in
the wound for a longer period and thus allow granulation tissue to
grow into the area. The soluble portion should be more easily
phagocytosed and replaced by osteogenic granulation tissue, whilst
the insoluble portion would remain as a matrix to allow healing to
progress throughout the defect before it was removed. It was felt
that the presence of fibrin would not be of benefit and it was
therefore omitted.
Soluble and insoluble collagen were prepared from bovine
corium after removal of hair and epidermis. The skin was ground
with acetic acid at 4°C to prevent heat denaturation of the triple
helix. The resultant material was protease digested to remove the
telopeptides and non-collagenous proteins. The acidic salt was
filtered, centrifuged, refiltered and dialysed against a phosphate
buffer before precipitation at 37°C. Insoluble collagen was
prepared as a water insoluble, glutaraldehyde cross linked acid
5.
salt of natural collagen. Details of the method of production are
retained by the manufacturer.
Varying mixtures of these soluble and insoluble collagens were
prepared and supplied as powders or mixed in varying proportions
with isotonic saline and a small amount of a tackifying agent
(Dextran 70 ). The samples were mixed to a semi-solid consistency
which could be extruded from a large orifice syringe. The varying
compounds were packaged in sterile syringes in plastic envelopes
and sterilised by cobalt irradiation. Initially eight variants of
the formula differing in the proportions of soluble and insoluble
collagens were prepared.
Each material was assessed clinically using the following
criteria. That they should
i) have no irritant effect on the surrounding tissues,
ii) be incorporated or absorbed,
iii) act as a bone sealant to oral fluids,
iv) be stable in serum with no volume change,
v) be non-antigenic,
vi) be easy to apply, and
vii) improve healing.
Little or no irritant effects or adverse tissue reactions were
noted with any of the test materials but the more soluble materials
were easily washed away and the more insoluble the material, the
more difficult it was to handle. A narrow range of suitable
materials was obtained and with minor modification, a suitable
formula was finally devised.
The collagen paste (Fig. 1) was supplied by the manufacturer
in a standard 1 ml plastic syringe inside a sealed clear envelope,
6.
Fig- 1 Collagen implant material in sterile syringe ready for
insertion into bony cavity.
7.
the completed package being sterilised by cobalt irradiation.





The material has been patented for use in bone healing (British
Patent No. 8234504).
This material was then used in a clinical trial comparing it
with a standard material (Zinc oxide/oil of cloves) for the
treatment of a dry socket as a dressing material only. (Permission
was sought and given by the Ethical Committee for this work.)
The results were encouraging and it was felt that sufficient
material remained in the socket to create a suitable environment
for healing by secondary granulation to begin. The surrounding
tissues appeared healthy at all times. The ultimate fate of the
dressing was unclear. Concomitantly with this clinical work,
implantation of this material in the laboratory rat was begun using
a 2 mm diameter, 4 mm depth of hole in the mandible. No real
conclusions were drawn from this laboratory work as it was found
that although the areas were clearly marked with sutures, the
defect healed so quickly it proved difficult to relocate and little
information could therefore be gained.
However, the clinical study showed that the test material
appeared to fulfil most of the criteria set out for an ideal bone
dressing and healing was improved with the collagen dressed areas
compared with those dressed with the previously accepted standard
dressing (Mitchell 1986).
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The clinical work showed promise and it appeared to the author
that this collagen preparation, if proven to be biocompatible and
biodegradable, could have a positive beneficial effect on the
healing of bony defects with complete restoration of tissue
integrity and contour.
The following study was thus designed to evaluate wound healing
and the inflammatory response to this material _in_ vivo and vitro
together with the immunological response produced by its use.
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CHAPTER 1
A REVIEW OF THE LITERATURE PERTAINING TO B^NE
HEALING AND THE USE OF BIOCOMPATIBLE MATERIALS
1. HISTORICAL CONCEPTS OF BONE
The nature of bone has been the subject of debate and
controversy from earliest times. Renowned Greek philosophers
regarded the tissue as an inert scaffold. Aristotle (De generatione
animalum) regarded flesh to be produced of the purest materials and
bone constructed from the residue. Such a view of the inorganic
nature of bone was shared by Hippocrates (De carnibus) and Galen
(Opera omnia) who further believed that bone was solidified by heat
which was produced internally to bake and dry them (Enlow 1963).
In the 16th Century, Andreas Vesalius (1514-1564) demonstrated
that bone was formed initially in cartilage ( De humani corporis
fabrica libri septem 1543) and Gabriele Fallopius (1523-1562)
identified the epiphyseal plate. Both writers held views that would
not be further elucidated for several centuries.
Until the 18th Century, views on bone constituents were
varied. The anatomist Alexander Monro (1733-1817) regarded the
constituents of bone as phlegm, spirit, volatile salt, fetid oil
and black caput mortuum whose proportions varied with age. Caspar
Bartholin (1655-1738) thought bone developed from a mucous
substance which later filled with sinew, became cartilaginous and
hardened into bone. Marcello Malpighi (1628-1694) also considered
bone to be fibrous in nature, having a matrix of fibres and
filaments with an intermediate osseous juice.
During the early 18th Century, the microscope provided a more
rational approach to the structure of bone. Antoni van
Leeuwenhoek (1632-1723) wrote to the Royal Society in 1693
describing his microscopic studies of bone. Examination of pieces
of broken bone had shown a solid matrix penetrated by "tubuli" of
varying size (Hancox 1972). Early microscopists viewed both plant
and animal tissues and made direct comparisons. Tree bark was
directly compared with periosteum and their internal structures
thought to have similar roles. Clopton Havers (1650-1702) also
identified canals in bone describing them as lying in longitudinal
and transverse directions. The former he regarded as effluent
channels for the expulsion of offensive vapours and the latter were
to transmit medullary oil to other regions of the bone (Enlow 1963).
This view was contradicted by Jacob Winslow (1669-1760) and
Bernhard Albinus (1697-1770) who both clearly confirmed an elaborate
vascular supply within the canal system. John Howship (1781-1841),
surveying longitudinal bone canals, showed a loss in part of their
smooth lining; in some areas a rough and uneven appearance was seen
with comparable areas externally exhibiting a granular appearance.
This observation demonstrated bone resorption and the name "lacuna"
linked with Howship was suggested by Todd & Bowerman (1845) who
also introduced the concept of the "Haversian system" (Hancox 1972).
John Goodsir (1814-1867) described bone "corpuscles" and their
canaliculi. He noted these cells contained nuclei and by studying
young and adult bone, he showed the close relationship between the
newly formed bone matrix and osteogenic cells (Goodsir reprinted
1965). His essays published in 1845 illustrate the change from
descriptive osteology to a dynamic study of bone as a tissue.
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Observation of bone physiology had been recorded in Greek and
Roman times; the dye madder (alizarin) had been seen to stain bone.
This was rediscovered in the 16th Century but the s-ignificance not
appreciated. Later John Belchier (1706-1785) demonstrated that
hogs fed on red madder developed stained bones with no staining in
other tissues. The observation that the staining only affected
growing bone marked the beginning of bone physiology (Belchier
reprinted 1965). The nature of bone growth was further elucidated
by John Hunter (1728-1793) who realised that bone underwent a
process of resorption in parallel with osteogenesis.
The accepted principle that bone transformed directly from
cartilage by hardening was repudiated by Heinrich Muller
(1820-1864) who showed that cartilage was a provisional tissue
which was destroyed and replaced by bone with bone forming cells
originating in the marrow. The osteoclast as a cell type was
described by Charles Robin (1821-1885) in 1864 and Koelliker in
1872 established the relationship between resorption, Howship's
lacunae and osteoclasts. Edward Klein (1844-1925) in 1883 showed
that the matrix of bone yielded gelatin on boiling and it must
therefore be of a dense connective tissue type.
Woven bone was first noticed by Muller in 1860 and further
fully described by Koelliker in 1886.
Thus by the end of the 19th Century, bone was known to be a
calcified tissue with an organised structure, a cellular complement
of different cells and an organic collagenous matrix. This
improved knowledge of bone histology and physiology had therefore
established the foundations on which our present concept of bone as
an active tissue was built.
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2. CURRENT CONCEPTS OF BONE REPAIR
A knowledge of the process of bone repair is necessary to
understand the influence that an implant material may have on the
host tissue.
The following brief account is a compilation of current texts
on fracture healing and endochondrial ossification of the epiphysis
with some current theories on areas of debate.
Repair of bone is generally by secondary intention which can
be compared initially to wound healing in any wound when the lost
tissue is replaced firstly with a vascular granulation tissue.
Primary bone healing is able to take place. This is
demonstrated in the rat tibia where holes of up to 800p can be
drilled and will be found to heal by primary intention. In these
experiments no cartilage or connective tissue was formed, the
cavity was closed by a sealing callus and bony splinters resulting
from the cutting were found to be incorporated into the osseous
framework (Draenert & Draenert 1980).
Secondary bone repair can be divided into several well
recognised phases and each can be regarded as a series of "still
photographs" in sequence. Attempts have been made to construct a
continuous sequence but this obviously has limitations.
Most texts on bone healing divide the events into the
following well recognised stages:-
1. Haemorrhage, coagulation, acute inflammatory reaction and
necrosis.
2. Proliferation of an osteogenic repair tissue.
3. Formation of new bone, fibrous tissue and not uncommonly
cartilage in the damaged area.
4. Bony defect filled with a woven bone callus.
5. Remodelling of callus.
When any tissue is damaged, blood vessels are torn and blood
extravasates into the damaged area and the surrounding soft
tissues. The first event is therefore blood coagulation in the
defect. Platelets play an important role in the blood clotting;
their haemostatic action is achieved by direct contact with exposed
type III collagen fibrils in damaged blood vessels,which results in
a release of platelet factors to initiate their aggregation (Wilner
et_ al 1968). Factors released by platelet aggregation thus set off
the theoretical cascade coagulation system (MacFarlane 1967) and it
is now considered that such factors also have a direct effect on
local tissue fibroblasts to induce proliferation in the early
stages of repair (Rutherford & Ross 1976). The formed clot acts as
a foreign body which must be removed and replaced.
Classically the polymorphonuclear leukocytes invade the area
after blood coagulation. Their presence is obviously useful when a
damaged area is infected but a direct role on the healing process
is in doubt. In the neutropenic host no impairment to the healing
of a non-infected wound has been found (Simpson & Ross 1972; Dale &
Wolff 1971). This is in conflict with earlier reports of the
function of the leukocyte in tissue repair (Page & Good 1958). The
polymorph reaction becomes maximal at about 24 hours then remains
or recedes depending on wound contamination. This acute
inflammatory response is seen well beyond the area of bony damage
and penetrates deep into any necrotic zone in the bone marrow.
After 24 hours blood monocytes are seen entering the wound
reaching a peak at about 48 hours and remaining for several weeks.
They are believed to modulate into macrophages which can
phagocytose coagulum debris when haemoglobin is degraded to
haemosiderin; with the aid of local tissue giant cells they also
remove collagen fragments and bone debris.
The cell population is now seen to increase with inclusion of
lymphocytes and mast cells. The latter may keep the inflammatory
reponse in progress by the release of agents such as histamine or 5
hydroxytryptamine; the former are capable of recognising antigen
and initiating an immune response.
Within the first 24-36 hours, a new cell population and a
vascular tissue are seen to be invading the damaged area. The
cellular component has the facility to form bone, cartilage and
fibrous tissue. These mesenchymal cells would appear to be derived
from the surrounding non-injured tissue, the bone medulla and the
cellular layer of the periosteum. It was originally thought that
these cellular elements were derived from blood monocytes but wound
healing studies using parabiotic rats, one of which had previously
been irradiated, have shown that leukocytes, lymphocytes and
macrophages are derived from the circulation while fibroblast
derived tissue is from the local cell population (Ross et_ al
1970) .
The musculature around the damaged bone is seen to be
hyperaemic and heavily infiltrated with leukocytes and monocytes;
it is from this surrounding mesodermal tissue and from the
medullary cavity that the new vascular sprouts are seen to arise
and supply the proliferating periosteal cells.
The fibrinolytic system is actively breaking the fibrin clot
into degradation products and together with local tissue enzymes
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and macrophages phagocytosing any other debris. Thus the area into
which capillaries will g-ow is rendered more fluid and this will
allow migration of the capillary arcades. These capillaries are
closely supported by mesenchymal cells, probably fibroblastic in
type, which can be demonstrated using an anticollagen antibody
technique (Ross 1980).
This migrating tissue, termed osteogenic granulation tissue
consists of three components; mesenchymal cells, able to
differentiate into osteoblasts, chondroblasts or fibroblasts; other
cellular elements, lymphocytes, monocytes and histiocytes, and the
budding capillary loops which will later canalise to form
functioning arcades. The proliferating and migrating vessels are
well demonstrated with microangiographic techniques (Sevitt 1971;
Carlsson et_ al_ 1960; Albrektsson 198 1).
If the nutrient artery to the area is damaged, it has been
shown that the response in the medulla is greatly slowed when
compared with that of the periosteum (Gothman 1961).
The osteogenic granulation tissue begins as multiple isolated
foci which expand and coalesce. As the foci expand, the solid
vascular buds are seen to precede open capillaries and in these
vascularised areas, there is early evidence of osteogenesis with
deposition of calcium salts and the production of an immature bone.
Over the past 50 or so years, many theories have been put
forward to explain tissue calcification. It would appear that in
our present state of knowledge the evidence suggests that "crystal
nucleation" is the initial mechanism allowing bone to calcify. The
nucleation also seems to be dependent on cellular metabolism and
the presence of a receptive matrix. Indeed, as early as 1921,
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before the evidence of the electron microscope (E.M.) a theory of
tissue calcification based on a specific interaction between matrix
proteins and calcium ions was propounded (Freudenberg & Gyorgy
1921). The theory suggested that calcium ions could be bound to a
protein and concentrated in a protein-calcium matrix which would
then bind phosphate ions, thereby releasing calcium phosphate and
allowing reformation of the calcium-protein complex. Although
simple, this seems to have been the first molecular theory of
calcification.
The use of E.M. has greatly increased the knowledge on
calcification of tissues. It has shown that the first calcium
salts are deposited a short distance away from the cells in an
amorphous matrix between cells (Fitton-Jackson 1960). It would
appear that there is a change in the matrix around the cells which
precedes calcification. These observations on the E.M. correlate
with the histochemical findings that where calcification was
imminent the area showed metachromasia to toluidine blue. This
reaction has pointed to chondoitin sulphate as an important agent
in calcification (Sobel 1955) but against this, is that chondroitin
sulphate is also present in the ground substance of non-calcifying
hyaline cartilage.
Collagen has also been implicated as the "local agent" in
tissue calcification. In vitro studies have shown that when
O
fibrils of collagen with a 640A axial repeat pattern are
precipitated from solution, they are able to initiate the
nucleation of apatite crystals from a calcium phosphate solution
O
(Glimcher & Krane 1968). Only collagen with the 640A pattern was
able to do this. Electron diffraction studies on undecalcified
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avian bone have identified particles of hydroxyapatite localised in
a circular fashion at regular intervals along the collagen fibres
(Randall 1956; Fitton-Jackson 1960). A close relationship between
the banding pattern of collagen and the position of growing
crystals has been shown (Bachra 1970).
The role played by alkaline phosphatase in calcification is
still unclear. The enzyme appears in the intercellular matrix in
developing bones and calcifying cartilage. It is easily measured
and found to be increased in growing bones and when bone turnover
is increased. Its high position in the theory of calcification may
thus be due to the ease of demonstrating its presence.
Thus in the initial stage of calcification, the "seeding", may
be achieved solely by the collagen fibrils; as a result of
interaction with collagen and chondroitin sulphate or by the
phosphorylation of collagen or other components of ground substance.
Against collagen solely as the seeding agent is that skin and
O
tendon also contain 640A bonded collagen and these tissues do not
calcify under normal circumstances. A major source of collagen
O
type I with 640A is rat tail, and this structure also does not
calcify (Bachra & Fisher 1968). E.M. studies on calcifying
cartilage and embryonic bone have also shown mucopolysaccharide
containing vesicles in the extra-cellular matrix which are seen to
accumulate apatite but have no direct relationship with collagen
fibres (Anderson 1969). It has also been seen that a purified
protein-polysaccharide material from hyaline cartilage can inhibit
the precipitation of apatite from a super-saturated solution.
We are left therefore to decide whether tissue calcification is
an active process, an inhibited reaction or a balance between these
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depending on the local environment. Calcification does
however seem to be dependent upon A.T.P. formation which suggests
that mineralisation must in part be under cellular control (Cartier
& Lanzetta 1961). This cellular control could explain the
influence that hormones and vitamins have on mineral balance.
Whatever the true method of tissue calcification, new bone
formation may be seen as early as day 7-10. At this stage a fine
network of reticulin fibres is formed radiating from the
osteoblasts which condense to become collagen fibrils around which
calcification takes place to form osteoid tissue. Osteogenesis
extends into the medulla as a vascular spearhead and new bone is
laid down as seams on existing trabeculae, some of which may be
necrotic; or as isolated foci in the marrow cavity. Thus by two
weeks much of the damaged marrow has been invaded by granulation
tissue and new spongy bone is being formed to fill the lost marrow
space. The proliferating vessels form a prominent series of
parallel structures directed across the gap and between them tiny
vessels are seen at right angles. These vessels and cells which
accompany them cross the bony deficit restoring medullary
circulation and by selective growth also restore the nutrient
artery. All the necrotic bone in the area is resorbed by
osteoclasts and the medullary space is therefore seen to increase
in capacity (Sevitt 1981).
At times islands of hyaline cartilage are formed in the
fracture callus and they may be prolific in the periosteal callus.
This is not the usual pattern of bone healing seen in man;
ossification is nearly always in progress before cartilage is
visible as the bony callus is not formed by the systematic
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endochondral ossification of cartilage (Sevitt 1981). The amount
of cartilage seen is variable and may be formed excessively where a
large amount of callus is deposited with little or none at all
being found when only small quantities of callus are produced.
Cartilage is relatively avascular and seems to be formed
preferentially in areas which are relatively ischaemic. Its
presence may be related to a paucity of vessels in the repair
tissue for when cartilage is transplanted to an extraskeletal site
where there is an unimpaired blood supply, then early endochondral
ossification is stimulated (Urist e^_ al_ 1965). Thus cartilage may
be temporarily laid down as a remaining stimulus for later
ossification when conditions become more favourable.
There are differences between endochondral ossification seen
in repair cartilage and at an epiphyseal plate. In callus, the
sites of cartilage activity are multicentre and the ossification
process is self limiting. Cartilage cells tend to be irregularly
arranged in callus compared with the regular pattern of epiphyseal
cartilage cells. In callus also, the ossification of cartilage is
always from the periphery with vessels penetrating at a number of
points. They form short tunnels in the areas of chondrolysis with
subsequent formation of small bone nodules in these areas which
coalesce to become woven bone.
Early work on fracture healing in rats showed a predominance
of cartilage in the initial repair and it is this that led to the
initial misunderstanding of bone healing in man. In man the
periosteal callus is important in fracture healing in its action as
the strut for bone stabilisation.
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Periosteal repair arises in the inner osteogenic layer of
periosteum and cellular proliferation begins some distance away
from the damaged area. Cells from this area multiply and migrate,
laying down new bone as they do on the outer surface of the
contiguous cortex. Bridging comes from both sides of the damaged
bone and is especially prolific under tissues, such as muscle,
with a good blood supply (Gothman 1961). The advancing cellular
periosteum lifts the fibrous layer of periosteum off the cortex and
the two fronts advance to form an arch over the damaged bone which
is obviously more easily achieved if the fibrous periosteum has
remained intact. On the inner aspect of this arch a space, the
callus space, is left. This area is initially filled with clot and
debris but later infiltrated by histiocytes and the mesenchymal
cells to form cartilage and bone.
At the height of callus formation, a series of slender
arteries arranged in parallel to each other and passing
perpendicular or oblique to the long axis of the bone, encroaches
the callus space. They branch within the callus and later
communicate with vessels in the cortex and in the medullary cavity.
When good union occurs, they are seen to regress and disappear
during the remodelling process. The initial woven bone formed does
not seem to have a regular structure but rapid rearrangement of
this new bone begins as soon as it is formed. Certain portions of
the first trabeculae formed are resorbed by osteoclasts, while
others are strengthened by osteoblasts. This action depends on the
stress to which the callus is subjected. By a process of adaptation
the bulky original osseous superstructure is gradually resorbed as
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a firm attachment between old and new bone becomes established.
This superstructure lost during the stage of remodelling, may, in
man, take several months or years to be removed.
This outline of bone repair will be used to view and explain
the effects of the collagen implant on the stages of healing.
3. THE USE OF BIOCOMPATIBLE MATERIALS TO REPLACE AREAS OF BONE
The use of implants in maxillofacial surgery has a long
history and a wide range of materials have been evaluated. Any
material used to replace bone should be stable in the presence of
body fluids and produce no cytotoxic effects on neighbouring
tissue. Also it is advantageous that as well as being
biocompatible, the material should be biodegradable and therefore
entirely replaced by the host tissue.
Bone as a tissue shows a remarkable potential for repair in the
laboratory animal and in the young subject. For example, if ribs
are removed for grafting and the periosteum is left _in situ, new
bone may be deposited at the donor site and the rib restored. Bone
will heal after destruction by disease, surgery or trauma and be
repaired whenever conditions are favourable, but there are limits
to its healing potential. The time taken for healing may also vary.
If there is a gap left between bone ends then, under favourable
conditions, there will eventually be sound union, but the time for
repair may be somewhat increased. The poor repair of enucleated
cyst cavities in the maxilla illustrates the poor potential of this
bone for complete osseous regeneration in man (Maclntyre &
Speculand 1983). A similar situation is found with large cavities
in the mandible of the dog, in that the healing in these areas
ceases with the formation of fibrous tissue (Hjorting-Hanson &
Andreason 1971).
In maxillofacial practice there are therefore situations where
the use of an implant to replace lost bony tissue is advantageous.
Such implants could be used to replace areas of excised bone in the
treatment of malignant disease; to increase osteogenic activity in
uniting fractures: to encourage bony union in osteotomies: to
restore bony contour often as onlay grafts and to fill bony
cavities after excision of pathological tissue.
When large areas of bone are lost, the most advantageous
method of replacement is with a vascularised bone graft, to restore
contour, consistency and function. If a good vascular pedicle is
provided these grafts survive well (Snyder al_ 1970; Taylor £t_ al_
1975). More recently, mandibular reconstruction using free
osteocutaneous flaps have been successful and these can be taken
from more distant sites (MacLeod & Robinson 1982). Success depends
on a viable vascular pedicle and a functional microvascular
anastomosis. If the blood supply is poor these grafts can
alternatively survive as fresh non-vital autogenous bone grafts
still with good osteo-inductive potential. Thus vascularised and
free bone grafts obviously have a major role in mandibular
reconstruction after resections, but when small areas of bone loss
are to be restored, they are impractical.
To induce osteogenesis in areas of poor bony healing, non-
vascularised bone has been used in the form of autografts,
homografts and heterologous grafts together with a variety of "bone
substitute" implants such as metallic prostheses, ceramics and
polymers. The following short account is an evaluation of some of
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these materials which are used in clinical and experimental fields.
Autologous non-vital bone grafts usually from the iliac crest
or rib areas are used extensively in maxillofacial surgery.
Results are varied. In a recent report quoting 72 cases (Kruger &
Krumholz 1984), 10 patients treated with a primary rib graft and 62
with a secondary rib or iliac crest graft, 20% of the primary
grafts were lost compared with 3.2% of the secondary grafts. The
incidence of pseudarthrosis was 30% in the primary group and 15% in
the secondary. An obvious disadvantage of autogenous grafting is
that a second procedure is required to harvest the bone. Although
autografts clinically seem to do well when transplanted, the
osteocytes do not survive (Ham 1952). Cells of the periosteum and
undifferentiated marrow cells may survive, and repopulation is
derived from these cells and from the marrow adjacent to the
implant site (Nade 1977). Where strength is required a strut of
cortical bone is advantageous, cancellous bone however does show
more rapid bone replacement as revascularisation of the more dense
bone is slower.
It would be simpler to replace lost bone with similar bone
that was not harvested from the patient. Both homograft and
heterograft bone replacements have been widely used. A stored
supply of human bone from a bone bank has been used in spinal
fusion (Cloward 1980). The results indicate that the percentage
"take" of this gas sterilised cadaver bone equals that achieved
with autogenous grafts.
Homografts and heterografts will trigger an immune response
(Langer ejj_ a_l 1975; Muscolo £t^ al^ 1976). To preserve bone grafts
and to reduce their antigenicity, bone has been treated chemically
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(Urist et_ al_ 1975; Goncalves & Merzel 1976) by freeze-drying
(Burwell 1976), by decalcification and demineralisation (Narang £t_
al 1971, 1972), and by lyophilisation. Cellular elements are
destroyed, in particular the highly antigenic cell membranes, but
other proteinous materials still remain which may be antigenic.
Several investigators including Burwell £t_ a_l (1963) claimed that
freeze-drying bone grafts results in loss of immunogenicity, but
fresh, deep frozen or lyophilised allogenic cortical and cancellous
bone is still antigenically active in experimental animals as
reported by several investigators (Langer £t_ a\_ 1975; Muscolo £t_ al
1976; Nisbet 1977).
'
All allogenic grafts are largely composed of an acellular
inorganic matrix which has to undergo resorption and replacement by
host bone. In comparison with an autologous bone graft, homograft
and heterografts show a vascular penetration which is six times
less and large areas of the allografts are totally excluded from
the circulation and may act as sequestrae (Stringa 1957). The
success of such grafts is totally dependent on the vascularity of
the recipient site (Marciani et_ al 1977). In the rat model, bone
heterografts behave as active foreign bodies often with total loss
(Goncalves & Merzel 1976). When allograft bone is used, results
with such grafts are variable but said to be improved if an
autologous marrow graft is used in addition, the latter providing
the lost cellular elements, the former the mechanical support (Nade
1977). Decalcified and demineralised bone grafts have been used
since 1898 (Oikarinen & Korhonen 1979) initially to fill bony
cavities resulting from osteomyelitis. Defatted calf kiel bone has
been extensively used in Europe; it is claimed to be osteoinductive
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and have no immunological complications (Taheri & Gueramy 1972).
The vascularisation of preserved bone allografts is said to be
slower than with autogenous bone grafts because of the density of
demineralised cortical bone and the graft versus host response
(Oikarinen & Korhonen 1979). The osteoinductive potential of
decalcified allogenic bone is said to be due to the uncovering of
calcification initiator non-collagenous protein (C.I.P.) which is
usually combined with bone morphogenic protein in tandem to bone
collagen. The release of C.I.P. is considered to initiate
calcification. Therefore the effects on osteogenesis of any form
of preserved bone are variable but improved results for mandibular
reconstruction are claimed with allogenic freeze-dried rib graft in
combination with autogenic marrow. Good revascularisation and
resorption with replacement was seen in 53 out of 56 patients in a
recent study (Kline & Rimmer 1983).
Within the last decade or so, more interest has been shown in
corals and ceramics which are said to have an osteoinductive
potential themselves.
Porites coral, a reef building coral, has a morphology not
dissimilar to dried bone, so the concept of supplying a non-vital
matrix from such a source seemed attractive (Holmes 1979). The
early results would suggest that the material is biocompatible and
Holmes reports that 29% of his mandibular implants were replaced by
lamellar bone after one year. An obvious advantage of corals is
that their strength is retained throughout the healing process.
Souyris et^ al_ ( 1985) report their implantation study of madreporaria
corals into the cranium and facial bones of animals. True
ossification is said to be seen with the wide porous varieties and
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with the others good tolerance and stability was reported. They
now report a three year study which is favourable for the use of
corals to stabilise osteotomies, for bone apposition and to treat
periodontal lesions. It is too early as yet to comment critically
on this work but as the skeleton of the corals consists of a high
proportion of calcium carbonate which can be converted to calcium
apatite their behaviour may be similar to other ceramic implants
(Roy & Linnehan 1974).
Ceramics in the simplest form of calcium sulphate dihydrate
(plaster of Paris) were first used in 1892 and several
investigators have continued using plaster as it excited minimal
tissue reaction, became resorbed and replaced with new bone
(Peltier 1961). Plaster has not been used extensively because of
its poor mechanical strength and because its rate of resorption is
greater than that for new bone formation (Frame 1980). It has been
used mostly to fill bony cavities and is resorbed and replaced by
granulation tissue from the walls of the cavity with partial, or,
in younger patients, total recalcification (Nielson 1944). By
modifying the material with a coating of cyanoacrylate, the rate of
resorption has been prolonged and, it is claimed, without
impairment to bony healing. However the implants failed to
completely bridge circular defects in the rabbit skull (Frame 1980).
Tricalcium phosphate reacts with water to yield a substance
crystallographically identical to hydroxyapatite (de Groot 1980).
There is therefore a close relationship between these inorganic
compounds and bone salts, such that theoretically both should be
biocompatible. The vascularity and ingrowth of new bone is
determined by the pore size of the ceramic (de Groot 1980) and
ceramic particles are phagocytosed by host cells. Bhaskar £t_ aj^
(1971) implanted tricalcium phosphate ceramic into the rat tibia
and showed profuse ingrowth of connective tissue into the periphery
of the ceramic. These results were verified in dogs (Levin e_t_ al_
1974) by filling periodontal pockets with the ceramic and observing
the material being removed by multinucleate giant cells and later
replaced by bone. Similar findings were reported by Mors &
Kaminski (1975) when clefts were treated in the dog palate.
Radiologically the graft resorbed and later histology showed
implant replacement by bone.
Hydroxyapatite synthetic implants have been shown to be
biocompatible and if the pore size of the ceramic is suitable to
allow the implanted area to be oxygenated, then new bone has been
seen to grow up to and just into the periphery of the material
(Nery e_t_ a_l 1975). However when implanted into the rat tibia, new
bone is seen adjacent to the implant and there is no implant
degradation at six months post-implantation (Denissen et_ al_ 1980).
Unlike tricalcium phosphate which is a brittle ceramic, apatite
ceramics are able to withstand high compressive forces.
Improvement in the properties of the ceramic materials is
claimed with resorbable polyphasic calcium aluminate ceramics.
When implanted in rhesus monkeys the material was impregnated and
replaced with mineralised tissue (Graves 1972). By altering the
manufacturing process of the ceramic, a wide range for times of
degradation can be achieved without loss of the strength of the
material. The performance of the ceramics has been compared by
Uchida et al (1984) and Nade et al (1983). In the former paper,
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implants were placed in skull defects in rats and rabbits. All the
materials used were biocompatible and tissue ingrowth was found in
pores of all implants but the depth of penetration was less for the
aluminate ceramics than the apatite or tricalcium phosphate. No
bone growth was found inside any of the ceramics. In the latter
paper, marrow was placed with the ceramics in an inter-muscular
site in the rabbit and newly formed bone was found to be strongly
adherent to all the ceramics. Although all these materials are
biocompatible, they do not appear to be biodegradable, at least in
the short term.
Metallic implants for reconstruction of segments of the
mandible have also met with varying degrees of success. The metals
most commonly used are titanium, stainless steel and cobalt chrome
alloys. Replacement of lost mandibular segments, including the
condyle, with preformed titanium bars including a replacement for
the condyle has been advocated by Bowerman & Conroy (1969). In
what was entitled a preliminary report, they advocate the
immediate replacement of any resected segment with the prosthesis.
Their report is enthusiastic but only quotes two clinical cases
with a follow-up time of only a few months.
It is considered that titanium and titanium covered implants
are biocompatible with bone and Albrektson et_ al (1981) suggests
the possibility of a direct bone to implant interphase contact. At
electron microscopy, it was shown that titanium was bordered by a
20 mm thick layer of proteoglycans characteristic of ground
substance. This separated bone from the implant surface; cells at
the interphase were observed to be likewise separated while
hydroxyapatite crystals were observed to be within this ground
substance layer (Linder £t^ a^ 1983). This close apposition results
in a sound mechanical lock when perforated titanium screws are used
to hold a metallic reconstruction plate or prosthesis to bridge
defects in the mandible (Raveh ej^ al_ 1984). There is such good
apposition in the cases quoted, that to remove the metallic support
when the gap had been bridged, the heads of the screws required to
be fractured off. Although the perforated hollow screws were left,
the authors suggested that all plates and screws should be removed
after bony union.
Stainless steel mesh trays have been used to support
cancellous bone grafts for mandibular reconstruction (Salyer £t_ a_l
1977). Three failures only were quoted in the 52 cases reported.
Apparently none of the successful tray implants required to be
removed. Terz e_t_ al_ (1978), using a stainless mesh prosthesis in a
series of 102 patients, suggests the failure rate may be as high as
50% especially in areas previously treated with radiotherapy.
Most prostheses seem to be lost due to subsequent exposure of the
plates. There are long term follow-up reports of patients with
metallic prostheses and Markowitz e_t_ a_l ( 1979) quotes a very
successful 10 year result of a hemimandibulectomy patient with a
prosthesis which included a temporomandibular joint section. The
tissues around the metal implant in this case were not subjected
previously to radiotherapy and the mandible was excised because of
fibrous dysplasia. This result is probably not directly comparable
to mandibulectomy for tumour, particularly if the area had
previously been irradiated.
Metallic implants in the mandible therefore can provide
stability and also continuity. If the prosthesis is in the form of
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a perforated or mesh tray containing autologous cancellous bone or
marrow grafts, it will also provide a support to increase graft
persistence and allow new bone to be deposited in it.
The filling of bony cavities and improvement of bony contour
has been treated over the last three decades or so by a variety of
other foreign implant materials which it was hoped would be
biocompatible and biodegradable.
Polymers have had a varied career. The early polyurethane
polymers of the 1950s proved disastrous due to their cytotoxic
effects (Redler 1962). Improved results were claimed for deeply
buried polyethylene implants used as bone onlay grafts. It was
claimed they were non-reactive and elicited no foreign body
reaction (Rubin e_t_ al^ 1971) and finally that a fibrous capsule was
formed around the material. The author's own experience with
Silastic, a silicone polymer, is that if buried deeply, a
membranous fibrous isolation barrier is formed around the material.
If placed more superficially when it is used, for example as a
replacement for the lost orbital floor in a blow-out fracture, most
eventually become extruded. Recently interest has been shown in
polyglycolate and polylactate polymers. Both are biodegradable and
work has been started implanting these materials in varying
proportions into bone (Miller et_ al_ 1977). Although lacking
strength, these materials can be reinforced with carbon fibre to
increase their durability.
There are therefore a great many materials used as a scaffold
for lost bone, from the minor losses seen with periodontal
pocketing to gross loss after malignancy surgery. None, except the
vacsularised and free autogenous bone transplants have the ideal
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properties of a bone replacement material; total biocompatibility
with complete, controlled biodegradability resulting in total
replacement by host bone. Therefore a study of biological
materials such as collagen, which is the main protein constituent
of bone, could offer another approach to finding suitable
replacement material for lost bone.
4. THE STRUCTURE OF COLLAGEN AND ITS ROLE IN BONE MORPHOLOGY
Collagen is phylogenetically a young protein present only in
multicellular animals. The number of acceptable mutations of its
amino acid composition is restricted by the physical requirements
of the secondary structure (Pikkarainen & Kolonen 1969).
Collagen is synthesised in the fibroblast in the form of a
precurser molecule procollagen. This molecule carries carboxyl and
amino terminal extensions which are later removed by separate
procollagen endopeptidases (Blobel & Doberstein 1975) to produce
the primary unit of collagen, the tropocollagen molecule.
Tropocollagen in the form of a triple helix is transported to the
cell membrane where the end chains are cleaved and the molecule
expelled (Feschler & Feschler 1978).
Tropocollagen is composed of three coiled amino acid chains.
Each individual chain has a left-handed helical conformation and
then like a three-stranded rope, the three chains are twisted
around a common axis with a right-handed coil (Ramachandran &
Kartha 1955). The three polypeptide chains each contain about 1000
amino acid residues (Cowan & McCravin 1955) wound in the triple
helix with short non-helical extensions of 5-25 amino acid residues
at both the carboxyl and amino ends of the chain.
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Collagen chains from all species examined have compos itionally
common features; at least one third of the amino acid residues are
glycine and about one fifth are proline or hydroxyproline (Rich &
Crick 1961).
Five genetically different collagen types are now recognised.
Type I, the first discovered, is found in bone, tendon and skin, it
is also the major component of rat and kangaroo tail (a major
source of research material). It contains two similar polypeptide
chains and one dissimilar and is given the formula [a 1(1)]2 062.
Type II collagen is unique to hyaline cartilage and vitreous
humour and has a chain composition [aKlI)]^.
Type III is found in skin, blood vessels and reticulin fibres,
the chain composition being [aKll)]^.
Collagen in basement membrane is termed type IV and the
collagen found in chorionic and embryonic membranes initially and
later also found in skin, synovial membranes, gingiva and tendons
is termed type V. The availability of types I and III has meant
they have been studied most.
Epstein et_ al_ (1971) have given the amino acid residue
composition of type I collagen (Table 1.1). These values for type
I collagen compare favourably with that given by Eastoe (1955) for
human bone collagen. Therefore all type I collagens seem very
similar and the quantities of proline and hydroxyproline are
essential for stabilising the helical structure. The non-helical
terminal ends of the chains, by virtue of their lack of
hydroxyproline and low glycine content, are unable to assume the
helical configuration (Rang et_ al_ 1967). The function of the
carboxy terminal extension may be to facilitate the folding of the
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collagen helix during biosynthesis (Bornstein 1974) and the primary
function of the amino terminal extension is to confer a high
stability on the triple helix (Horlein et_ al_ 1979). This area is
very resistant to heat and chemical denaturation. It is only after
the removal of 30% of the amino and carboxyl terminal sequences by
enzymatic digestion, that the tertiary structure is lost. A
further function for these extensions has been shown by Wiester. et_
al (1979) who suggest that they are specifically inhibitive to type
I collagen synthesis.
Types I and III collagens contain small amounts of
carbohydrates, glucose and galactose in the helical portions of the
molecule and they are attached to hydroxylysine residues. It has
been suggested that the carbohydrate residues may regulate the
formation of cross links or lateral aggregation of the collagen
molecules into the quarter stagger arrangements (Light & Bailey
1981). There are two physiologically important areas within the
triple helix that are concerned with inter molecular cross linking
and they are the only examples of a sequence repeat within the
a chain (Fietzek et_ al^ 1977). These regions can react with
residues on the non-triple helical extensions to form cross links
(Light & Bailey 1981). The possible locations for cross linking
are numerous but highly specific and the cross linking enzyme lysyl
oxidase only acts at specific lysine residues (Light & Bailey 1981).
There is much discussion about how the tropocollagen molecules
are organised into the long striated fibrils seen on electron
microscopy (E.M.) By X-ray diffraction, a periodicity for dry
O
fibres of 640A is demonstrated which corresponds with the
periodicity reported by E.M. using solubilised collagen. This
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TABLE 1.1
Amino acid composition per 1000 residues in
type I collagen (Epstein et^ al 1971) and
human bone collagen (Eastoe 1955)
Amino Type I Collagen Human Bone
Acid a 1 chain a 2 chain Collagen
Glycine 352 350 319

































banding pattern is characteristic even though the macromolecular
structure of the tissue may vary, i.e. the collagen lattice becomes
calcified in bone, which differs from type I collagen in skin.
Bone is a complex biological tissue composed of cells and
intercellular substance. The intercellular matrix is composed of
collagenous, elastic and reticulin fibres and a ground substance
whose main components are glycosaminoglycans, protein poly¬
saccharides, non-collagenous proteins and lipid either existing
alone or in juxtaposition to each other. Ground substance is
difficult to preserve during storage and sample preparation
procedures (Frasca e_t_ al_ 1981). Chondroitin sulphate and sulphated
protein polysaccharide are among the biochemical compounds that
comprise it and it appears as a smooth amorphous material on E.M.
scanning.
Collagen fibrils in bone are highly elongated and approximately
O O
circular in cross section, their diameter ranging from 80A to 4000A
(Parry & Craig 1978). The fibres are composed of fibrils and
bundles of fibres are visible by light microscopy. The fibre
bundles are seen to branch out and interconnect with other bundles
(Boyde 1972) and the smaller connecting fibre bundles may branch
either perpendicularly or obliquely from the main fibres (Frasca et_
a_l_ 1981).
As collagen matures, the proportion of cross links decreases
in most connective tissues to less than 10% of that found in the
young animal. As they age, the fibres become increasingly less
soluble and less susceptible to proteolytic enzyme action, thus
becoming stiff with a decreased tensile strength (Vogel 1976).
This is also seen when prepared collagen is artifically cross-
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linked with more than an optimum number of linkages, when it also
becomes very brittle.
In adult bone 70-80% of the mineral is located within the
intermolecular spaces between fibrils and it is postulated that
bone collagen acts as an _in vivo catalyst for mineral deposition
(Katz & Li 1973) during growth, repair and remodelling. Many of
the properties attributed to collagen could therefore support its
uses as a scaffold to aid bony repair.
5. COLLAGEN AS A BIOMATERIAL FOR CLINICAL USE
Collagen, as a major constitutent of structures rich in dense
connective tissue, such as dura mater, deep fascia or intestine
(catgut), has been used as a natural product in various applications
in surgery for almost a century (Chvapil 1977). For clinical use,
collagen as a biomaterial is dependent upon its capacity for
modification. To increase its tensile strength it must be made less
soluble and this can be achieved by increasing the number of cross
linkages in the molecules. When dispersed in acid solution, the
original cross linkages in natural collagen are broken and when used
in a reconstituted form,replacing and increasing the cross links
restores the unique properties of the original fibres. This is the
art of "tanning" (used in leather manufacture for more than a
century) and cross linking is achieved with chromium sulphate or
aldehydes such as glutaraldehyde, used under conditions of
controlled temperature and pH. Thus the extent of tanning will
control the rate of collagen resorption.
The material must be sterilised in such a way that its
properties are not altered. Moist heat (autoclaving) will denature
collagen but gas sterilisation with ethylene oxide and Y irradiation
from a cobalt 60 source will sterilise collagen for medical use
with pnly slight denaturation (Chvapil et_ al_ 1973).
The rate of resorption of collagen will also depend upon the
site of implantation and the local blood supply. There is a
difference of opinion concerning the ultimate fate of implanted
collagen or catgut sutures. Salthouse et_ al_ (1969) showed that
there was a macrophage infiltration around catgut sutures. When
used as a vascular prosthesis (Krajicek e^ al_ 1967) or as a
collagen sponge (Chvapil 1977) it was suggested originally that the
entire graft was gradually replaced by host tissue. Other workers
including Potenza (1962 & 1964) have found that some implanted
collagen is preserved and recellularised.
Current theory would suggest that collagenase is the agent
responsible for the degradation of collagen and in recent years a
number of mammalian collagenases have been detected in a variety of
tissues (Harris e_t_ al_ 1969; Harris & McCroskery 1974: McCroskery £t_
al 1975; Weeks 1976; Erlich et_ al_ 1977). The enzyme appears to be
produced by a number of cell types (Lazarus £t_ al^ 1968; Pelletier
et al 1977; Turto-Lindy et al 1977). Collagenases examined so far
appear to cleave the triple helical structure at or near the same
locus, some three quarters of the way from the amino terminus of the
a chain (Davison & Brennan 1982).
Mouse and rabbit fibroblasts and macrophages from many
sources have been cultured independently and together; the cultured
macrophages varied greatly in their potential for collagen
degeneration. The fibroblasts showed a far greater potential for
collagen digestion than the macrophages alone. In combination the
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macrophages secreted a factor, a monokine that activated collagen
destruction by the fibroblasts. The latter are therefore thought
to be the major effector cell active in connective tissue
degradation occurring in chronic inflammation (Laub e_t_ £l 1982).
Collagenase is secreted from the fibroblast as a combination of two
zymogen granules which combine to become the active enzyme (Welgus
et al 1980). Mineralised collagen can only be fragmented by
collagenase when the inorganic phase has been removed (Krane 1982).
Suppression of collagenase activity is considered to be
effected by the production of inhibitors by the fibroblast (Krane
1982). Other factors which control collagenase activity are the
primary structure of the collagen molecule, type II showing a
slower rate of degradation than types I and III. Cross linking of
the molecules also greatly influences the extent and the rate at
which collagen is denatured (Chavpil 1977; Krane 1982).
Collagen has been produced in various physical forms
for surgical application - a solution, gels, films, membranes,
sponges and tubing. In an extremely pure form, collagen is used as
a plasma expander or to replace vitreous humour. Collagen in the
form of a powdered fleece is considered an efficient haemostatic
agent (Avitene™). In the form of films, membranes and tapes it has
been shown to have a supporting role and it is used as a temporary
wound dressing (Zenoderm™). In the form of fibres, collagen is
still widely used as a resorbable suture material. Until the 1960's
there was little information on collagen applicable to bone surgery
as osseous replacement was mainly with the inorganic materials
previously described.
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Colago £t_ al_ ( 1965) implanted a collagen powder extracted from
the deep flexor tendons of cattle into the rat tibia and dog rib.
He reported complete absorption of the collagen implant within 14
days and showed no difference in the rate of healing of collagen
treated compared to control sites. There was however a
significantly higher incidence of complications seen in the treated
groups. It was concluded that collagen exerted little or no
beneficial effect on the healing of bony wounds but the implant was
very soluble and probably easily removed. The method of
preparation did not include reconstitution of cross links, thus the
material would be expected to be resorbed rapidly.
A report by Shoshan & Finkelstein ( 1970) concerning the effect
of collagen on wound healing was more encouraging. They implanted
collagen into the guinea pig lumbar muscle and claimed that in the
early phase of wound healing, swelling, haemorrhage and
inflammation were reduced and that mature fibrocytes were present
within the labelled collagen implant by the sixth day. At 21 days,
both the implanted and control sites were completely healed. The
material used was a poorly cross linked homograft and no indication
was given about the numbers of animals used in the work.
However, this view of a positive effect on wound healing was
supported by Cucin et_ al_ (1972). They used a poorly cross linked
lyophilised collagen preparation and implanted the material into
resected rib sites in the rabbit. The periosteum was carefully
retained and replaced during the operation. Radiographically they
showed a more dense abundant callus at the implantation sites
compared with the controls. Histologically a decrease of 30%-40%
of the implanted collagen mass was noted at seven days but the
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implants became revascularised and were shown to be included in the
granulation tissue and callus before being replaced. This study-
concluded that no adverse reactions to the implant were seen and
the material positively aided bone reconstruction. Only 11 animals
were used in this study.
A collagen arterial graft of bovine origin was available in
the 1960's which was highly cross linked. Devore (1973) compared
this material cut into small segments with aldehyde cross linked
calf skin collagen and non-cross linked calf collagen. The
implants were placed in a resected area of the lower border of the
rabbit mandible. The highly cross linked graft was readily
accepted with little adverse reaction seen clinically or
histologically. It seemed to become united to bone then gradually
resorbed with bony invasion subsequently. The non-cross linked
calf collagen was completely degraded and replaced with fibrous
tissue by four weeks and although degradation of the aldehyde cross
linked collagen was progressing it was at a much slower rate. New
bone formation was noted throughout the collagen grafts.
This work was later extended (Devore 1977) to investigate the
rates of degradation,and subsequent replacement with host bone, by
bovine collagen cross linked to varying degrees by aldehydes
including formaldehyde and glutaraldehyde. The rabbit mandible was
again used as the site for implantation. At one and two weeks, the
implanted sites remained unchanged and no fibrous tissue was found
in the control areas. At two months, bone was seen to be
permeating the formaldehyde grafts whilst others became
encapsulated. At three months in the formaldehyde treated group,
the operated areas seemed to be replaced almost completely by bone
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whereas the highly cross linked glutaraldehyde treated implants
remained intact and some became extruded below the lower border of
the mandible. At one year, the control group had filled in the
surgical defects with notching of the lower border of the mandible,
whereas normal contour was regained in the formaldehyde group. The
glutaraldehyde treated sites still showed evidence of the graft
remaining at one year but with complete graft to bone adaptation
and no loss of graft contour. In isolated areas, new bone was
formed within this graft away from any areas of host bone. It was
assumed therefore that the collagen materials placed into the
defects initiated or aided the total replacement of lost bone and
the greater the degree of cross linking, the longer the time for
degradation.
Cochrane & Hiatt (1975) created defects in the iliac crest and
femurs of dogs and filled test sites with microcrystalline collagen
(Avitene). When compared with untreated sites the implanted areas
showed variations of normal healing. Some sites filled with fibrous
tissue alone, whilst others filled with bone. There was, however,
no detectable acute foreign body reaction to the implant and no
residual material could be identified at any site after three weeks.
Whilst it was concluded that the implant had no detrimental effects
on the cellular repair of bone, there is no indication from this
work that any positive effect was seen.
Hunt & Benoit (1976) evaluated the same material (Avitene™)
in the post-extraction tooth socket in the cat. They found that it
greatly improved wound haemostasis but the acute inflammatory
reaction around the sockets was more severe and extensive when
compared with the control sites. Although not commonly found,
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foreign body giant cells were seen resorbing the collagen
fragments. Healing was delayed in the treated sockets at two weeks
but by four weeks all the implant had been removed. Healing in both
treated and untreated sockets showed new bone formation by six
weeks but in the central region of the treated sockets, the bone
was sparse. This work concluded that the effect on haemostasis was
beneficial but a denser, longer lasting reaction with a delayed
healing time was evident. A retardation of healing was also
observed by Debalso & Adrian (1976) implanting collagen in tibial
defects in guinea pigs and Moskow ej^ al_ (1976) implantating sites
in the rabbit femur.
An opposite view is held by Joos & Ochs (1980) who imply that
implanted collagen may calcify directly and quickly lead to new
bone formation. They claim that bone formation is induced by
collagen, which is seen initially as mineralisation of acellular
collagen later followed by cellular migration of osteoblasts and
fibroblasts to form bone spicules which coalesce within the
implanted area.
Krekkler et_ al^ ( 1980) support such a view with their work on
bony pockets in beagle dogs. They further claim that marginal bone
grows into the collagen fibres and thus bony regeneration is
accelerated. A human study by the same authors (Fabinger et_ a_l_
1980) placed the material into periodontal pockets. In these sites
it proved difficult to keep in place and close apposition between
bone and implant was lacking but they still claimed an increased
bone growth of 32%—7 1 % in selected bony pockets. No time scale is
given in this report and long term follow-up of patients is not
commented upon.
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Further human studies implanting collagen into cyst cavities
and bony defects in the mandible and maxilla have been performed
(Fabinger et_ al_ 1983; Zetzmann et_ al_ 1982). Both series report
highly favourable results with implanted collagen for bone
regeneration compared with control sites, results were monitored
radiographically. A late reaction, possibly to the implanted
material, of a lymphonodular foreign body reaction two years after
implantation is reported by Zetzmann et_ al_ ( 1982) as the only
complication found in the series.
Further animal work using glutaraldehyde cross linked collagen
and collagen mixed with apatite particles was reported by Hayashi
et al (1982). The resected rabbit fibula was used as the
implantation site. They showed that in the cross linked collagen
group, inactive osteogenesis was seen around the implant with no
ossification activity invading the collagen and a new bone only
being formed around the implanted material. More vigorous
osteogenesis was seen in both the control group and the collagen
with apatite implant group; repair in the latter group was reported
as being more advanced than the control and no loss of bony contour
was eventually found.
The authors concluded that ossification was inhibited in the
cross linked collagen implanted defects and did not support the
earlier findings of Cucin £t_ al_ (1972) and Devore ( 1977) that
foreign body reactions were rarely seen and that ossification was
enhanced by the collagen implants.
It would seem that opinion is divided on the merits or
otherwise of collagen as a biomaterial to assist in the healing of
bony wounds. Most authors agree that the material is biocompatible
but there are obvious differences in the degree of cross linking of
the collagens used and therefore in the behaviour of the implant.
Several species of experimental animal have also been used, there
are variations in the sites chosen for implantation and different
sources have been used to obtain the collagen implant materials.
These differences may in part account for the variance of the
results obtained. A suitable material would therefore be one which
was cross linked to allow for a prolonged resorption but not so
highly cross linked that it was physically brittle and could not be
resorbed.
6. IMMUNOLOGY OF COLLAGEN
Knowledge concerning any implanted protein is incomplete
without an account of its immunological reactivity. Much
controversy has arisen on this subject concerning collagen.
Initially the problems were thought to be due to the lack of
"purity" of the substrates used since the presence of even small
amounts of contaminants such as serum proteins have been shown to
produce antibody formation (Engel & Catchpole 1972).
In 1930 Loiseleur & Urbain first tested the ability of an acid
soluble collagen from rat tail tendon to induce antibody formation
in rabbits. Antibodies were produced and demonstrated using
complement fixation. The collagen preparation seemed poorly
purified and it was difficult to ascertain which antigen was being
demons trated.
In 1949 Waksmann & Mason, using a chemically "purified" human
and rabbit collagen free from extraneous protein and lipid,
injected it into rabbits. No complement fixing antibodies nor
precipitating antibodies could be demonstrated and it is arguable
that the crude method of purification may have affected the
antigenicity of the injected material.
Repeating the earlier work, Watson e_t_ al^ (1954) using acid
soluble rat tail tendon collagen and Schmitt et_ al_ (1964) using
calf collagen, showed a weak antigenic response in the rabbit by
complement fixation. The early work was thus conflicting but now
the picture is becoming a little clearer.
The primary structure of collagen and chains has been
elucidated (Mark 1981) and it is seen that the species variation in
the amino acid sequence of the helical portion is minimal. This
area shows a high degree of evolutionary stability and more
variability is seen in the terminal non-helical portions.
Anti-collagen antibodies have been raised in rabbits, rats,
mice, guinea pigs and chickens and a variety of routes of
immunisation used. The methods of detection used, include
complement fixation, immunofluorescence, radioimmunoassay and
immuno-precipitation. It has also been shown that the nature of
the immune response does vary between species and the
immunogenicity of a whole and a denatured collagen preparation
varies considerably (Michaeli et_ al_ 197 1). Denatured bovine type I
collagen was found to be non-immunogenic in mice but a good
response was found with the natural form (Nowack £t_ al_ 1975). A
similar bovine collagen injected into the rabbit shows no
difference in immunogenicity between the native and denatured state
(Steffan £t_ a^ 1968).
Protein molecules may be separated into antigenic determinant
areas and immunosilent regions (Sela 1969). In the collagen
molecule there seems to be two categories of antigenic determinant.
Firstly, a linear amino acid arrangement, i.e. a non-conformational
determinant and secondly, a conformational dependent determinant
which reacts only in the native molecule and not the denatured
collagen (Sela £t^ al^ 1967). Rabbits produce conformational
dependent compliment fixing antibodies to calf collagen (Schmitt et_
al 1964) but conformational independent antibodies to rat collagen
(Timpl e_t^ al_ 1972).
In 1964 Schmitt et^ al^ postulated that for collagen the major
antigenic sites were located at the terminal non-helical regions.
Steffan £t_ al^ 1968 demonstrated three different sites for rabbit
antisera to bind with bovine collagen, two were pepsin stable and
one pepsin labile, thus concluding that part of the immunological
response was in the helical and part in the non-helical region of
collagen molecule. However, pepsin cleaves only the C terminal end
of the protein (Beil e_t^ al_ 1973) and protease did not affect the
antigenic activity of collagen in mice (Nowack et_ a_l_ 1975). Further
evidence was needed to determine the specific antigenic sites as it
was also known that collagen degradation by collagenase, trypsin or
other proteases produced peptides that still retained or had a
greater antigenic potency (Kirrane & Robertson 1968).
A more successful approach towards the localisation of the
antigenic sites in collagen was shown by Michaeli e_t_ al_ ( 1969)
using cyanogen bromide peptides (CNBr) derived from individual
a chains to show antigenic determinants in non-helical segments and
non-conformational sites.
Radioimmunoassay studies on CNBr peptides (Lindsley et_ al_ 1971)
showed that the major antigenic determinant of the a chain of rat
skin collagen was at the C- terminal region but there was a late
appearance of antibodies directed also to the N terminal site of
the a chain (Timpl et_ 1972). It would also appear that each
antigenic site in the non-helical region is unique for collagen of
a given species.
Antibodies to central helical sites show a high degree of cross
species reaction (Timpl et_ al 1971). Calf collagen antigen injected
into the rabbit shows the major antigenic site is in the terminal
non-helical peptide chains but the helical portion does act as a
minor antigenic site (Michaeli ^t_ al_ 1969). If the same collagen is
injected into the rat, the major site of antibody production was
against the helical portion with the terminal sites not being
involved. These antibodies did not react with the denatured
molecule but when returned to the triple helical structure, there
was recovery of antigenic activity (Beil et_ al_ 1973).
The conclusion from the available literature is that antigenic
sites on the collagen molecule depend on the origin of the collagen
injected and the species of animal used. They may be predominantly
terminal or helical in origin. However, according to Timpl (1976),
insoluble cross linked collagen is substantially lacking in
immunogenicity. Other biological parameters may also contribute to
the successful production of antibodies. Apparently different
immune response genes govern the optimal production of antibodies
against type I collagen, type III collagen and procollagen. The
control of the immune response to collagen requires co-operation
between thymus dependent T cells and bone marrow derived B
lymphocytes. Nowack et_ al (1976) showed that response to native
calf collagen was T cell dependent in mice but Fuchs e_t_ al (1974)
demonstrated thymus independence of a collagen like synthetic
polypeptide and rat collagen in mice, but the need for both T and B
lymphocyte co-operation in the immune response to gelatin. Several
different genes may therefore be involved in the control of the
antibody response to collagen.
In vivo the cell mediated response to collagen was studied by
Grillo & Gross (1962). Implants of calf skin collagen were
injected into rabbit toepads in Freund's complete adjuvant. The
24 hour response to injected and control animals was similar.
Implanted animals showed a slight rise in reactivity at one week
which fell to its initial level at six weeks. It was felt,
however, that the collagen was impure and if prepared pure, would
not excite such a reaction.
The experiment was repeated by Adelmann et_ al_ ( 1972) who
showed that a delayed type hypersensitivity reaction was maximal at
20 days after immunisation and persisted for a further three weeks.
The skin reactions were species specific and always greatest
against the initial immunizing agent, but cross reactions were
readily obtained with other mammalian collagens except in the
guinea pig experiments. Guinea pigs given homologous or
heterologous collagen showed no cell mediated reaction at all. The
ability of the individual chains to induce cell mediated reactions
had also been shown. All individual chains were capable of
inducing cell mediated immune reactions with considerable cross
reactivity but the strongest reactions were against the initial
immunising agent indicating some degree of species and chain
specificity.
Adelmann & Kirrane (1973) using pepsin digested collagen
showed no change in strength of species specificity of the
reactions and indicated for cell mediated immunity the determinants
probably lay in the helical region of the molecule. After heat
denaturation of the helical structure, cell mediated immunity could
still be induced but-there was no subsequent reaction when the
native material was used as the challenge agent Adelmann (1972).
Thus it would appear from the evidence that conformation may be of
significance in the induction of a humoral and a cell mediated
response.
Presently the consensus of opinion is that the intact collagen
molecule is considered as a "weak" antigen but a single exposure
can be enough to obtain a measurable antibody response. This level
of response is said to remain essentially unchanged after
subsequent injections (Kirrane & Robertson 1968). The original
hypothesis for "weak" immunogenicity thought to be the homology
between collagen molecules of different species (Kirrane & Glynn
1968) has not really been substantiated (Pawlowski e_t a^l 1975).
There are therefore many unanswered questions concerning
collagen immunology. In particular, the genetic factors that govern
"major" and "minor" antigenic sites which seem to depend on the
species of collagen substrate and the recipient animal species;
also to what extent the primary, secondary, tertiary or quarternary
structure of collagen is involved in its immune response.
The immunology of collagen is therefore a debated subject. The
material used in this thesis is highly purified and any immune
response elicited by its use is assumed to be directly related to it.
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7. ADVERSE EFFECTS OF COLLAGEN IMPLANTS
Several collagen preparations are now available for commercial
use. Two such preparations, Avitene™ and Zyderm™ have been used
clinically. Avitene™ is produced as a sterile water insoluble
fleece and has been shown to be effective when used as a topical
haemostatic agent in man and experimental animals (Hiat et_ al^ 1973;
Alexander & Rabinowitz 1978; Evans et_ al^ 1979; Vistnes et^ al^ 1974
and Abbott & Austen 1974). Zyderm™ is a purified collagen
suspension kept in a solution at 0-5°C of buffered physiological
saline and a local anaesthetic. Its molecules thus remain
suspended and separated. When the temperature of the material is
brought to 37°C during its implantation in the dermis, the physical
properties change. It undergoes fibrous transformation into an
opalescent gel and then to an opaque semi-solid mass of orderly
condensed fibrous collagen with the loss of water of hydration.
This framework serves as a support for ingrowing vessels and cells
to restore dermal tissue lost in acne scarring and by age in the
majority of cases so far treated.
Bovine dermis is the source of collagen used in both
preparations which has been partially digested to cleave the main
antigenic determinants from the triple helix and produce a product
of supposed low immunogenicity.
Little has been written concerning adverse effects produced by
Avitene™ used as a topical haemostatic agent. When it was buried
in the peritoneal cavity in a report by Park £t_ al_ (1981), some
doubt was caused about its totally benign nature. The material was
used in conservative ovarian surgery as a haemostatic agent.
Avitene™ was seen to have reacted as a foreign body when the
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abdomen was reopened, an extensive granulomatous mass being found
in the implanted area. The tissues may react differently when the
material is buried in the abdomen.
There are conflicting reports concerning the disposal of
implanted collagen. Oliver et_ al ( 1982) have demonstrated that
transplanted dermal collagen is resorbed by a non-specific
digestion with tissue collagenases rather than by cellular or
humoral mediated immune responses. Using a range of homogenic,
heterogenic and xenogenic collagen implants, they have shown that
the collagen did not provoke an immune response but that unless the
material was fixed with substances such as glutaraldehyde to
protect it from collagenase digestion, then the implant would be
resorbed. This view did not support the work by Trentham et_ al^
(1978) who suggested that in the rat model, homologous,
heterologous or denatured collagens were capable of inducing both
cellular and humoral responses.
In the general population it would perhaps be expected that
some patients would be innately sensitive to injected foreign
proteins and in others repeated injections of an allergen may
produce sensitisation.
Over the first five years there have been a small number of
reports concerning reactions to injected collagen either at a test
site or an implantation area (Barr et_ al_ 1982; Brooks 1982; Swanson
et al 1983; Cucin & Barek 1983; Barr & Stegman 1984). Such
reactions were known and considered during the initial trials with
Zyderm™ from 1979 to 1981. The information from the Collagen
Corporation concerning these trials shows that over the two year
period, 9427 patients received collagen implants and 5109 were
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followed up. The majority were treated for age related dermal loss
and acne scarring. Many had repeated implants to maintain the
maximum correction achieved. All 9427 patients were given a test
intradermal dose. Two hundred and eighty four patients (3%)
developed a reaction at this site and 54 of them also complained of
more generalised symptoms such as arthralgia, myalgia, pruritus or
rash. Of the patients followed up, 1.3% (5109), developed implant
site reactions after a negative test site reaction. A localised
area of swelling, induration, erythema, urticaria or pruritus was
seen. All such reactions were seen within the first four
injections and it would appear they had become sensitised during
their treatment. The incidence of adverse reactions is thus low,
but significant.
Several further studies have served to clarify the situation
with regard to the immunogenicity of bovine collagen implants.
Kramer & Churukian ( 1984) gave their results of a retrospective
study from 1979 to 1982 of 300 patients. They found a positive skin
test in 3.5% and local and systemic reactions to implanted collagen
in 1.3%.
Cooperman & Michaeli (1984') selected patients who had reacted
to the implants in a retrospective study. They found in this
series that 31 patients had developed a test site reaction alone,
35 experienced generalised symptoms with no test site reaction and
six reported both a local and a generalised reaction. The sera of
all these patients was examined for anti-implant antibodies by a
radioimmunoassay technique.
Significant correlation was found with patients who had
developed local reactions showing elevated levels of antibody to
Zyderm™ collagen. Systemic complaints could not be correlated with
antibody titres. As well as this retrospective study the authors
had undertaken a prospective study (Cooperman & Michaeli 1984 ).
Two of 61 subjects (3%) experienced a self limiting inflammatory
response to implanted material and in only these subjects could
elevated levels of anti-implant collagen antibodies be
demonstrated. It was also shown that these antibodies did not cross-
react with human dermal collagen nor did they result in elevated
levels of circulating immune complexes. The reacting areas were
biopsied and showed a mixed inflammatory infiltrate (neutrophils,
eosinophils, lymphocytes and histiocytes) found predominantly
around vessels and foci of the implant. Fibroblasts were found
within the implant material. The clinical response reported by the
two subjects was prior to elevated antibody levels. Elevated
levels were first measured at the six month follow-up period.
If collagen is a T cell dependent antigen and the response
depends on appropriate presentation of antigen to T cells, then it
may be that localised cell mediated reactions could precede the
presence of detectable anti-implant antibodies.
From the information available so far it could be concluded
that the anti -collagen antibodies are specific for the type of
collagen implanted and probably should not cross react with human
collagen. It is still wise, in the present state of knowledge, to
exclude patients with autoimmune diseases, those with a history of
anaphylactoid reactions or pregnancy from any studies with collagen
implants. It has also been shown that, in the experimental animal,
when autoimmune disease has been attributable to collagen
antibodies, it is type II collagen that has been implicated; no
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reference has been made to an adverse immunological response to
type I (Trentham et_ al_ 1978; Cremer et_ al_ 1983).
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CHAPTER 2
THE EFFECT OF A HETEROLOGOUS COLLAGEN MATERLAL
ON BONE HEALING - THE ALMS OF THIS STUDY
The aim of the study was to investigate the effects and
subsequent replacement by host tissue of the reconstituted collagen
paste of bovine origin described in the introduction. The study
used an artificial bony defect created in the rabbit mandible to
demonstrate the effects on healing and then further considered the
effect the material had when placed in bony cavities caused by
disease in the jaws of man.
a) Wound healing and the inflammatory response
The effect the material had at a cellular level was
demonstrated In vitro by its effects on human fibroblasts grown in
tissue culture. The effects in vivo were seen by a longitudinal
histological examination of healing bony wounds created in the
rabbit mandible. Two comparable bony lesions were created, one
used as a control area, the other implanted with the collagen
paste. The early effects on bone healing as the osteogenic
granulation tissue advanced were attempted to be shown by a study
following the revascularisation of the surgical defect with a
radiopaque dye injection technique. The effect the material had
on calcification of the surgical defects was to be shown directly
using an _i_n vivo bone staining method, undecalcified sections and
ultraviolet microscopy.
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b) The immunological response
The immune response shown by the rabbit was viewed in the
longitudinal histological investigation by examination of the cell
types present during healing of the operated areas and the
degradation of the bovine collagen matrix. Co-operation between
T and B lymphocytes appears to be responsible for the humoral
response shown to implanted collagen. Antibody directed against
bovine collagen was demonstrated by an enzyme linked immunoassay
(ELISA). Changing levels of antibody were monitored by weekly
serum sampling from implanted animals.
c) Clinical applications of heterologous bovine collagen
in bony defects in man
To test the clinical safety and efficacy of heterologous
bovine collagen, a human implantation study was used. Bony
cavities caused by local disease in the maxilla and mandible were
used as the sites for investigation. The jaws are useful as
lesions of localised bone destruction up to 5 cm in diameter are
common and easily accessible. A comparison of control areas and




CLINICAL METHODS I. ANIMAL INVESTIGATION
Introduction
Draenert & Draenert (1980) have shown that in the rat tibia
bony defects up to 800p in diameter will heal by primary intention,
therefore by inference a larger area will heal only by secondary
intention. The early work for this thesis had shown how difficult
it was to follow healing by secondary intention in a defect in the
rat mandible 1 mm in diameter and 3 mm in depth. To demonstrate
healing potential, a bony lesion should therefore be of an
effective size, be easy to duplicate in each animal and able to be
identified later.
Several authors (Nathanson 1977 and Devore 1977) have used the
lower border of the rabbit mandible as an implantation site. The
lower border is of the order of 5 mm in width below the molar teeth
and at this site an area of 10 mm x 5 mm can be removed with ease
via a submandibular approach. This area is therefore constant and
comparable defects can be made in each animal. Unfortunately the
roots of the molar teeth and the inferior dental canal will be
severed when this area is removed. The available data from the
previous studies indicates that no untoward effect is seen to the
molar teeth in the mandible itself. This site was thought to be
suitable, because of easy access, to cut a bony cavity so that a




Thirty one young adult female New Zealand white rabbits
approximately six months old and weighing 2.46 Kg to 3.62 Kg
(average 3.08 Kg) were operated on. Originally 30 animals were to
be used, being divided into 10 groups of three, but one animal died
under anaesthesia and was therefore substituted to make the total
of 31 .
Each animal was allocated a unique number and each group of
three animals allocated a group number. The group number signified
the survival time. Groups 1, 2, 3 and 4 were sacrificed at three,
five, seven and 10 days respectively. Groups 5, 6, 7, 8 and 9 were
sacrificed at weekly intervals from two to six weeks and animals in
Group 10 survived for 12 weeks.
One animal from each of Groups 3 to 10 inclusive was given
tetracycline and haematoporphyrin for bone labelling between
operation and sacrifice. The remaining two animals in each of these
groups were used for routine histological examination and mandibular
radiology. One animal designated A2 from Group 5 (14 day survival)
was used to demonstrate the microcirculation by the radiopaque dye
injection technique. Two animals, A27 and A32, from Groups 9 and 10
(42 and 84 day survival) were used in the immunological study.
Serum samples were taken from A32 from weeks 0 to week 6 and from
A27 from week 7 to week 12 inclusive. Two animals were used for
the 12 week period, as repeated venepuncture at weekly intervals
for six weeks caused considerable damage to the ear veins of the
first animal. The use of both animals resulted in continued


















































The anaesthetic agents used in the experiment were:-
Hypnorm™ (Fentanyl citrate 0.315 mg/ml with Fluanisone 10
mg/ml) and Diazepam™ injection B.P. containing 5 mg Diazepam™
per ml).
The animals were firstly anaesthetised with Hypnorm™ being
given intramuscularly in a dose of 0.2 ml/Kg body weight then when
drowsy they were given Diazepam™intravenously into a vein in the
ear in a dose of 1 mg/Kg body weight. If the animal was not fully
anaesthetised and reacted during hair clipping, a further dose of
Diazepam™ of 0.5 mg/Kg was given intravenously before the operative
procedure began.
The fur was shaved under both sides of the mandible from the
trachea to the symphysis menti with electric clippers.' The animal
was turned firstly into the left lateral then right lateral
positions for operating on the respective sides of the mandible.
The freshly prepared skin was cleaned with 70% isopropyl alcohol.
An incision was made through the cleaned skin using a No. 15
Swann-Morton blade between the two halves of the mandible from the
symphysis menti distally to the trachea. As the tissues are lax,
the skin wound was advanced over the lower border of the right
mandible and the incision deepened under the body of the mandible
separating the digastric and zygomatico-auricularis muscles. The
periosteum was therefore exposed over its lower border, from anterior
to the masseter muscle and facial vessels,to below the diastema
region posterior to the incisor teeth. The periosteum was incised
1 Harvard Bio-Science, Fircroft Way, Edenbridge, Kent.
and elevated from the underlying bone with a Howarth's periosteal
elevator to expose an area of the lower border of the mandible of
about 2 cm.
An electrically operated micromotor handpiece' with isotonic
saline as a coolant and irrigation was used to drive a flat fissure
burr to cut a rectangle of bone 10 mm x 5 mm from the lower border
of the mandible across its entire width. All visible bone debris
was removed by warmed saline irrigation and suction. The block of
excised bone contained the contents of the inferior dental canal and
the apices of the adjacent molar teeth and initially the area bled
profusely. The rabbit mandible and a diagram to illustrate the
segment removed are shown in Figures 2 and 3.
The collagen paste was expressed from the sterile syringe into
the mandibular defect on the right side to completely fill the
cavity and moulded into shape with the Howarth periosteal elevator.
After haemostasis was achieved, the animal was turned and via the
same skin incision, the left mandible was exposed by advancing the
skin wound to the left side and a similar block of bone excised from
the lower border. The resultant cavity on the left side was allowed
to fill with blood clot.
The right mandible in all cases was implanted with collagen and
the left side contained blood clot. When there was haemostasis in
both operated areas, the periosteum and overlying muscles were
closed with 4/0 polyglycolic acid (Dexon™) sutures and the single
skin incision was approximated with a continuous 6/0 prolene suture.
1 Quayle Dental Company, Dominion Way, Worthing, Sussex.
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Fig- 2 Lateral view of normal adult rabbit mandible.
Fig. 3 Diagram to show site, size and shape of area of
operation on lower border of mandible.
The animals were allowed to recover in the operating area then
replaced in their cages and later fed on the standard pellet diet'
and water, supplemented by cabbage leaves,until sacrifice.
b) Microangiographic Study of the Microvascular System
in the Healing Bony Defect
The report by Shoshan & Finkelstein (1970) suggested that
collagen had a positive effect on wound healing reducing the tissue
reaction in the early phase. Cucin et_ al_ (1972) also suggested a
positive effect on wound healing by collagen. If the time taken
for proliferation of osteogenic granulation tissue can be reduced,
then a microvascular circulation should be seen earlier on the
implanted side compared with the control area. It was therefore
considered that one animal in each of Groups 1 to 6 inclusive
(survival times 3 days to 3 weeks) should be infused with a
radiopaque contrast medium to detect the time the microcirculation
could be demonstrated in the implanted and control areas.
Microangiography, introduced by Barclay (1947) involves
filling of a vascular system with a contrast medium. The medium
should have a well defined particle size, small enough to fill the
vessels to be observed, and have no tendency to aggregate. The
reagent selected for this study was Hypaque™ (Hypaque sodium
consists of 25% w/v sodium dinitrozoate B.P. The anhydrous material
contains 59.87% iodine.) It was chosen as it was known to be safe
for human use and had a suitable particle size.
1 Special Diet Services Ltd., 1 Stepfield, Witham, Essex.
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Method
The technique mainly followed that of Danckwardt-Lilliestrbm
(1969). The first animal to be used for this investigation was A2
(Group 5, 14 days survival time). At 14 days post-surgery the
animal was anaesthetised again,as previously described, with Hypnorm™
0.2 ml/Kg body weight intramuscularly then Diazepam™ 1 mg/ Kg
body weight intravenously and placed in a supine position. Both
common carotid arteries were exposed in the neck and cannulated in
the distal direction with gauge 32 intravenous cannulae. Under
slow and gentle pressure, 10,000 U of heparin' (5,000 units of
sodium heparin per ml in 8 ml N saline) was administered by way of
a two-way extension set into both common carotid arteries over a
five minute period.
A solution of Hypaque™25% (200 ml in 500 ml warm physiological
saline) in a sterile container was suspended from a drip stand and
then infused under a pressure of 200 cm of water over a 2 hour
period via an intravenous infusion set to the extension set and
into the cannulae in the common carotid arteries. Blood was
withdrawn via the jugular veins to reduce the venous congestion.
The animal survived for 10-15 minutes and the infusion was
therefore mainly carried out after death. After infusion of the
700 ml of solution, the mandible and surrounding musculature were
removed and the tissues frozen at -40°C.
After thawing, most of the soft tissue was excised carefully
not disturbing the implanted and control operation sites. The
denuded mandible was then bisected at the symphysis menti. Each
1 Leo Laboratories Ltd., Aylesbury, Bucks.
half was placed on Ultraspeed D dental occlusal film. A Phillips
Oralix' tube set at 50 kv was placed with a fixed focal distance of
18 inches from the film and the mandibles radiographed with an
exposure time of 1.04 seconds. The focal distance was then reduced
to 16 inches and subsequently by 2 inch intervals to 10 inches to
try and find a suitable distance for optimal resolution in the
operated area. The exposure time remained constant at 1.04 seconds.
c) Fluorescent Bone Labelling
Tetracycline labels are deposited as permanent markers within
bone mineral at the calcification front in the presence of active
mineralisation of new osteoid in the centres of new bone formation.
If labelled bone is decalcified, the tetracycline is lost, so
undecalcified sections must be used. This bone marker has been used
for over 30 years and has been found to be safe and effective (Frost
1969). More recently, there has been a tendency to use more than
one label to follow the continuous laying down of new mineral.
Tetracycline produces a yellow band under ultra-violet light,
. 2
haematoporphyrin is probably fixed to new bone in the same way as
tetracycline and shows red (Olerud & Lorenzi 1970).
One animal from each of Groups 3 to 10 inclusive was selected
for this study, survival times were thus from one to 12 weeks. The
animals used were Al, A4, A7, A10, A14, A18, A25 and A30. Animal
A16 was substituted for A14 after the latter developed a wasting
1 Phillips Medical Systems, Earls Gate Lodge, St. Ninian's Road,
Stirling.
2 Sigma Chemical Company Ltd., Fancy Road, Poole, Dorset.
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condition with ataxia and joint swelling after injection of
haematoporphyrin and had therefore to be sacrificed at 3 weeks, not
5 weeks, as originally intended.
Table 3.2 confirms the animals used and their survival times.
The reagents used for jui vivo bone labelling were Achromycin™
and haematoporphyrin.
Achryomycin™ consists of tetracycline hydrochloride 250 mg per
vial buffered with 625 mg of ascorbic acid. The solution was
reconstituted by the addition of 5 ml of water for injection
immediately prior to use.
Haematoporphyrin as used as the hydrochloride; the solution
was prepared as follows:- 3 g of haematoporphyrin H 1875 were
dissolved in 100 ml of 2% sodium carbonate. Solubility was
increased by adding alcohol in a concentration of 10% and warming
the solution to 40°C. The solution was then filtered to remove any
undissolved particles.
Immediately after operation, while the animals were still
anaesthetised, 50 mg/Kg body weight of Achromycin™ was administered
by intramuscular injection into the thigh. Seven days later, 10 ml
(300 mg)/Kg body weight of haematoporphyrin was administered
subcutaneously into the loose connective tissue of the neck
posteriorly, over a period of 15 minutes. One week later, a
further similar dose of Achromycin™ was given intramuscularly then
haematoporphyrin one week later. This alternate weekly labelling
was continued until seven days before sacrifice (Table 3.3).
For the long term surviving animals, A25 and A30, haemato-
porphyrin was not used because of the severe toxic effects found in
animal A24, therefore only tetracycline (Achromycin ) given at two
weekly intervals on weeks 0, 2, 4, 6, 8 and 10 was used.
After sacrifice, all the mandibles were immediately harvested
and deep frozen at -40°C. The animals used, their survival times
and their times for bone labelling are shown in Tables 3.2 and 3.3.
d) Radiological Study of Healing Bony Cavities
New bone formation is said to be seen histologically as early
as 7-10 days post injury when osteoid tissue is produced. Radio-
graphically at this stage the quantity of calcified matrix is not
sufficient to be detected by standard radiographic means. Much more
calcium must be deposited before there is a change in radiodensity
visible on radiograph. Earliest ossification will be seen
peripherally as the osteogenic granulation tissue advances into the
defect. Initially the sharply cut bone edge at the margin of the
defect will become less distinct radiographically as the early
multicentre ossification proceeds in an irregular fashion; then as
the areas coalesce, a more distinct calcification front will be
produced. Radiological assessment of the bony wounds is used to
compare the degree of calcification in the implanted and control
areas. This should be comparable with calcification seen in the
fluorescent bone study. The information from this study will serve
as a basis for the radiological assessment of the healing bony
defects in the jaws in the human implantation study.
Method
After death, mandibles from animals in Groups 2-10 inclusive
(Table 3.4) were removed as previously described, with some




Group Survival Time Animal No.
3 7 days A7
4 10 days A10
5 14 days A1
6 21 days A4, A14
7 28 days A18
8 35 days A16
9 42 days A30
10 84 days A25
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TABLE 3.3
Administration of Fluorescent Bone Labels
n a • i *t Weeks Post-operationGroup Animal No. j 234579 11
3 A7 T
4 A10 T
5 A1 T H
6 A14, A4 T H T
7 A18 T T T
8 A16 T H T T
9 A30 T T T






Group Survival Time Animal No.
2 5 days A22, A23, A24
3 7 days A8, A9
4 10 days A12, A13
5 14 days A2, A3, A 17
6 21 days A5, A6
7 28 days A19
8 35 days A15
9 42 days A3 2
10 84 days A27
7 1.
The bisected halves were each placed in turn on a Kodak Ultra-
speed D dental occlusal film. A Phillips Oralix tube was used for
the exposures which were taken with a fixed focal distance of 18"
and an exposure time of 1.04 seconds at 50 KV.
The films were developed using M & B Matalex developer' and
2
fixed with M & B fixer plus, by automatic processing in a Pantomat .
The intra-oral films were processed on a six minute cycle.
Radiological changes at the sites of operation were then
compared.
1 May & Baker, Dagenham, Essex.




a) A Longitudinal Histological Examination of the Inflammatory
Response, the Immune Response and Wound Healing by Light
Microscopy
All wounds show an acute inflammatory response followed by an
immune response; examination of the changing cell population in the
implanted area and control site will show the effect exerted by
heterologous collagen. The duration of the acute inflammatory
response is affected by the presence of foreign protein; as the
acute inflammatory cell population diminishes it is replaced by
mononuclear cells. In the immunologically mature animal contact
with antigenic material not only leads to the production of
antibodies but also to the development of a cell mediated response.
This latter response characteristically follows the injection of an
antigen into a previously sensitised individual and is seen to
develop clinically over 48-72 hours.
Mononuclear cells, lymphocytes and macrophages make up the
general cellular population in such a response and giant cells
derived from the macrophages are seen to form around any large
particles of foreign protein. When large particles are not phago-
cytosed by macrophages, the giant cells may form into a syncytial
mass around the foreign body. Delayed hypersensitivity reactions
have developed clinically after dermal injections of Zyderm™ soluble
collagen in susceptible individuals.
This histological study will show the changing cell population
and the time taken for incorporation or disposal of the collagen
implant. The relative times taken for the appearance of osteogenic
granulation tissue, formation of woven bone and the time taken for
callus to fill the bony defect will be compared for the implanted
and control areas to determine the total effect of the material
throughout healing.
Method
The animals were sacrificed at the pre-determined times shown
in Table 4.1 ranging from 3 days to 84 days. All animals were
sacrificed by barbiturate overdose using Nembutal' given
intravenously.
The mandibles and surrounding musculature were excised,
bisected at the symphysis, clearly labelled and fixed in a 4%
solution of phosphate buffered formaldehyde (10 ml of 4% formalin
[37-40% formaldehyde solution] added to 90 ml of phosphate buffer)
for not less than four days. The mandibles were then removed and
rinsed for one hour in phosphate buffer (0.2 M solution of dibasic
sodium phosphate Na2HP0^ prepared with 71.64 g and distilled
water to 1 litre. 0.2 M solution of monobasic sodium phosphate
Na2H2PO^ 21^0 prepared with 31.21 g in 1 litre of distilled water.
Phosphate buffer at pH 7.0 at 25°C prepared by mixing 61 ml 0.2 M
dibasic sodium phosphate and 39 ml monobasic sodium phosphate.).
They were then placed in a decalcifying solution of 10% formic acid
in 7% trisodium citrate (7% trisodium citrate solution prepared by




Group Survival Time Animal No.
1 3 days A20, A21
2 5 days A22, A23, A24
3 7 days <J\<00<
4 10 days A 12, A 13
5 14 days A2, A3, A 17
6 21 days A5, A6, A14
7 28 days A17, A19, A28
8 35 days A15
9 42 days A3 1 , A32
10 84 days A27, A28
dissolving 70 g in 1 litre of distilled water. 100 ml of 10% formic
acid solution were added to 900 ml trisodium citrate solution for
2 1 days.
After washing under continuous tap water, the mandibles were
dehydrated through 10%,20%, 50% and absolute alcohol, then a further
two changes of absolute alcohol. They were then cleaned with two
changes of chloroform' and finally left overnight in chloroform.
The material was then vacuum embedded in three changes of paraffin
2 2
wax at 60°C over 6-9 hours and blocked out in fresh paraplast.
The blocks were cut with Reichert disposable blades mounted on
3
a Spencer AO microtome to a thickness of 6p. Sections were
floated in 1% albumin solution mounted on glass slides and then
dried overnight. They were then deparaffinised with 2 x 5 minute
4
changes of xylene , rinsed with absolute alcohol and taken through
two baths of absolute alcohol (5 minutes) then rinsed in 50%
alcohol (5 minutes) and finally under running water for 5 minutes.
The sections were stained in Weigernt's iron haematoxylin
(haematoxylin 1 g produced in 100 ml absolute alcohol; 4 ml of 30%
aqueous solution of ferric chloride prepared in 100 ml distilled
water and 1 ml hydrochloric acid. Equal parts of both reagants were
mixed immediately before use.) for 20 minutes then in 1% acid
alcohol (1% hydrochloric acid in 96% alcohol) and blued in Scott's
tap water solution (sodium bicarbonate 3.5 g and magnesium sulphate
1 BDH Chemicals Ltd., Poole, Dorset.
2 Oxford Labs, International Co. Sherwood Medical Co., Kildare.
3 American Optical Co., Instrument Division, Buffalo 15, New York.
4 Fisons Ltd., Loughborough, Leicester.
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20 g were dissolved in 1 litre of tap water and thymol added as a
preservative), then washed under running water. They were then
placed in 1% alcoholic eosin (1 g alcoholic eosin' in 100 ml of 90%
alcohol) for 1 minute, dehydrated in two changes of absolute
alcohol, cleared in two changes of xylene and mounted under glass
with DPX mountant (BDH Chemicals). Sections were viewed with an
2
Orthoplan Widefield microscope . Selected fields were photographed
using Kodak PAN-F film.
b) Collagen Implantation: The Humoral Response
Control of the immune response to collagen requires co¬
operation between T and B lymphocytes. The only known function of
B lymphocytes is to produce antibodies. Antibody-antigen
interactions can be measured in many ways. Many tests depend on
secondary reactions that follow as a consequence of the primary
antigen-antibody interaction. These secondary reactions include
precipitation, agglutination and complement fixation reactions. All
these methods have been previously used with varied success to
demonstrate anti-collagen antibodies.
Alternatively now, radiolabelled, fluorescent on enzyme-coupled
antibodies can be used to detect specific molecules in cells or
tissues. Specific antibodies in serum to a particular antigen can
now be detected and measured by an ELISA.
1 G.T. Gurr, Romford, Essex.
2 E. Leitz (Instruments) Ltd., 48 Park Street, Luton.
Immunoglobulins against implanted bovine collagen were measured
using a two-step indirect microplate ELISA using a method similar
to that described by Voller et_ al_ (1976).
Animals A27 and A32 were used in this study. The dates of
sacrifice were 6 weeks (A32) and 12 weeks (A27). For A32 a 5 ml
aliquot of venous blood was removed by venepuncture from an ear vein
at operation. The blood was allowed to clot and then placed
overnight in a refrigerator at +4°C. The following day it was
placed in a centrifuge and spun at 2000 revs/min for 10 minutes and
the resultant serum was then removed using a suction pipette, placed
in a sterile container and then stored in a deep freeze at -40°C
until used for the ELISA. Further samples were taken by
venepuncture from A32 until the date of sacrifice at 6 weeks.
Similar 5 ml samples of blood were taken from animal A27 from week 7
post-surgery with death at week 12. All specimens of serum were
stored at -40°C until use and after thawing were kept at +4°C to
repeat the experiment.
c) The Quantitation of Specific Immunoglobulins using an
Enzyme Linked Immunosorbant Assay (ELISA)
Reagents
The coating buffer for sensitising the plates, a carbonate-
bicarbonate buffer (pH 9.6) consisted of 1.59 gm of Na^CO^, 2.93 gm
of NaHCO^ and 0.2 gm of NaN^ made up to 1 litre with distilled
water. This was stored at 4°C for no longer than two weeks. The
phosphate buffered saline-tween 20 mixture (PBS-tween) consisted of
8 gm of NaCl, 0.2 gm of KH2P04, 2.9 gm Na2HP04, 121^0, 0.2 gm KC1
and 0.5 ml of tween 20 in 1 litre of distilled water. Anti-rabbit
IgG alkaline phosphatase conjugate' lot no. 94F 8840 and substrate
p-Nitrophenyl phosphate disodium (Sigma No. 104-0) 1 mg/ml in 0.1 M
glycine buffer pH 10.4 containing 0.001 M MgCl^ and 0.001 M ZnC^
were used for convenience. Immediately before use, one 5 mg
p-nitrophenyl phosphate tablet was dissolved in 20 ml of
.2
diethanolamine buffer containing 97 ml of diethanolamine , 800 ml
of distilled water, 0.2 gm of NaN^ and 100 mg of MgC^ bl^O; 1 M
HC1 was added until the pH reached 9.8 and then distilled water was
added to a final volume of one litre.
Method
0.5 ml of collagen paste was shaken with 20 ml of carbonate
buffer at pH 9.6 in a sealed container and after thorough shaking a
cloudy suspension of collagen was produced. Wells of polystyrene
3
disposable, flat-bottomed, 96 well microtitration plates were used
on the solid phase. 50pl of the collagen suspension was dispersed
into each of the wells except for the final row. This now contained
carbonate buffer alone to act as a negative control. The plates
were sealed and stored at 4°C for 24 hours to allow collagen to
adhere to the polystyrene surface. The plates were then washed
three times with PBS-tween and tapped dry. 50pl test samples of
sera were then serially diluted from 1 to 1/960 and dispersed into
appropriate wells. A reference serum consisting of pooled sera
1 Sigma Chemical Company, St. Louis, Mo., U.S.A.
2 Fisher Scientific Company, Silver Spring, Md., U.S.A.
3 Flow Laboratories (UK) Ltd., Woodstock Hill, Harefield Road,
Rickmansworth, Herts.
from all the samples in serial dilution was used for calibration.
All samples and reference sera were diluted in PBS-tween containing
1% newborn calf serum. The plates were sealed and incubated at 4°C
for 1 hour. The plates were then washed three times with PBS-tween
and tapped dry. lOpl of goat anti-rabbit antibody alkaline
phosphatase conjugate (Sigma Chemical Company) was diluted in 5 ml
of PBS-tween containing 1% newborn calf serum and 50pl aliquots of
the material dispersed into appropriate wells. The plates were
again sealed and incubated at 4°C for 1 hour. Plates were again
washed three times with PBS-tween and tapped dry before 5-pl of
alkaline phosphatase substrate solution was added to each well.
Control wells contained neither primary antibody nor alkaline
phosphatase substrate. The plates were incubated at room
temperature; the rate of substrate degradation was indicated by the
colour change which is proportional to the antibody concentration
in the sample. The absorbance of the yellow colour produced by the
reaction of the enzyme with P-nitrophenyl phosphate was read at
405 nm using a Titertek Multiskan (Flow Laboratories). Sequential
readings were taken until optimal curves were obtained. Positive
and negative controls were run during the experimentation. The
experiment was repeated four times.
d) Preparation of Dndecalcified Sections to Demonstrate
Fluorescent Bone Labelling
Mandibles of animals given tetracycline and haematoporphyrin
bone labels were removed from the deep freeze at -40°C. Before
thawing, a section of each mandible containing the operation site
was removed by sawing and this block was placed in 4% phosphate
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buffered formaldehyde [(BDH Chemicals) (37-40% formaldehyde
solution 100 ml, water 900 ml, acid sodium phosphate monohydrate
4.0 g, anhydrous disodium phosphate 6.5 g. The solution has a pH
of 7.0.)] for 48 hours at room temperature. After washing, the
blocks were dehydrated in alcohols from 10% through 50% to absolute
alcohol over 4 hours and then into 100% acetone for 1 hour.
Impregnation of the blocks with resin was produced by placing
the block centrally in a mould base and placing Metsee' resin S.W.
without hardener under vacuum in the mould to the desired level
above the block for 6 hours. Part of the resin was removed and
replaced by resin mixed with hardener under vacuum for 30 minutes
and then the blocks were allowed to polymerise overnight at 37°C.
[Metsee mounting plastic consists of polyester resin S.W. (98.75%)
and hardener (1.25%). Full hardness is reached 10-15 hours after
mixing at 37°C.] The hardened blocks were later mounted on dowel
with the same resin. To verify comparable areas from each block
were being used, each mounted block was radiographed (Figs. 4a&b)
then accurately cut to the level of the second molar tooth before
further sections were taken for viewing. Sections approximately
250p thick were cut from the second molar area on a Pultra lathe
under continuous irrigation.
Resultant sections were initially cemented onto glass slides
with a variety of cements for grinding and polishing; none proved
suitable to hold the section. The sections were therefore finally
hand held before mounting and initially ground on fine emery cloth
then polished with Durmax alumina extra-fine polishing fluid (BDH
1 Metallurgical Services Laboratories, Surrey.
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Fig. 4 (a) Undecalcified block (to demonstrate fluorescent
bone labelling) showing bony defect and area of
second molar tooth before cutting.
(b) Similar block to Fig. 4a after cutting at the
level of the second molar tooth in the area of





Chemicals) on a polishing cloth. Many of the sections disintegrated
when ground and polished, but a small number survived and were
finally polished to between 100p and 150p thickness.
The final sections were mounted on glass slides and viewed
under a Leitz Orthoplan universal large field microscope with U.V.
excitation. The ultra-violet source was a mercury lamp HBD 200W/4
with filter D in position 2. Selected specimens were photographed
with a photomicrographic camera (Leitz) using Agfacolor
professional film XRS 100.
e) Cytotoxic Effects of Heterologous Collagen on a Culture
of Human Oral Fibroblasts
Materials which are biocompatible should not interfere with the
growth and maturation of cell populations in close proximity. To
assess the cytotoxicity of any material for human use, its effect on
a population of human cells should be elicited. The growth of a
colony of human fibroblasts can be followed and any adverse effects
can be seen at a cell or subcellular level.
The culture medium for this investigation was made up as
follows:-
Glasgow's minimal essential medium' 10%; Sodium pyruvate' 1 m
Mol/litre; L-glutamine' 200 m Mol/litre; Non-essential amino acids'
1%; Pooled human serum 10%; Sodium bicarbonate' 20 m Mol/litre;
Penicillin' lOOu/ml; Streptomycin' lOOpg/ml; Fungizone' 0.25pg/ml.
1 Flow Laboratories Ltd., Woodcock Hill Industrial Estate,
Harefield Road, Rickmansworth.
The culture medium was buffered with sodium bicarbonate and
the pH maintained by incubation in an atmosphere of 95% air and 5%
CC^. Antibiotics and antifungal agent, Fungizone, were added to
prevent infection. Pooled human serum was prepared by clotting
whole blood obtained by venepuncture at 4°C overnight then
centrifuging the blood at 2000 rpm for 10 minutes and removing the
serum supernatant. The serum was heat inactivated by placing it in
a 60°C oven for 30 minutes. Sera were sterile filtered and stored
in 5- ml aliquots at -20°C.
Method
Pieces of normal human oral mucosa obtained from healthy
subjects after the surgical extraction of teeth were sent to the
laboratory in transport medium. This medium consisted of Glasgow's
M.E.M. 10; sodium pyruvate 1 m Mol/litre; L-glutamine 200 m
Mol/litre, non-essential amino acids 1% and newborn calf serum 10%.
In the laboratory, the mucosa was cut into fragments of
3
approximately 1 mm . Eight fragments were placed in each petri
dish and were anchored in place using a sterile glass coverslip.
Tissues were bathed in the culture medium, 4 ml per dish and
incubated in 95% air 5% CO2 being left undisturbed for two days.
Outgrowths from the explants were monitored by phase contrast
microscopy. As the cultures reached confluence, they were washed
in 10 ml of phosphate buffered saline and 1 ml of trypsin solution,
(a solution of trypsin 0.05% and chicken serum 0.05%) made up in
sterile phosphate buffered saline (PBS), and disodium ethylene
diamine tetra-acetic acid (EDTA) 1 m Mol/litre was added to each
dish which was then incubated at 37°C until cells began to detach.
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The cells were gently dislodged by pipetting and medium containing
serum was added to stop further trypsinization. The cell suspension
was then centrifuged at 500rpm for 5 minutes and the supernatant
decanted. Fresh medium was used to resuspend the cells which were
plated in a 1:2 split ratio. Small pieces of collagen were placed
in the centre of a confluent layer of fibroblasts and the cells
were monitored after 24 hours and 48 hours and their condition
noted. The condition of cells adjacent to collagen was viewed by
phase contrast microscopy (Leitz) and electron microscopy' to show
the effects at cellular and subcellular level.
f) Preparation of Cultures for Electron Microscopy
Method
The growth medium was removed from the petri dishes containing
the fibroblast/collagen culture and replaced with 2.5% glutar-
aldehyde in phosphate buffer at pH 7.2. This phosphate buffer was
prepared as follows
A 0.2 M solution of dibasic sodium phosphate Na„HP0, 12H.0 was
2 4 2
prepared using 71.64 g with distilled water to 1 litre. A 0.2 M
solution of monobasic sodium phosphate Nal^PO^ 2^0 was prepared
using 31.21 g with distilled water to 1 litre. A 0.2 M phosphate
buffer at pH 7.2 at 25°C was prepared by mixing 72 ml of 0.2 M
dibasic sodium phosphate and 28 ml of 0.2 M monobasic sodium
phosphate. The cells were fixed overnight at 4°C.
1 Pye Unicam Ltd., York Street, Cambridge.
An ampoule containing solid osmium tetroxide was dropped into
a clean brown glass stoppered bottle and phosphate buffer added to
produce a 1% solution. The cells were then post-fixed in the 1%
osmium tetroxide in phosphate buffer at pH 7.2 for 1 hour. After
osmication the culture was washed in 10% ethanol and the cells
dehydrated in absolute alcohol with three changes at intervals of
30 minutes. Cells were then cleared in propylene oxide for 30
minutes.
Araldite™ mixture was prepared in the following way:-
500 ml Araldite™ resin (CY212) was thoroughly mixed with 500
ml hardener (HY 906) at room temperature. 5 ml of accelerator (DMP
30) were mixed with 20 ml dibutyl phthalate and kept at 4°C. 1 ml
of accelerator mixture was added to 19 ml of resin mixture and
mixed by continuous rotation for at least 12 hours at room
temperature.
The cultures were transferred from propylene oxide to shallow
polythene containers filled to a depth less than 1/4" of Araldite™
mixture and left at room temperature for at least 12 hours. The
polythene containers were then placed in an oven at 60°C, the
Araldite™ decanted and replaced by fresh warmed Araldite™ and
hardened by replacement in an oven at 60°C for 48 hours.
The Araldite™ blocks were mounted on dowel with sealing wax
and thin sections obtained from the blocks. The sections were
mounted on Gilder grids' without a supporting membrane.
1 Polaron Equipment Ltd., Watford.
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The sections were stained by floating the grids, section down,
on prepared lead citrate solution 0.2% in 0.1 N NaOIi' for 2 minutes,
then passing the grids held in forceps under a solution of distilled
water for 10 seconds. The grids were then immersed in 5 ml of a
saturated solution of uranyl acetate in 50% ethanol' prepared
immediately before use, for 10 minutes and finally held in forceps
moved under a 50% ethanol solution for 20 seconds. Sections were
examined using a Phillips EM30 1 (Pye Unicam Ltd.).
1 TAAB Laboratories, Emmergreen, Reading.
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CHAPTER 5
CLINICAL METHODS II. HUMAN IMPLANTATION STUDY
Introduction
A bony cavity in the mandible or the maxilla from which
pathological tissue has been removed begins healing with the
organisation of the extravasated clot. Blood clot is replaced by
osteogenic granulation tissue. Osteogenesis spreads inwards from
the periphery and in a small defect the blood clot is replaced by
bony trabeculae within a few weeks. The healing process is
completed by cells that differentiate from the endosteum or marrow
spaces with little or no part being played by periosteum
(Kramer £t_ al_ 1968). The defect fills from the periphery over a
period of many months. Incomplete bony regeneration following the
removal of a maxillary cystic area may be encountered and there are
instances when such cavities never fill with bone, only scar
tissue. In others, the retained radiolucent area does reduce in
size, but incomplete bony infilling remains for many years.
Radiographic studies have shown that most of the bony healing
will occur in the first post-operative year with little further
radiographic change seen after four years (Rud £t_ al_ 1972).
Experiments in the dog confirmed that when both the inner and outer
cortical plates are destroyed, the cavity is likely to fill only
I!
with fibrous tissue (Hjorting-Hanson & Andreason 1971).
In the maxilla, there is little cancellous bone that can
contribute to endosteal osteogenesis and the likelihood of total
osseous repair is further reduced in large cavities, especially when
both cortical plates are penetrated. Healing of bony cavities in
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the jaws, shown radiographically, will be used to show the effect
of implanting the collagen paste in man and a comparison made with
similar non-implanted areas used as controls for this.
Patient Selection
One hundred patients (41 males and 59 females) were included in
this study. All patients presented to the Edinburgh Dental Hospital
and School with an acute or chronic inflammatory area in the
mandible or maxilla. A clinical history was obtained from each
patient and if there was a history of an auto-immune disease, a
collagen related disorder or a current pregnancy, they were
excluded from the trial. All patients had radiographs taken of the
affected area in the Radiology Department of the Edinburgh Dental
Hospital and School. Patients presenting with acute symptoms had
abscesses drained when present or were placed on a five day course
of antibiotic if a cellulitis was present clinically. The
antibiotics used were phenoxymethyl penicillin 250 mg q.i.d. or
erythromycin 250 mg q.i.d. if the patient claimed hypersensitivity
to penicillin. All patients were operated on after an acute
exacerbation had subsided.
A schedule for 100 patients had been previously compiled by a
random selection method; each patient was allocated a consecutive
number and the appropriate treatment given to that specific number.
In all cases the area of chronic infection or a cystic lesion in the
mandible or maxilla was to be explored and all pathological tissue
removed by curettage. From the compiled schedule, 50 of the
patients would have the area curetted free of the pathological
tissue and the area then allowed to fill with blood clot. The
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other 50 patients had the affected area, after curettage, filled
with the experimental collagen paste.
From the schedule of the 50 patients placed in the control
group, 22 were male and 28 female. The collagen implant group
consisted of 19 males and 31 females.
The trial submission was approved by the local Ethical
Committee.
Method
All patients were treated under regional block or local
infiltration anaesthesia. A suitable flap of mucoperiosteum was
raised widely over the pathological area so that the resultant
defect would be totally covered by soft tissue when the flap was
replaced. If cortical bone had not been breached,a window was made
with a chisel or conventional surgical burrs under warm saline
irrigation to allow good access to the pathological cavity. When
the apices of teeth were involved in the pathological lesions, and
these teeth were non-vital, then an apical seal of dental amalgam
was placed in the root apex if the conventional root filling did
not adequately seal the root canal. The cavity was thoroughly
curetted of all pathological debris and irrigated continuously with
warmed normal saline. When the cavity was deemed clinically to be
clear of all debris, it was dried with sterile pledglets and in
cases selected for implantation, the cavity was completely filled
with the experimental collagen paste dispensed from its sterile
syringe. In the control group the cavity was allowed to fill with
blood clot. The mucoperiosteal flap was sutured in its original
position with 3/0 Dexon™ sutures.
All patients were asked to return immediately if there was
persistent pain, swelling or erythema or if they became generally
unwell. Antibiotics were not prescribed routinely at the time of
operation. Only patients who returned with cellulitis were given
penicillin or erythromycin in appropriate dosage.
After an initial post-operative review at two weeks, all
patients were asked to return at three months and subsequently at
six months and 12 months post-surgery for clinical assessment and
radiographs to be taken of the operated area.
Radiology
The majority of bony lesions operated on were in the upper
anterior region of the maxilla (75) and lower anterior region of
the mandible (19). Six were sited more posteriorly in both jaws.
In the anterior regions of mandible and maxilla, intra-oral
dental film (Kodak Ultraspeed D) was used when radiographs of small
lucent areas were taken and where the pathological areas were more
extensive then occlusal film (Kodak Ultraspeed D) was used.
All radiographs were taken with a Phillips Oralix machine.
Intra-oral films were taken from a fixed focal distance (FFD) of 16
cm with a tube angle of 55°. The exposure time for the upper
anterior region was 0.35 sees and for the lower anterior region of
0.2 sees. Anterior occlusal films were taken at 55° but with an FFD
of 18 cm and an exposure time of 0.56 seconds.
Radiolucent areas in the posterior areas of the mandible and
maxilla were demonstrated and compared by an orthopantomograph
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(OPG). Radiographs were taken on the Morita Panex machine'j the
machine was constantly set so all films were comparable. The
relevant section on the OPG was removed for comparison.
All films were processed automatically in a Pantomat (Siemens
Ltd.) using M & B Matalex developer and M & B fixer plus. Oral and
occlusal films were processed on a six minute cycle and the OPG on
a four minute cycle. Films were dated and clearly labelled with
patients' names and the date.
When patients returned at three months, six months and one
year, similar radiographs to those taken initially were obtained so
a direct comparison could be made of the change in radiodensity of
the operated area. For a more reliable comparison of operated
areas, the lucent zone on the radiograph was measured in two
directions at right angles, with an allowance for magnification, and
three groups were then compiled. The groups consisted of lesions
less than 1 cm in diameter; those between 1 and 2 cm and those
greater than 2 cm. It was considered the results would be of more
value if areas of similar dimensions within the jaws were compared.
Bony defects less than 1 cm in diameter were called 'small' (S),
between 1 and 2 cm 'medium' (M) and those greater than 2 cm were
termed 'large' (L).
In the collagen implanted group, 27 defects were small, 18
medium and 5 large. By comparison in the implanted group, 27 were
small, 19 medium and 4 large. In the implanted group, 37 lesions
were in the maxilla and 13 in the mandible and in the control group
38 in the maxilla and 12 in the mandible (Tables 5.1 and 5.2).
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This study has investigated the use of a formulated collagen as
a bone implant in several ways. Materials which are biocompatible
would be expected to behave differently from non-biological implants
which may be regarded by the host as foreign. The bio-compatibility
of the test material has been shown _in vitro by the effect on human
fibroblast tissue cultures. The effect of the material on the
stages of wound healing has been demonstrated in vivo using
comparable bony lesions in the rabbit mandible as test and control
sites. A longitudinal histological study of the bony wounds from
three days post-operatively until 12 weeks has shown the progress
of test and control sites. Paralleled with the histological
findings, early mineralisation and subsequent patterns of
calcification have been compared by bone labelling. It was also
considered that differences in the vascularity of the operates
areas would be informative.
All foreign proteins elicit an antibody response; cells present
on the histological study of healing demonstrate the type of
reaction elicited, but more specifically antibody levels against the
implant material have been measured. Radiology of the rabbit
mandibles and the above results provide the basis for interpreting
the findings of the human study.
The results are presented in the following order:-
1. Cytotoxic effects on fibroblast culture.




4. Radiology of the animal model.
5. Human implantation study.
The relevant figures and tables are shown at the end of each of
these sections.
1. Cytotoxic Effect of Collagen on Oral Fibroblast Culture
Materials which are biocompatible should have no cytotoxic
effects on cells grown in tissue culture. Twelve different human
fibroblast cultures were grown from oral mucosa as previously
described. Pieces of collagen were placed in the centre of
confluent layers of cells and the effect viewed after 24 and 48
hours. The relationship of human oral fibroblasts grown in tissue
culture with collagen implant material is shown in Figs. 5 to 12.
At low magnification (x 320), a normal growing and dividing
fibroblast colony is shown to be closely related to pieces of the
collagen matrix (Fig. 5). At higher magnification (x 640) under
phase contrast microscopy (Figs. 6 & 7), the cells do not appear to
be damaged by the presence of the material and would appear to have
an intimate relationship lying inferiorly, superiorly or possibly
growing through the matrix. During processing it may be expected
that the material would be lost but it would seem that the
fibroblasts may actually hold the implant _in situ.
At higher magnification (x 2,100) electron micrographs further
demonstrate this very close relationship between cell and implant
(Fig. 8). The fibroblast nuclei were of normal size and shape with
normal numbers of compact nucleoli, no irregularities and no
intranuclear inclusions. An indentation is shown in Fig. 8 but
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this was not typical. The cell cytoplasm appeared normal and
contained a satisfactory distribution of organelles. The
mitochondria appeared well preserved but typical of cells in
culture there was a poor complement of endoplasmic reticulum but an
abundance of free polyribosomes reflecting active protein
synthesis.
Golgi complexes were poorly developed probably reflecting the
emphasis on growth and multiplication rather than differentiation
and function. Some empty spaces with no apparent membrane
structures were seen; these were thought to represent a fixation
artefact, possibly the result of loss of lipid material.
At magnifications of x 5,600 and x 14,000 (Figs. 9 & 10) the
intimate relationship between cell wall and implant fibrils is
further demonstrated, several areas of direct contact being seen.
The results are confirmed by Fig. 11 again showing collagen fibrils
adjacent to the cytoplasmic membrane and at higher magnification
(x 14,000 Fig. 12) the cell wall appears to hold the fibrils in
situ. Cells in culture grew and matured without effect from the
exogenous implant material and this was verified by a dye exclusion
technique using trypan blue.
96.
Fig. 5 Normal growing and dividing fibroblasts in close
relation to collagen implant material.
Phase contrast x 320
Fig. 6 Higher power view of implant material seen in Fig. 5
with fibroblasts appearing to lie inferiorly, superiorly,
or through the matrix.
Phase contrast x 640
Fig. 7 An area adjacent to Fig. 6 confirming
relationship shown in Fig. 2.




Fig. 8 Low magnification micrograph shows the characteristic
features of massed collagen fibres seen lying in
different orientations and closely related to a
fibroblast. The nuclear size and shape are normal but
an indentation is noted. There is a normal distribution
of chromatin. The cytoplasm appears normal showing
rough endoplasmic reticulum, mitochondria,electron dense
granules and empty spaces with no membranes, probably a
fixation artefact^ possibly due to loss of lipid
material.
Electron micrograph x 2,100
Fig. 9 Higher power view of area A confirming very close
relationship of fibroblasts with collagen implant and
confirming intact plasma membrane.
Electron micrograph x 5,600
Fig. 10 Higher power view of area B showing nucleus and nuclear
membrane, mitochondrium and several areas of intimate
contact of cellular membrane and collagen. Collagen
fibrils show characteristic cross-bonding.
Electron micrograph x 14,000
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Fig. 11 Close relationship of normal fibroblast and collagen
fibrils.
Electron microgrsph x 3,500
Fig. 12 Higher power view of area C which shows the
appears to hold the collagen fibrils _in situ.
Electron micrograph x 14,000
cell
 
2. Operative Surgery using the Animal Model
Thirty one rabbits were finally operated on in this study, one
died immediately post-operatively leaving 10 groups of three
rabbits per group. The animals were operated on in the order of A1
to A32 because of the lack of accommodation (only six rabbits could
be housed at any time); the survival times and group numbers do not
follow in a chronological order. The experimental date concerning
each animal used in the studies is summarised in Table 6.1.
Animal All died under anaesthesia, proabably due to the
anaesthetic agents used. As a result Group 4 (10 day survival)
then had animal A13 substituted for All. To compensate for this
loss, as the rabbits with a three day survival were to be used for
the longitudinal histological study alone, only two animals were
placed in this group, A20 and A21. In Group 10 (84 day survival),
animal A26 died immediately postoperatively, again probably due to
the anaesthetic agents. A28 was placed in this group which then
consisted of A25, A27 and A28. Animal A29 injured itself in its
cage and was therefore felt to be unsuitable for use. Finally,
Group 9, the last group operated on therefore comprised animals
designated A30, A3 1 and A32.
Wound infection was seen in only two animals. One, A20 was
sacrificed at three days and therefore not treated; the other, A3,
was successfully treated by local cleansing and a topical poly-
antibiotic medicament.
Two animals died prematurely, A17 (Group 7, 28 day survival)
died at 14 days and A28 (Group 10, 84 day survival) died after four
weeks. The cause in both cases was respiratory infection.
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+ Used for microcirculation.





















(4) All Died under anaesthesia.
10 days A12 ♦
A13
(8) A14 ♦ Adverse reaction to haetnato-










♦ ■¥ Oied at 14 days.
(1) A2Q + Wound infection.









(10) A26 Oied immediately post-operation.
84 days A27 ♦
A28 ♦ Died after 28 days.









Rabbit A14 suffered a toxic reaction to haematoporphyrin.
After the subcutaneous injection of the dye at day 14, the animal
began to lose muscle bulk, developed joint swelling and ataxia. The
condition steadily deteriorated over the following week and it was
then sacrificed at 21 days.
In view of this toxic reaction to haematoporphyrin, it was
decided it should not be given to animals A25 and A30 in Group 9
and 10 (42 and 84 day survival). The final schedule of
administration therefore labelled these animals only with
tetracycline and it was given at intervals of two weeks until
sacrifice.
All rabbits showed a weight loss immediately post-surgery of
up to 200 gm, but the pre-operative weight was normally regained by
the first post-operative week, although three animals did require
two weeks.
a) Microangiography study on the new vascular circulation
in the healing bony defect
It was hoped that this study would demonstrate differences in
the early phase of wound healing between control and test sites.
Animal A2 (Group 5, 14 day survival) was re-anaesthetised with
Hypnorm™ intra-muscularly and Diapezam™ intra-venously as previously
described (0.2mg/Kg body weight of Hypnorm™ intra-muscularly and
then lmg/Kg Diazepam™ intra-venously). The infusion of Hypaque™
saline was then begun. Within the first 5 minutes, the animal
became tachypnoeic then the rate of respiration slowed and death
due to cardio-respiratory arrest was noted 10-15 minutes after the
infusion began. As the infusion proceeded over the following two
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hours, there was marked soft tissue oedema in the head and neck
region with sero-sanguinous exudation appearing at the external
nares. A total volume of 700 ml of radiopaque fluid was infused
into the animal.
Radiographs of the bisected mandibles after removal of the
surrounding soft tissues, described in Chapter 3, failed to
demonstrate any radiopaque dye in either the implanted or control
operation areas. There was no difference noted between each half
of the mandible radiographically. Thus in view of the difficulty of
the technique and in the absence of a demonstrable result, this
method of assessment of healing was abandoned.
b) Light microscopy
A longitudinal histological study was used to show the response
of the tissues to implanted collagen; the effects on stages of wound
healing; the disposal of the implant material and its effect on the
inflammatory response.
i) 5 days post-operatively
Animals A22 and A23 were sacrificed at 5 days. On the
implanted side (right) much of the collagen implant material was
seen rn situ. The interstitial areas between the material showed
abundant granulation tissue (Figs. 13a,b,c). Small fragments of
bone remaining from the operative procedure were seen to be
resorbed by local osteoclasts and some trabeculae of woven bone
were noted within the rich granulation tissue.
The control lesion on the left side (Figs. 14a,b) demonstrated
very similar features with abundant granulation tissue, some areas
of residual bone fragments and the formation of areas of woven
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bone. The micrographs of the granulation tissue (x 360) from
implanted and control areas (Figs. 13c & 14b) showed no significant
differences. Neither demonstrated the retention of the features of
the acute inflammatory response due to infection nor a foreign body
giant cell reaction in relation to the implanted area.
ii) 10 days post-operatively
The animals sacrificed at 10 days were A12 and A13. At low
magnification (x 40) the implanted area (right) demonstrated strands
of cell rich fibrous tissue (Fig. 15a) which were maturing from the
granulation tissue. Much implant material was still present. At
higher magnification x 360 (Fig. 15b) fibrous tissue was noted to
be developing adjacent to the implant material; again no foreign
body giant cells were noted in relation to the foreign matrix. In
contrast the control area (left) (Fig. 16a) demonstrated a more
advanced state of healing with finely trabeculated bone advancing
into the fast maturing fibrous tissue (Fig. 16b).
iii) 14 days post-operatively
Animals A2 and A3 were sacrificed at 14 days. Collagen implant
material was still demonstrable at 14 days on the right side
although it was beginning to fragment and the operation site was
being replaced by mature granulation tissue (Fig. 17a). The
healing process appeared to be maturing with early fibrocytes seen
swarming over and through the fragmenting implant material (Fig.
17b). Although at this stage the material was becoming fragmented
the debris was not being removed by giant cells. The control area
(Fig. 18) showed a very mature fibrous tissue and advancing front
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of bone of repair.
iv) 21 days post-operatively
The animals sacrificed at 21 days were A5 and A6. By 21 days
the implanted area showed an advancing bony front with progression
to lamellar bone (Fig. 19). Implant material was however still
visible and seemed to be occluding the surgical defect thus slowing
the advancing reparative bone. The control lesion (Fig. 20), by
comparison, showed the surgical defect to be almost completely
occluded by mature granulation tissue and plentiful trabeculae of
bone.
v) 28 days post-operatively
Animals A17 and A19 were sacrificed at 28 days. The
surgical defect on the implanted side was still present and
advancing tissue of repair had not as yet filled the area (Fig.
23). By comparison at 28 days on the control side, trabeculated
bone was seen to extend throughout the surgical defect (Fig. 24).
vi) 35 days post-operatively
The animal sacrificed at 35 days was A15. At this time, no
evidence of any retained implant material was found. There was
continued formation of woven bone within the fibrous granulation
tissue which was seen to be advancing throughout the whole of the
implanted surgical defect (Fig. 27).
The control area by comparison demonstrated complete bony
replacement of the surgical defect at 35 days (Fig. 28).
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vii) 84 days post-operatively
Animal A27 was sacrificed at 84 days. A comparable
histological indication of healing to that shown at 35 days on the
control side was not seen on the implanted side until 84 days. At
this time, the implanted surgical defect was replaced by bone
showing a comparable trabecular pattern (Fig. 31).
c) Fluorescent bone labelling
The effect the collagen implant had on calcification of the
surgical defect was shown directly by an in vivo bone staining
technique using tetracycline and haematoporphyrin.
Animal A4 was sacrificed at 21 days. The control area (left)
at 21 days showed an ordered trabecular network of bone which was
seen to be extending from the periphery of the control lesion
towards its centre (Figs. 21a,b,c). Bone labelling showed an
uptake of three labels used in this animal. The tetracycline given
on the day of operation showed a continuous narrow yellow band
peripherally closely related to the periosteum. The second wider
band of haematoporphyrin (orange) given at seven days, showed a
uniformly advancing front indicating a more pronounced formation of
new bone. The second tetracycline label (yellow) given at 14 days
showed a wider zone growing into the defect. The pattern of growth
demonstrated showed parallel trabeculation from the periphery to
the centre of the lesion. The banding would indicate little bone
formation before day seven and then a marked increase in the
deposition of new bone from day seven to 14 which was maintained or
increased over the following seven days. The speckled areas noted,
were a constant feature and difficult to interpret as they only
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showed yellow staining. They were thought to represent contained
osteocytes and thus appeared throughout the stained areas. Higher
power views (x 560) showed the incremental pattern of ossification
over the 21 days (Fig. 21c).
In comparison (Fig. 22) at the site of collagen implantation
the advancing bony front was much less well orientated, lacked the
fine trabeculation seen in Figs. 21a and 21b and was noted to be
restrained when coming into contact with the non-staining,
amorpohous implant material. Contained osteocytes were seen but
they were sparse in comparison with the control area. Isolated
lacunae however (Fig. 22c) showed a very similar incremental pattern
of ossification as the control (Fig. 21c) which would confirm that
the underlying healing process had not been altered fundamentally,
only retarded and disorientated.
At 28 days (Figs. 25a&b), animal A18 was sacrificed and in
this animal only tetracycline was used as a bone marker. There was
continued regular organised ossification occluding the control
surgical defect with a high concentration of contained osteocytes
that seemed to make a concentric pattern around the lacunae
(Fig. 25b). When comparing the implanted area (Fig. 26), the
presence of foreign material seemed to retard the healing and the
pattern for ossification seemed to show a much more disorganised
and rather patchy distribution where it was laid down around
retained implant matrix.
At 35 days (Animal A16) when the implanted defect was compared
to the control area (Fig. 29a), the areas of ossification in
relation to the implant were still more disorganised and there were
many more localised areas of ossification. (An example is shown in
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Fig. 29b.) The trabeculation pattern of the newly formed bone was
noted to be sparse and less well organised. The labelled control
lesion (Fig. 30) demonstrated at 35 days confirmed the histological
findings that the surgical defect was fully replaced by a calcified
matrix which showed a much more regular pattern throughout.
It was finally confirmed that by 84 days in animal A2 the
implanted area was totally replaced by bone (Fig. 31). As
tetracycline only was used as a bone marker, the pattern was not
well defined but the stain was shown to be throughout the original
surgical defect. Finally there was therefore little difference
between the bone patterns shown on the implanted and control areas
but the time for healing was delayed considerably by the implanted
collagen.
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Fig. 13 5 days - collagen implant
(a) Section shows implanted material (M) associated
with abundant granulation tissue (G) and spicules
of vital bone (B). Trabeculae of woven bone (W)
are identified.
H & E x 40
(b) Section shows resorption of vital mature bone by
osteoclasts (arrowed) and development of woven bone
within the granulation tissue.
H & E x 144
(c) Fibroblast rich granulation tissue.
H & E x 360
Fig. 13
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Fig. 14 5 days - control
(a) Comparable field with Fig. 16 shows cytologically
similar granulation and bone tissue.
H & E x 144
(b) High power view of area A in Fig. 14a showing
granulation tissue with no significant difference
from that seen in Fig. 13c.
H & E x 300
Fig. 14
1 10.
Fig. 15 10 days - collagen implant
(a) Strands of cell rich fibrous tissue (F) maturing
from granulation tissue associated with implant
material (M).
H & E x 40
(b) Higher power view of fibrous tissue (F) developing
around implant material (M). Note absence of
inflammatory cells.




Fig. 16 10 days - control
(a) Section shows fine trabeculation of bone (B) within
granulation tissue which occupies the area of bone
resection.
H & E x 40
(b) Fast maturing fibrous tissue (F) within the
granulation tissue. A post surgical spicule (S) of
bone is identified as well as advancing trabeculae
of new bone (B).
H & E x 144
 
1 12.
Fig. 17 14 days - collagen implant
(a) Section shows fragmented implant material (M)
partially replaced by granulation tissue.
H & E x 40
(b) High power view shows early fibrocytes (cf.
fibroblasts) swarming over and through fragmenting
implant material. (Note absence of foreign body
giant cell reaction.)
H & E x 360
Fig. 17
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Fig. 18 14 days - control
Comparable control shows much more mature fibrous
tissue (F) as demonstrated by cell cohesion and regular
orientation.
H & E x 40
Fig. 18
1 14.
Fig. 19 21 days - collagen implant
Advancing bone front shows progression to lamellar bone
(B) and minimal bone trabeculae but occlusion of
surgical defect by retained implant material (M).
H & E x 96
Fig. 20 21 days - control
Nearly complete occlusion of surgical defect by
granulation tissue (G) and plentiful trabeculae of bone
(B).
H & E x 144
Fig. 19
1 15.
The following six colour illustrations show the colour banding
associated with tetracycline (yellow band T, day of operation),
haematoporyphyrine (orange band H, 7 days) and tetracycline (yellow
band B, 14 days).
Fig. 21 21 days - control
(a) Regular advancing trabeculae of new bone.
x 144
(b) High power view of advancing front of osteoblasts.
x 320





Fig. 22 21 days - collagen implant
(a) Compared to Fig. 9a the advancing bone is less well
orientated and lacks the fine trabeculation.
Amorphous implant material (M) is identified.
x 144
(b) Slower rate of replacement of implant material by
bone is evidenced by the lack of fine trabeculation.
Area A Fig. 22a.
x 300
(c) Lacunae again show incremental pattern of
ossification demonstrating the underlying process




Fig. 23 28 days - collagen implant
Surgical defect still present.
H & E x 40
Fig. 24 28 days - control
Bone trabeculae (B) now shown to extend throughout the
surgical defect.
H & E x 40
Fig. 23
1 18.
Fig. 25 28 days - control
(a & b) Tetracycline only. High and low power views
show continuation of more regular organised





Fig. 26 28 days - collagen implant
At 28 days the presence of the implant material (M)
still retards healing and the pattern of ossification




Fig. 27 35 days - collagen implant
Low and higher power views (a) and (b) show woven bone
(B) still forming along with fibrous granulation
tissue (G). N.B. Implant material is now no longer
evident.
(a) H & E x 40
(b) H & E x 144
Fig. 27
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Fig. 28 35 days - control
Bony replacement of surgical defect.
H & E x 96
Fig. 28
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Fig. 29 35 days - collagen implant
(a) and (b) confirm the more disorganised and localised
(b) areas of ossification compared with the more





Fig. 30 35 days - control
In centre of original defect there is now an organised
and more regular pattern of ossification with total




Fig. 31 84 days - collagen implant
At 84 days a comparable bony trabecular pattern to that
seen in Fig. 16 (35 days) on the control side is now
evident.
(a) H & E x 60
(b) H & E x 144
Fig. 31
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d) The quantitation of immunoglobulins specific to
collagen implant matrix
In addition to the histological examination of cell types, the
immune response was demonstrated directly by monitoring antibody
levels by an ELISA.
Serum taken from animals A27 and A32 was used in the study.
Samples were taken at the time of operation (week 0) and at weekly
intervals up to 12 weeks. Aliquots of each serum sample were mixed
and used as a combined reference serum.
The positive change from colourless to yellow indicated
the presence of antibody specific to the implanted collagen.
Dilutions of serum from 1 to 1/2187 were used. Control wells and
those from week 0 showed no colour change (Fig. 32).
Absorbance values were measured from 30 minutes to 120 minutes
at intervals of 15 minutes. Optimal readings were recorded at 120
minutes. A curve for the reference sera plotting optical density
against serum concentration was compiled (Fig. 33a). Using this
curve at concentrations of 1/27 and 1/81 the optical density was
given an arbitrary value of 100 ELISA units. The weekly serum
samples were given values for their optical densities in ELISA Units
at the same concentrations of 1/27 and 1/81 with reference to the
standard value of 100 units.
An actual set of values obtained is shown in Fig. 33b. Values
for the four occasions the experiment was repeated were found to be
very similar.
Although serum samples from two animals were used and the
antibody response theoretically would be unlikely to be identical,
it is of interest that the two halves of the response shown in
126.
Fig. 33b are complementary in forming one confluent curve.
The antibody response shown by the animal A32
appears to be immediate with a high level of detectable antibody
present by the end of week one. The levels then began to fall
sharply after week 1 until sacrifice at week 6. Animal A27 (weeks
7 to 12) showed an initial response at week 7, less than the
previous level for animal A32. The level of detectable antibody






Fig. 32 Flat bottomed polystyrene microtitration plate showing
colour change from colourless to yellow (positive
result) from which absorbance is measured by Titertek
Multiskan.
128.
Fig. 33 Antibody Response to Collagen Implant
(a) Reference sera
A set of values of optical densities (O.D.)
recorded for serial dilutions of the combined
reference sera using a semi-log scale, is shown.
Readings for O.D. at dilutions of 1/27 and 1/81 are
marked.
The O.D. for these dilutions is given an arbitrary
value of 100 ELISA units.
(b) Antibody response
Each sample of rabbit serum, removed at weekly
intervals, is serially diluted. O.D. readings for
each sample at dilutions of 1/27 and 1/81 are
recorded. With reference to the O.D. of the
combined reference sera above, given a value of 100
units at these dilutions a value is recorded for
each serum sample.
These values are plotted against time (in weeks) to
















e) Radiology of rabbit mandibles
Radiological changes at operation sites in the rabbit were used
to confirm the findings of the fluorescent bone labelling study and
to show how early these effects could be seen radiographically.
They were further used to confirm the extent that mandibular
architecture could be restored.
Radiographs taken of mandibles up to 10 days after surgery
showed no detectable changes in the radiolucent areas. The cut
margins of the defects were clearly defined and the radiological
density seemed unchanged (Figs. 34 & 35). At 10 days (animal A12)
the margins of the lesions on the control side appeared to be less
distinct when compared with the implanted side (Fig. 36).
At 14 days (animal A2) (Fig. 37) the implanted area still
demonstrated clear cut margins with no change in the density of the
lucent zone, while the control area had lost the clear margins and
the density of the area showed an increase in opacity.
At three weeks (animal A5) (Fig. 38) the control area showed
more marked opacification and the lower border of the right
mandible was becoming reconstituted. By comparison, the implanted
area showed that the clear cut margins were becoming rounded off,
the defect was still very obvious but an increase in radiodensity
was noted. The lower border of the mandible was not reconstituted.
By four weeks (animal A19) the site of operation was less
obvious on the implanted side (Figs. 39) with a marked increase in
radio-opacity and the lower border of the mandible was beginning to
be reformed. The control side again showed a more advanced state of
healing with the lower border then in continuity.
Figs. 40 indicated the picture at five weeks (animal A15).
Bony regeneration at the apices of the roots sectioned at operation
was seen at both control and implant sites. In this animal
reconstitution of the lower border is more advanced on the implanted
side compared with the control.
By six weeks (animal A32) (Figs. 41) there was no further
change on the implanted side from Figs. 39 at four weeks with the
lower border as yet not restored. The degree of bony replacement
was still far behind that seen on the control side.
By 12 weeks (animal A27) post-operatively both sides of the
operated mandibles had filled with bone and the lower borders were
reconstituted. There was, however, "notching" of the replaced
lower border which seemed more pronounced on the side that was
implanted with the collagen matrix.
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Fig. 34 5 days: No radiological changes, cut margins still
clear, defects still radiolucent.
Fig. 35 7 days: No radiological changes.
Fig. 36 10 days: Cut margins now becoming less distinct,
especially the control (L) side, with reduction in
radiolucent area.
R (implant) L (control)
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Fig. 37 2 weeks: Control (L) side shows opacification of the
defect. The implanted (R) side appears more
radiolucent and the margins are still quite distinct.
Fig. 38 3 weeks: On the control (L) side there appears to be
calcification in the defect with the lower border of
the mandible almost reconstituted. The (R) side shows
increased opacification, the cut margins being rounded
off but the defect is still obvious radiographically.
Fig. 39 4 weeks: Control (L) side shows new bone deposited
around the apices of the cut teeth. The lower border
of the mandible is in continuity. The implanted side
(R) shows increased opacification with bone
regeneration but the defect is still visible and the
lower border of the mandible not yet restored.
R (implant) L (control)
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Fig. 40 5 weeks: Control (L) side shows bony regeneration at the
apices of the cut teeth but in this animal the lower
border is not yet reconstituted. On the implanted (R)
side, there is also bony regeneration in the defect and
the lower border of the mandible is being reconstituted.
Fig. 41 6 weeks: The control (L) side shows recontour of the
mandibular defect with good bony deposition. Some
"notching" in the lower border is noted. The implanted
(R) side shows bone deposited around the cut apices but
the defect is still obvious and the lower border is not
reconstituted.
Fig. 42 12 weeks: Both sides show the defects have now been
filled with bone and the lower borders reconstituted.
The bone on the control side (L) would appear to be
denser than the (R). There is "notching" in the lower
border on both sides but this is more pronounced on the
implanted (R) side.
R (implant) L (control)
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3. Human Implantation Study
The safety and efficiency of the collagen implant for human use
was assessed clinically and radiographically after implanting the
material into cavities, created by disease, in the maxilla and
mandible.
Pathological cavities may breach both cortical plates on
only the buccal or lingual cortex; the original radiological
density of the area is different in the two situations. When both
cortices are fenestrated the area is totally radiolucent but where
only one plate is intact, there remains a radiopacity depending on
the thickness of bone remaining. It was assumed that the collagen
matrix would not change the radiopacity of the bony cavity. To
verify this, cavities were cut in a pig mandible, two fenestrating
both inner and outer cortical plates and two cut only into half the
mandibular width. Collagen was placed in one of the full thickness
cavities and one of the partial thickness and the others used as
controls. Radiographs of the mandible (Fig. 43) showed the
comparable radiological densities of these cavities. There is an
obvious radiological difference between a cavity which in depth is
the whole thickness of the bone and that of half the mandibular
width. Little radiological difference is detected between such
cavities containing the collagen implant and those without. A
change in radiological density of the operated area is therefore of
significance as it would indicate that the area is being replaced
by a more radio-opaque, calcified matrix.
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a) Radiological variation
When radiographs of the healing bony cavities were compared,
some variations within the implanted and control groups were found.
There were also similarities between the two groups. The following
examples are used to show the variations seen and they are then used
to demonstrate the similarities and differences between the two
groups.
A typical cystic area, as indicated in Fig. 44a, is seen to be
well circumscribed with a well defined margin. The cyst has been
enucleated, the cavity filled with haematoma and allowed to heal.
Six months after enucleation, radiating trabeculae of new bone are
seen from the periphery of the original area towards the central
zone (Fig. 44b) which in comparison now appears more radiolucent.
The well circumscribed original margin by this time has been lost.
At one year post-surgery, the original area is almost completely
replaced by bone of repair (Fig. 44c). In comparison a similar
state of healing can also be demonstrated (Figs. 45a,b,c,d) when
such an area has been implanted with the collagen matrix. At three
months, there is a peripheral radiopaque zone surrounding a more
radiolucent central area (Fig. 45b). By six months, this peripheral
zone shows the radiating trabeculae of new bone formation while the
central area is still radiolucent (Fig. 45c). At one year (Fig.
45d), the original area has filled with bone of repair.
Figs. 46, 47 and 48 relate to the control group and indicate
some of the variants seen radiographically in the healing pattern.
Areas may fill with bone of repair (Fig. 46) but leave a small
radiolucency adjacent to the seal placed in the apex of an adjacent
root^ possibly a fibrous barrier. This is also demonstrated with a
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larger initial area (Fig. 47) when such a radiolucent residue may
still be detectable two years post-surgery. In larger areas, when
the original bony defect, in part, is through the full thickness of
the bone, breaching both cortical plates, then, although reparative
bone can be seen in the peripheral area the central area (with full
thickness defect) still remains as a radiolucent zone which may be
permanent (Fig. 48). It is assumed that as such areas are
symptom-free healing has taken place by fibrous tissue alone. These
areas do not calcify nor are they replaced ultimately by bone.
Similar variants have been noted in the implanted group. In
Fig. 49 bony repair has taken place at the periphery of the
original lesion but the central zone has remained as a well
circumscribed radiolucency. This situation thus compares directly
with Figs. 48. A comparison of Figs. 50 and 46 can be made when,
although healing of the bony defect has taken place, a well
circumscribed lucent area still remains around the apices of roots
involved in the original area. Figs. 51 and 47 are also directly
comparable demonstrating at two years post-surgery a small lucent
area related to an apical seal is still present. It can therefore
be inferred, with the examples used, that a similar healing process
shown radiographically can take place in both control and implanted
groups with similar variations.
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Fig. 43 Pig mandible to show density of defects with and without
collagen paste.
A Cavity full thickness of mandible + collagen.
B Cavity full thickness of mandible.
C Cavity half mandibular thickness + collagen.
D Cavity half mandibular thickness.
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Fig. 44 Healing of non-implanted cystic lesion of the maxilla:
a) Original well-circumscribed cystic lesion.
b) Six months post-cyst enucleation showing radiating
trabeculae of new bone radiating in from periphery
of original area towards central zone. Note also
loss of well-circumscribed margin.
c) Original area now almost completely replaced by
radiating bone of repair.
Fig. 45 Healing of cystic/granulomatous lesion of the mandible
with implant:
a) Shows extent of original lesion.
b) Three months post-operatively demonstrating a
peripheral radio-opaque area with a more lucent
central area and margin of lesion still demonstrable.
c) Six months post-operatively shows that the peripheral
zone is replaced by radiating trabeculae of bone, the
original margin has become lost and a small lucent
area remains centrally. Small fragments of amalgam
used as an apical seal are seen.




Radiographs to demonstrate classification of lesion by size and
show the healing process. Magnification of the area by the
radiograph is taken into account when estimating the size of the
bony defect.
Fig. 46 (a) S (small) area <1 cm in diameter.
(b & c) Gradual replacement of the area with
trabeculated bone over one year. Note small
radiolucent area in C adjacent to amalgam seal
at root apex. Probably this area remains as a
fibrous seal and does not calcify. (Control
group)
Fig. 47 (a) M (medium) area 1-2 cm in diameter.
(b & c) Again demonstrate bony repair and (c) shows
again a small lucent area at root apex two
years after surgery. (Control group)
Fig. 48 (a) L (large) lesion 2 cm + in diameter.
(b) At one year shows radiating trabeculae of new bone
• filling more than half the original defect but a






Radiographs show cases where clinically healing has taken place,
but radiographically the area has not been fully replaced by bone.
Fig. 49 (a) Maxillary cyst removed from an area where
supporting bone has been lost through the whole
depth of the maxilla. Bony repair has taken place,
(b) but a well demarcated area at apex of root shows as
a radiolucency. This area where there has been loss
of the whole depth of the maxillary bone is healed
probably by fibrous tissue alone. (Collagen implant
group)
Fig. 50 (a) Shows apical cystic granulomatous lesion.
(b) Shows healed lesion with residual radiolucent area
around apices of adjacent teeth after one year.
(Collagen implant group)
Fig. 51 (a) Shows early peripheral radio-opaque zone
progressing from original margin (arrowed) three
months post-surgery.
(b) At two years the original defect has become
replaced by bone but a small lucent area related to
the tooth apex is noted. (Collagen implant group)








The progress of patients allocated to each group is shown in
Tables 6.2 to 6.7 and individual patient progress shown in Appendix
1. The healing of bony cavities in the jaws of man with a collagen
implant and in a control group was shown radiographically with
comparable films taken for each patient at intervals of three, six
and 12 months.
Tables 6.2 and 6.5 show that groups were comparable. The
allocation for the implant group was 19 males and 31 females,
compared to the control group of 22 males and 28 females.
In the implant group, 13 areas were present in the maxilla in
the males and six in the mandible compared with 17 and five in the
control. Twenty four areas were present in the maxilla in the
female implant group and seven in the mandible, compared with 21 and
seven in the control group.
Tables 6.2 to 6.4, show the progress of the collagen
implanted group. At three months,seven of the group did not return
and from the remaining 43, only 14 showed increased opacification
of the original area. By six months, however, of the 41 patients
who returned for review, 38 had evidence of some new bone present
within the original healing area. At one year only 37 patients
returned; 22 showed complete healing of the area with bone of
repair being demonstrated. In another 14 cases, the areas were
partially replaced by bone with central lucent areas still
remaining (Figs. 48 & 49). One patient showed a radiolucent area
which had not changed, and although the patient was clinically
symptomless, radiating trabeculae of new bone were not
demonstrable; it must be assumed that healing was by fibrosis only.
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The results for patients in the control group are shown in
Tables 6.5 to 6.7. At three months, nine patients failed to return
and 32 of the remaining 41 patients showed radiographically by an
increasing opacification that healing was progressing. In many
instances there was loss of the original clean cut margins. At six
months a figure similar to that at three months of 32 from 39
patients returning demonstrated evidence of healing progressing by
the deposition of new bone. At one year only 35 patients returned;
27 showed the original lesion to be fully healed and replaced by
bone. A further five showed bony repair in part of the original
lesion and three showed no evidence of repair by bone.
It is noted in Appendix 1 that two patients KC and KV in the
control group required the original defects to be re-explored due to
persistent residual infection.
For descriptive purposes and for comparison, the sites of
operation used in this study have been divided into three groups
with an allowance made for magnification of the films. Areas <1 cm
in diameter (S group) are shown in Fig. 46; defects 1-2 cm in
diameter (M group) are shown in Fig. 47, while lesions >2 cm in (L
group) are demonstrated by Fig. 48.
Table 6.8 shows the state of healing seen in the control and
implant groups at three months related to size of the original bone
cavity. Fifteen from 20 small areas showed bony deposition in the S
control group, whilst only six from 24 were seen in the implant
group. The M sized areas in the control groups also showed a high
rate of bone deposition, 15 from 17, whilst the implant group only
showed six from 15. The large areas in both the implant and
control groups showed similar figures, two from four.
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By six months, Table 6.9, most of the S areas in the implant
group showed evidence of bony formation, 18 from 20, and in the
control group, 14 from 19. Similar figures were found in both the M
and L areas for both groups, the majority of lesions showing bony
deposition.
By one year similar numbers in all three groups, S, M and L
showed fully healed wounds in both control and implanted groups. A
difference between control and implant groups was shown in the
number of areas with only partial repair by bone. In the controls,
only five patients showed partial repair, one in the S group, three
in the M group and one in the L group. By comparison, seven in the
S group, four in the M group and three in the L group of the
implanted patients only showed partial repair.
The figures in Tables 6.8, 6.9 and 6.10 comparing healing of
S, M and L areas within their own groups, were found to have no
statistical significance. However, if the control and implant
groups are compared at three, six and 12 months, the results show a
difference.
Shown in Table 6.11 at three months the control group showed
bone deposition in 32 of 41 patients compared with 14 of 43
patients in the implant group. These figures are shown to be
statistically significant (P = 0.0001) which confirms the earlier
results that there seems to be a significant delay in the collagen
implanted wounds during the early stage of healing. By six months,
similar numbers in both groups show evidence of bone deposition and
at one year the difference between the control and implant areas is






HEALING OF BONE BY SITE AND SEX
Increase in „ , . _ „.
, No change in Patients
radiological ,. , _ _ _ ,Site , . _ . radiolucent not Totaldensity in
, area returning
operated area
Maxilla 1 9 3 13
Mandible 2226
Maxilla 8 15 1 24
Female
Mandible 3317





HEALING OF BONE BY SITE AND SEX
Evidence of No change Patients
Site deposition of from 3 not Total
new bone months returning
Maxilla 11 1 1 13
Male
Mandible 4 2 6
Maxilla 17 2 5 24
Female
Mandible 6 1 7






HEALING OF BONE BY SITE AND SEX
Area fully Trabeculated No radiological „ ,.
Patients
_.. healed with bone of repair evidence of , , ,
Site
, ... , . not Total
deposition in part of repair with
of bone original area bone
returning
Maxilla 25 - 6 13
Mandible 41 - 16
Maxilla 10 8 1 5 24
Female
Mandible 6 - 17







































HEALING OF BONE BY SITE AND SEX
Evidence of No change Patients
Site deposition of from 3 not





















HEALING OF BONE BY SITE AND SEX











of bone original area bone
Maxilla 5 3 1 8 17
Male
Mandible 3 - - 2 5
Maxilla 13 2 2 4 21
Female
Mandible 6 - - 1 7
Total 27 5 3 15 50
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TABLE 6.8
HEALING OF BONE BY SIZE OF ORIGINAL CAVITY

















chi square = 2.97493
P = 0.2259
















Total 29 14 43




HEALING OF BONE BY SIZE OF ORIGINAL CAVITY

















chi square = 2.52513
P = 0.2829



















Total 38 4 1




HEALING OF BONE BY SIZE OF ORIGINAL CAVITY




















chi square = 4.65141
P = 0.3250


















































































Restoration of the aesthetic and functional properties of bone
is the aim of the maxillofacial surgeon when there is loss of
facial architecture. Vascularised bone grafts replace the lost
tissue with a similar viable identical matrix and may be
satisfactory in restoring the local contour. Autogenous
non-vascularised grafts also show a high rate of success, restoring
contour and consistency but they are totally dependent on the local
blood supply for survival. A secondary operation is always
required to harvest these graft materials.
The use of homologous and heterologous prepared bone has met
with a limited rate of success. The local vascular supply is of
great importance, but equally the foreign matrix may stimulate an
immune response to any trace of foreign protein components in the
material.
Non-biological allogenic grafts which do not contain protein
residues will preclude humoral immunological effects. The results
with metallic prostheses and ceramics have been varied. These
materials replace the mineral component of bone and some are said
to be biocompatible, i.e. capable of coexistence without harm to
the host in a manner similar to natural host tissues. Some are
claimed to be biodegradable, i.e. able to be digested by normal
host enzymes or disposed of by cellular elements and replaced by
natural host tissue. Few are both biocompatible and biodegradable.
Metallic prostheses provide strength and aesthetics when used to
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replace segments of mandible but they may eventually become
extruded. The ceramic materials which have excited much interest
recently are claimed to be biocompatible, some are biodegradable
but there is debate on the extent of host tissue penetration and
replacement of these materials.
An ideal allogenic material has yet to be found. Collagen,
which forms the major protein mass in bone matrix, in a
heterologous form could theoretically offer an alternative approach
by providing a biological matrix which is both biocompatible and
biodegradable. If this were correct, it could be supplied in
various forms, with differing properties, to temporarily replace a
range of lost tissues. A biodegradable scaffold could be used to
replace bone and if, as is suggested by some authors, that collagen
itself calcifies (Shoshan & Finkelstein 1970) or increases the rate
of wound healing (Solomons & Gregory 1966), then additional
strength could be provided earlier during bony repair. As the
material is incorporated it would eventually be replaced by host
bone during the normal revision of local bony architecture.
Theoretically this would be possible only if the implant
collagen had very specific properties. As discussed in Chapter 1,
the resorption of a collagen matrix is variable depending both on
the local tissue environment and its own physical properties.
Soluble collagen with little cross linking is removed relatively
quickly. The rate of elimination of collagen decreases with the
degree of cross linking and highly cross linked collagen becomes
extremely brittle and may not be degraded at all. The animal work
on which many of these observations have been made, have shown
species specificity. There have also been variations in behaviour
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of the materials at different sites of implantation and the results
differ with a change in the source of the collagen.
This thesis has considered all the factors outlined in Chapter
1 to form a working hypothesis that a combination of a soluble
collagen with a lightly cross linked material could improve healing
in areas where bone matrix is lost, and could maintain the local
tissue contour. The soluble component should be easily eliminated
to allow rapid replacement by host repair tissue; the insoluble
portion would be maintained as a scaffold to support and guide the
repair tissue to ensure total restoration of the bony architecture.
If the collagen itself did calcify, then an early increase in
strength at the site of repair could be expected. Heterologous
collagen is a foreign protein but as all mammalian collagens
exhibit a similar structure differing mainly in the constitution of
the non-helical portions, they are regarded by many authors as only
"weak" antigens and should therefore be safe materials to use for
implantation. This study has attempted to show the effects and
subsequent replacement by host tissue of such a specially
formulated bovine collagen. Its desired properties should be that
it is shown to be biocompatible; it should be totally resorbed,
replaced or incorporated into the host with no detrimental effects.
It should be non-antigenic and improve or accelerate healing. Its
physical properties should be such that it is easy to manipulate;
is stable in tissue fluids and shows no volume change.
To assess these theoretic possibilities, the thesis has shown
the effects of the material at cellular level on human oral
fibroblasts and followed the effect on healing in a prepared bony
cavity in the rabbit mandible. These effects have been compared
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with a control area using a longitudinal histological study,
paralleled with bone labelling and radiology. The immunological
response has been viewed histologically and the B lymphocyte
activity shown by measuring, with an ELISA, the antibody levels
raised specifically to the implanted collagen. The preliminary
results from these investigations together with the results of
earlier work by the author when the material had been used as a
bone dressing in dry sockets (Mitchell 1986) had shown no untoward
effects, and the material was therefore considered safe and
suitable for use in a human implantation study. In this study the
material was placed in bony cavities in the jaws after the local
diseased tissue had been removed. It was considered that small
areas should be treated initially so that should any adverse local
effects due to the material be noted, the situation could be
resolved without detriment to the patient. This study demonstrated
the behaviour of the material as a bone implant.
The results of this research will now be discussed in detail.
The behaviour of the material when implanted into cell
cultures of human oral fibroblasts confirmed its compatibility.
More specifically, all cells in the study showed a normal shape and
complement of intercellular organelles. The indented nucleus seen
in Fig. 8 is not an uncommon finding on tissue culture and taken
with an overall picture of healthy cells does not appear to have
any significance. The fibroblasts were invariably seen to be in an
actively dividing phase which was confirmed by the comparative lack
of rough endoplasmic reticulum which would be abundant in cells
actively producing tropocollagen. There was little doubt therefore
that the collagen fibrils seen in the figures were the implant
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material alone. An intimate relationship must have developed and
been maintained between the implant material and the fibroblast
colony as the material seemed adherent to the cell layer and did
not separate when the material was processed for microscopy. This
symbiotic relationship would suggest that the material should have
no adverse effect at a cellular level during wound healing. The
absence of cytopathic effect further confirmed the material
suitable for implantation. This method was simple, easy to perform
and sensitive (Autian 1970).
The prepared cavity cut in the lower border of the rabbit
mandible was used to compare healing at a site implanted with the
collagen matrix to one which was initially filled only with blood
clot. In the control area the blood coagulum would be replaced by
ingrowth of osteogenic granulation tissue and lysis of the clot
would immediately precede this advancing healing tissue. In the
area implanted with collagen, it was considered that the provision
of a biological scaffold could increase the rate of wound healing.
Such an increase had been shown by Shoshan & Finkelstein (1970)
3
when H proline labelled collagen was implanted into muscle wounds
in the guinea pig back. It was demonstrated in the guinea pig that
the collagen matrix reduced the early haemorrhage and oedema which
had been seen on the control side. At six days post-implantation,
mature fibrocytes were seen to be producing newly deposited
non-labelled collagen fibrils and the control area was retarded by
comparison. By day 11 in their study, healing of the implanted
area with newly formed collagen was well in advance of the control
wound and by three weeks both wounds had healed, the collagen
implant being almost completely replaced by new host collagen. The
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control wounds, although comparably well healed, still showed
microscopically areas of degenerated muscle and lymphocyte
infiltration. Their conclusion was that a collagen implant had
produced a beneficial effect on healing of a muscular wound in the
guinea pig back. Although the guinea pig muscle implant study was
not directly comparable to the use of collagen in a bony cavity,
the findings of this thesis related to the early period of healing,
refutes their results.
The animal model in this study showed a fibroblast rich
granulation tissue, at a period of five days after surgery,
surrounding areas containing the collagen matrix and trabeculae of
new bone were beginning to be laid down (Figs. 13a,b,c). A very
similar finding was seen on the control side except that remnants
of blood clot substituted for collagen (Figs. 14a,b,c). At 10
days, the control area exhibited a mature osteogenic granulation
tissue with advancing bony trabeculation (Figs. 16a,b) which seemed
to be in advance of the implanted area, contrary to the findings of
the guinea pig study.
At 14 days implant material was still evident, but it was
fragmenting and fibrocytes were seen swarming into and around it
(Figs. 17a,b). By comparison now the control area showed a regular
orientation of fibrous tissue and a more mature advancing bony
front (Fig. 18). It was more definite at this stage that healing
of the control area was in advance of the implanted site. It was
hoped that this would be further verified by the microvascular
study but this was unfortunately abandoned as stated in Chapter 6
and will be discussed later.
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By comparison, the results of the guinea pig study (Shoshan &
Finklestein 1970) and this thesis have shown that the site of
implantation must be important and muscle may have been a more
suitable vascular bed for implant material. The results may have
demonstrated species specificity and have shown how unreliable
conclusions from animal work may be when applied to another animal
or to the human situation. If we now consider the reports of
Devore (1977), Fabinger et_ al_ (1980) and Joos £t_ al_ (1980) who all
claimed that wound healing was accelerated and improved when
collagen was implanted into bone-, we find that they contradict the
findings of this thesis.
The latter two studies were probably not strictly comparable
with this investigation. They were dealing with periodontal
pockets and using the material as a bone dressing they showed
that the collagen left _iri situ in these pockets directly calcified
initially. Calcification was then followed by early penetration of
fibroblasts and osteoblasts with subsequent formation of bone. The
control areas also showed bony regeneration but in a haphazard
fashion and to a lesser extent. Devore's study (1977) is more
directly comparable with this thesis, in that it deals with similar
collagen implants, the rabbit model and a bony cavity. The results
of Devore's work showed that by two weeks there was little change
in the grafted or control regions, progress being similar in both
areas. However, by eight weeks the defect on the control sides had
begun to fill but with marked notching of the inferior border of
the mandible, while healing at the implanted sites was much more
advanced, with little or no notching. At three months the healing
at the implanted sites was still more advanced with almost complete
replacement by bone and only a minor degree of notching on the
lower border when compared to a more significant notching at the
control areas. A similar picture was also noted at one year. The
study concluded that the cross linked collagen implant initiated or
aided the total replacement of the area by host bone and healing
was accelerated.
This thesis does not support the findings in Devore's study.
There are features in the studies which appear similar. In this
thesis the collagen matrix could be seen histologically at 28 days
and was finally eliminated by 35 days. This rate of implant
elimination was comparable with the material used in Devore's study
at 42 days. Thus, if the time of elimination of the material is
proportional to cross linking, then the material used in this
research would appear similar to that used by Devore. To further
complicate the situation, Colago et_ a^ ( 1965) showed no beneficial
effect from a collagen implant, that was eliminated by 14 days, on
bone healing in the rat.
It is not apparent why healing at the implanted area should be
delayed in comparison with the control in this thesis, but
experimental evidence by Silver ( 1980) suggests this should be
expected. It was demonstrated that the micro-environment during
wound healing shows a fall in oxygen (O2) tension and a rise in
carbon dioxide (C^) with increases of H+ and K+ ion
concentrations. The oxygen tension is known to be critical to
wound healing, hypoxia being detrimental, as normal cellular
function is dependent on more oxygen supporting pathways in
preference to anaerobic conditions (Silver 1980). Indeed it has
also been demonstrated that wound healing is directly related
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to oxygen tension and can be improved by an increase in oxygen
tension (Niinikowski 1980). In wound cavities initially the 0^
tension is low and the tension high but with the ingrowth of
granulation tissue and formation of endothelial bands, the pCC^
decreases and the pC^ is seen to gradually increase. The presence
of foreign bodies in wounds interferes with the ingrowth of
granulation tissue thereby influencing the ozygen tension and
interfering with the supply of nutrients to the wound. The
importance of nutrients has been demonstrated by placing in the
centre of an implanted cellulose sponge a highly nutritional medium
of glucose, amino acids, electrolytes and vitamins which produce a
significant increase in the local deposition of collagen. It can
thus be argued that the provision of a collagen matrix in this
research had produced in the local wound environment an oxygen and
nutritional lack which retarded the healing process. This view is
perhaps supported by Cochran & Hiat ( 1975) who showed that bony
defects in the pelvis and femur filled with collagen demonstrated
comparable healing with non-implanted controls, showing no evidence
of enhanced bone healing. Hunt & Benoit (1976) may further support
the argument as they concluded that collagen placed in the feline
tooth socket resulted in delayed bony repair.
If this hypothesis is acceptable it is not clear how Devore' s
study was so positive in its inferences on the positive effect of a
collagen implant matrix to wound healing.
The impression of healing retardation in this study was
further examined by considering the progress of the comparable bony
lesions in the rabbit from the third week to the twelfth week.
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At a period of three weeks after surgery, histologically the
control area showed almost complete occlusion of the surgical
defect with granulation tissue and plentiful bone trabeculation
(Fig. 20). By comparison, the, implanted site (Fig. 19)
demonstrated that although healing was taking place, the presence
of implant material prevented the advancing granulation tissue from
completely filling the defect. Healing was therefore retarded.
This situation was further exemplified by comparing Figs. 21a,b,c
(control) with Figs. 22a,b,c (collagen implant); both are
undecalcified preparations showing bone staining. It was evident
from Figs. 21c and 22c that a similar healing process was taking
place but in the control area (Figs. 21a,b), there was a highly
organised advancing bony front with parallel trabeculation from the
periphery of the defect towards the centre. The pattern observed
on the implanted side was very different. The advancing bony front
was less well orientated and lacked the fine trabeculation seen on
the opposite side. The presence of implant material appeared to be
disrupting the organised pattern of ossification. It might have
appeared as though small islands of stained calcified matrix were
present within the implant material. They formed no regular
pattern and appeared as isolated areas. This could have been
interpreted as calcification of areas of the matrix itself.
Another, perhaps more credible explanation may be that the soluble
component of the implant was lost initially and the space was taken
by the ingrowth of osteogenic granulation tissue, which deposited
bone. There seems little evidence to support the theory that
calcification may be induced by the presence of collagen itself, as
the pattern of calcification which might be seen would be expected
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to be widespread and dense, not sparse and localised as shown in
Figs. 22a & b.
The surgical defect at 28 days was still much in evidence on
the implanted side and implant material still present, while the
control area was almost fully replaced by bone (Figs. 23 & 24).
This finding is verified by Figs. 25 and 26 in which tetracycline
bone staining has shown that there was regular organised
ossification at the control site and a disordered retarded pattern
at the implanted site. Collagen material was again in evidence and
all the bone staining appeared around the matrix remnants, none
appearing within.
The control area was seen histologically to be completely
replaced by bone at five weeks (Fig. 28) and employing bone
staining (Fig. 30) the organised pattern was evident. Figure 30
showing the advancing bony front is stained only with tetracycline,
as after week 2, the haematoporphyrin was discontinued because of
the toxic effect seen in animal A14. By comparison the implanted
area is beginning to conform to a trabeculated pattern in parts
(Fig. 29a). This shows staining with both tetracycline and
haematoporphyrin (given at week 2) and Fig. 29b shows one of many
isolated foci of ossification. At 42 days the histology and bone
staining was little advanced from the appearance at 35 days and
only at 84 days did the implanted area show good bony
trabeculation. This seems clear evidence that although the implant
material did not excite a foreign body reaction, it had to be
eliminated before ingrowth of osteogenic granulation tissue could
take place to allow the area to heal by the deposition of bone.
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The undecalcified sections in this investigation have clearly
shown that the advancing front of osteoblasts was regularly
arranged on the control side and advanced from the periphery to the
centre of the defect. The implanted area demonstrated that this
orientation was completely lost and there was a lack of the fine
trabeculation seen at the control site. Fundamentally the same
repair process was taking place; the lacunae on both sides showed a
similar incremental pattern. More localised areas of ossification
were noted in the implanted area and in general the ossification
appeared to show a more haphazard picture. Such a disorientated
picture did not conform with the pattern of calcification seen when
collagen was transplanted into the rabbit peritoneal cavity
(Mergenhagen et_ al_ 1960). An ordered pattern of calcification of
collagen was said to be seen at this location. The studies by
Devore and others failed to comment on the pattern of
calcification seen with collagen implants. Devore's study was also
limited by the lack of observation between two and eight weeks.
In this investigation, it would seem possible to offer an
explanation of the way collagen is treated by the tissues. The body
recognises the need to deal with any space occupying material or
foreign protein. Materials which are not biocompatible may cause
an intense inflammatory reaction with the production of granulomas
and the appearance of multinucleate giant cells. The area may then
settle to produce a more quiescent zone of chronic inflammation.
Materials designated as biocompatible, such as metals and
silicones, eventually may become enveloped by fibrous tissue
containing giant cells which help to isolate the implant.
Biodegradable materials may cause the tissues to respond in a
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different way and if the necessary enzymes and biochemical
processes are present locally, the implant will be lysed. It is
known that haematoma and liquified fat will delay wound healing
until they are disposed off, when healing will progress normally.
In this investigation the acute inflammatory response seen
histologically can only be described as comparable with a normal
response to injury. In all the sections examined, there was a
marked absence of giant cells in relation to the collagen implant.
It can be said that the material was therefore not subject to a
fibrous reaction but that local tissue collagenases were
responsible for its dissolution and it had been dealt with in a
manner comparable to other biological "space fillers".
Collagenases have been found in a number of mammalian tissues
and are produced by a variety of cells (Chapter 1). Their mode of
action appears to be to cleave the triple helix. It would follow
therefore that the greater the cross linking, the longer the time
for degradation and this has been shown experimentally (Devore
1977). Tissue fibroblasts activated by macrophages are thought to
be the effector cells of tissue destruction by collagenase (Laub et_
al 1982). The cell population is prominently fibroblastic in the
healing wound so it is assumed that as well as producing
tropocollagen molecules, they are also digesting the heterologous
matrix.
The use of a mixture of soluble and insoluble collagens has
presented the local cell population with an easily digested soluble
matrix interspersed with a more highly cross linked component which
is more difficult to digest. The implant matrix in evidence in
Figs. 13, 15, 17 and 19 probably mainly consists of the insoluble
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component which retards the progress of osteogenic granulation
tissue, does not directly calcify and must therefore be removed
before the wound can heal.
It may be assumed that however the repair tissue is guided
into the defect, it can easily replace blood clot which is probably
lysed just in front of the advancing granulation tissue. Soluble
collagen can similarly be easily digested by collagenase and may
not significantly retard the progress of healing. The presence of
insoluble collagen may be the component which causes the healing
process to be delayed and it must be eliminated before the area can
be replaced by bone. Implant material was detected up to five
weeks after surgery in this study and this is longer than in the
other studies (Colago et^ al 1965) but compared favourably with the
time taken for the material in Devore's study (1977). This resulted
in healing taking nearly twice the time taken by the control area.
In order to further assess the reports of authors that
collagen could enhance wound healing, it was hoped that the
detection of the early microcirculation up to a period of three
weeks, in parallel with the histological evidence, may have proved
conclusive. Unfortunately, radiographs of the operated areas after
infusion of Hypaque failed to demonstrate an increase in opacity
and therefore did not show the degree of neovascularisation in the
repair tissue. Thus it may be assumed that the radiological
technique, the infusion technique, the biological model or a
combination of these factors was at fault.
The infusion technique may be questioned and several reasons
for poor contrast filling have been suggested by Rubin (1964), Rubin
et al (1964) and Skoglund et al (1978). The reasons suggested
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include low infusion pressure; too large a particle size of the
medium; vascular spasm as a reaction to the dye and a reaction with
platelets or other cells in the circulating blood to form micro-
precipitates, which are too large for infusion into bone
capillaries. It was also considered by Carlsson £t_ al_ (1960) and
Lundskog et_ al_ (1968) that micropaque (particle size <0.5p) in 50%
or 25% dilution was insufficient for complete filling of the
vascular bed. The particle size of Hypaque™ is also less than 0.5p
and the infusion pressure used in this study was similar to that
used in other investigations. The administration of heparin prior
to the dye infusion should have minimised cellular aggregation of
blood components and thereby prevented the formation of micro-
precipitates. However, only a 25% dilution of the dye was used and
vascular spasm possibly as a result of a cooling infusion may have
caused poor dye penetration. Although initially the infusion was
given at 37°C, its temperature was not kept constant over the whole
of the procedure and it was probably at room temperature after
death of the animal. According to Albrektsson (1981), the
observable contrast medium circulation in bone stopped with death
of the animal or very shortly afterwards, thus there may have been
insufficient time for the infusion of contrast medium before death
in this study.
Theoretically Hypaque™, with a particle size of less than 0.5p,
will readily fill any tube which has the diameter of a blood
capillary but it is questionable whether this is a satisfactory
comparison with vessels Tn situ in a biological system. Albrektsson
(1981) has also shown that micropaque and Indian Ink contrast media,
on average, will fill less than half of the functioning vessels in
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a defined bone compartment in the rabbit tibial metaphysis. The
results of his study further showed that the range of functioning
vessels filled with micropaque was from zero to 81%. This
incomplete filling may have resulted from blockage by contrast
medium or may represent a functional resting state in the bony
vascular bed as described by Rhinelander £t_ al_ (1968). Anatomical
factors may also be significant; according to Debruyn et_ al_ (1970),
using the guinea pig model, the nutrient artery branches may enter
the marrow spaces at an acute angle and they are often extremely
narrowed ('2p to 4p) thus not allowing sufficient filling with
contrast material.
Although the method used would appear to be satisfactory, in
practice a more sophisticated approach to the neovascularisation of
the areas in this study would have been appropriate. Such a study
would have to be prepared in a similar manner to that described by
Albrektsson (1978), perhaps using an implanted titanium bone
chamber. Such an involved study could only be undertaken as an
entity in its own right.
Finally, the radiological technique may have been
inappropriate. The quality of the film used and the apparatus may
not have been able to achieve the high degree of resolution
required.
The results from this research will now be considered in more
detail with the comparable study by Devore (1977). The
histological evidence from the animal studies should be directly
comparable. In Devore's study a large number of animals were used
and collagens with different cross linkages were compared. The
impression of improved bone healing was shown by the formaldehyde
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cross linked collagen which was present for up to 42 days at the
implant sites. At five weeks, it was reported, new bone was seen
forming at the graft site with a distinctly stellate pattern and
the graft material was virtually resorbed. At one year, the area
was shown to be fully healed. No mention was made of the
histological appearance of control areas, we are only informed that
they healed.
In this thesis the test material was eliminated by five weeks
and at this .time, the process of repair was delayed and there was
no pattern to the irregular ossification in relation to the graft
material. At three months, in this research, control and implanted
areas were healed. Contour of the control area had been better
restored. Why do the results of similar experiments appear
contradictory? The article by Devore (1977) was not reported in
depth, specific times were chosen for the results and control areas
were omitted. No figures were given concerning the numbers of
animals displaying the improved healing or the specific pattern of
calcification mentioned. It is clear in this thesis that the
presence of a similar collagen (comparable by the similar periods
taken for elimination from the test site) retarded progress and
delayed bony repair. If a few specific times were taken out of
context in this thesis, then the reported results could have been
different and probably more supportive. This could have been further
enhanced by omitting the findings in the control areas. One can
only speculate about dissimilar results from comparable research,
perhaps unsupporting results have been excluded or only specific
examples used, with the intent of clarifying the data but with the
result of unwittingly altering the conclusions.
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An alternative method used to further evaluate and investigate
the effect of the collagen implant on the host was to look
specifically at the immunological response to the material.
The immunological response to implanted collagen did not
conform to the primary response to a foreign antigen. A slow rise
in antibody level would be expected after an initial delay period
of seven to 10 days then a more rapid, rise in detectable antibody
over five to seven days, followed by a gradual fall to a basal
level over the next three weeks. If the animal has already been
exposed to an antigen and subsequently re-exposed, then in the
first seven to 10 days there is no delay period but a rapid rise in
antibody levels to a far greater extent than the primary response.
This elevated level of antibody persists for a longer period before
slowly declining. This response is termed a secondary response.
It is evident that the response shown by Fig. 33b does not
appear to be a classical primary or secondary response curve; it
seems to combine the high rise in antibody level within seven days
of a secondary response, then shows a gradual primary response
decline. It is of interest to speculate why this should be so,
especially in the light of the inconclusive evidence so far
reviewed in the literature cited in Chapter 1.
The majority of reports showing positive antisera to collagen
have resulted from hyper immunizing animals with collagen
preparations in Freund's complete adjuvant with repeated
applications subcutaneously or intramuscularly (Kirraine & Glynn
1968; Steffen et_ al_ 1970; Schmitt e_t_ a_l 1964). Collagen injected
intravenously failed to produce a detectable antibody response
(Rubin et al 1968).
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Devore ^t_ al_ ( 1974) further examined the antibody response to
repeated injections of a soluble collagen preparation in Freund's
complete adjuvant and also investigated the antibody response shown
to collagen implanted in bone. Antibody responses were shown by a
gel diffusion technique. The work showed that eight days after a
third injection of antigen, a single precipitin line response was
exhibited by the technique, indicating one dominant antigen in the
collagen-adjuvant material. By comparison, and with the same
method, no response could be demonstrated in any of the 12 animals
used when the collagen was implanted into bone. Serum from these
animals was examined one week and four weeks postimplantation.
Such a lack of response has not been verified by this study. Figs.
33a & b clearly demonstrate that detectable antibodies are produced
to collagen implanted into bone. The results shown by Devore £t_ al_
(1974) compare favourably with other similar studies using injected
soluble collagen in Freund's adjuvant, one diffusion line being
indicative of a dominant antigen. The failure to show an immune
response to collagen implanted into bone was questioned and several
explanations were offered by the authors. They suggested that the
cross linked collagen did not behave as an immunogen. This
suggestion is not substantiated by the results in this thesis.
To explain the antibody curve and the differing opinions, the
present knowledge of the immune system concerning "self" recognition
may be relevant.
In early lymphocyte development those T and B cells with
receptors for antigenic determinants on "self" proteins are
eliminated or suppressed so that the immune system responds only to
foreign antigens. Part of the response to any foreign protein is
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played by the memory T cell such that a secondary response to the
same antigen is greater and faster (Triplett 1962). The host's
immune system is genetically capable of responding also to "self"
proteins but learns not to do so. If tolerance to self antigens is
compromised, then T or B cells or both may be primed to react
against host tissue and produce a so-called autoimmune reaction.
Regulator T cells interact with B cells and other T cells by
recognising foreign antigen attached to the surface of an
interacting cell. These regulator T cells may communicate with
target lymphocytes by secreting helper and suppressor factors (Tada
& Okumura 1979). Thus when T cells are stimulated by antigen, they
are seen to divide and differentiate into activated effector cells
and cytotoxic T cells which are able to dispose of foreign
antigens. Helper T cells and specific T and B lymphocytes respond
to the presence of antigen and also secrete lymphokines such as
macrophage migration inhibition factor (M.I.F.) to activate these
cells and increase their efficiency at phagocytosis. Lymphocytes
also secrete interleukins such as interleukin 2 (T cell growth
factor) which stimulates activated T cells to divide and
proliferate. The suppressor T cells depress the response of the T
and B cells to antigens. It is seen then that helper T cells and
suppressor cells act as synergistic regulators of the immune system
(Amos 1981).
All mammalian collagens, as discussed in Chapter I, are
structurally very similar, and in the immunologically mature
animal, the normal response to a "self" protein is suppressed. If
the system is then exposed to a high level of antigen which is
structurally very similar to self then the memory T cell may or
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may not recognise it as foreign. If it is recognised as "self",
then no antibody response may be initiated and this may explain the
lack of positive findings in some reports, which may perhaps show
species specificity.
If the material is initially recognised as foreign and memory T
cells are primed, then the immunological balance may be in favour of
the production of helper T cells which will specifically activate B
cells and quickly produce high levels of antibody, as shown by Fig.
33b. However, as the heterologous collagen molecule resembles the
host natural collagen and the immune system is primed to suppress
self antigens, then it would be expected that the initial response
by the T helper cells would change rapidly to produce an increasing
level of suppressor T cells. The immunological balance then tips
in favour of suppression of the antibody response and the antibody
level is seen to diminish as the level of suppressor T cells rises.
This may also parallel the dissolution of the implant material. In
this study by week 9, after implantation, the antibody response
shown had fallen to a basal level and the immunological balance was
then in favour of T cell suppression.
Clearly if this hypothesis is credible, then there could also
be species specificity and individual variations which could explain
the range of reactions seen in animal models and in the human
reactions to a test dose of Zyderm™.
In neither the animal study nor the human implantation study
in this thesis, were any adverse effects clinically evident that
could be attributed to the implant material. The ability of T cells
to activate macrophages is an important step in cell mediated
immunity. Antigen triggered the secretion of lymphokines by memory
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T cells, such as macrophage migration inhibition factor, mitogenic
factor, chemotactic factor or skin reactive factor. Histologically,
after the early acute inflammatory response with polymorph
infiltration, the area is filled by an accumulation of macrophages,
lymphocytes, mast cells, epithelioid and giant cells often with
tissue necrosis and the formation of granulomata.
There was no evidence of granulomata or tissue necrosis seen
in the animal or human studies. The animal study showed
histologically only an acute inflammatory reaction which did not
last longer at the implanted site; both control and implant areas
showed that inflammatory cells were gone by 10 days. There was
neither a dense macrophage infiltration seen nor evidence of
foreign body giant cells related to the collagen. A cell mediated
response of a delayed hypersensitivity type was not demonstrated
and the response to a heterologous collagen implant in the rabbit
was predominantly humoral.
The major antigenic determinants of bovine collagen type I are
said to be located at the non-helical terminal ends of the molecule
(Rauterberg ^ al_ 1972) with only about 20% of the antigenic
determinants related to the helical portion (Timpl £t_ al^ 1971).
Pepsin digestion will remove the major antigenic determinants. The
presentation of pepsin digested collagen to the rabbit, as in this
thesis, induces an immediate antibody response. This is quickly
followed by antibody suppression.
If a similar antibody response to that shown in the animal
model is seen in the human situation, then a temporary rise in
circulating antibody level should not produce any clinical symptoms.
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Radiologically the results of the animal work compared
favourably with those seen in the histological study. The human
study was assessed radiographically so that a comparison could be
made with the animal radiological findings and so infer the
underlying pattern of healing seen with the collagen implant
material.
Animal experiments which are properly standardised and use
identical controls should produce meaningful and reproducible
results. The major disadvantage of any animal work is that there
can always be species specificity and direct comparisons with the
human situation cannot be made, only inferred (Autian 1970, 1981).
This must therefore be considered when the results are interpreted.
The results from the histological study of rabbit mandibles,
using decalcified and undecalcified sections, showed that the
collagen matrix itself did not calcify. Figure 43 (pig mandible)
showed that there is little change in the radiodensity of the areas
when a collagen implant is placed in_ situ. Any change in radio-
density must therefore have been caused by the deposition of bone.
The earliest radiographic changes were seen 10 days post¬
operatively. On the control side (Fig. 36 L) the original clear
cut surgical margin had become less distinct and this was again
shown at 14 days (Fig. 37 L). At 14 days on the control side, the
area was beginning to show an increasing opacity. The histological
picture at this stage (Fig. 18) confirmed that the osteogenic
granulation tissue was laying down bone. At three weeks, the
stained undecalcified sections (Figs. 21a,b) showed organised bone
trabeculation and this was confirmed on the control side
radiographically by a more dense radiopacity. It was also noted
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radiographically at this stage that the lower border of the
mandible showed evidence of reconstitution.
The implanted areas at 10 days and 14 days comparable to the
above showed histologically that healing was occurring but compared
with the control areas, it was retarded (Figs. 15 & 17). The
original defect was still very obvious radiographically at four
weeks on the implanted side (Fig. 39 R) whereas the control site
(Fig. 39 L) showed good bone deposition and the lower border of the
mandible was reconstituted. These radiographic changes paralleled
the bone deposition seen by microscopy (Figs. 24 & 25a,b) on the
control side. The less dense radiographic change on the implanted
side confirmed the retarded bone deposition seen histologically
(Figs. 23&26). The impression up to week 5 was that histologically
and radiographically the test site had shown retarded healing.
The radiographic appearance at week 5 did not follow this
pattern. The control area (Fig. 40 L) shows bony regeneration
around the cut tooth apices but the lower border was not yet
reconstituted. Bony regeneration was also seen at the site of the
implant but the lower border on this side (Fig. 40 R) had been
reconstituted. With regard to the microscopy of these areas (Figs.
27a,b & 28), the implant material was no longer visible and woven
bone was seen (Fig. 27a). Histologically the appearance at the
control area (Fig. 28) was of more complete bony regeneration. It
is important to note that the radiology and histology are of the
same animal. Comparing Figs. 29a,b with Fig. 30, the undecalcified
sections again exhibited a more organised pattern of bony
replacement at the control site but the implanted area did contain
much stained bone albeit in a more disorganised fashion. This
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would indicate that when the implant material had been disposed of,
then the osteogenic repair tissue was able to invade the whole area.
The earlier impression of retarded healing due to collagen is
confirmed radiographically at six weeks (Figs. 41 R&L). Both areas
showed bony deposition, but the lower border was reconstituted only
on the control side.
At 12 weeks both defects were filled with bone and showed
comparable radiological densities, but both had notching of the
lower border which seemed more pronounced on the implanted side
(Fig. 42 R). Devore's similar study (1977) showed that the
collagen implanted area developed less notching than the control
and the implant area was thus better restored. This is not
confirmed by this study. The earliest radiological evidence of
calcification with implanted collagen was shown by Fabinger et_ a1
(1980) to be at two weeks and this time verifies the radiographic
changes at three weeks in this study. Devore's study does not
comment on the radiographic appearance of the period between two
weeks, when no changes in the radiolucent regions were seen and two
months when the defects were largely filled with bone. Devore's
study utilised a solid collagen matrix which was soaked in saline
prior to implantation. The proportion of collagen in the material
was not given. The collagen paste used in this thesis contained
only 44% collagen, half as the insoluble material and half soluble.
A high percentage of fluid was therefore present which may have
been lost immediately after implantation, leaving the area under-
restored. This thesis agrees with Devore in that the control site
will show notching of the lower border and this may be due to the
shrinkage occurring in connective tissue as it matures. The
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difference in the implanted group in this thesis compared with
Devore's may be that a more dense collagen implant was able to
restore tissue contour to a greater extent.
Support for this hypothesis is provided by the use of Zyderm™
for soft tissue recontour. This material contains soluble collagen
which constitutes 25-30% of the volume injected only.
Over-correction of the defect is advised and a variable number of
treatments has to be given before sufficient collagen matrix has
been deposited to improve the contour. The soluble portion of the
collagen paste described in this thesis may also be eliminated
quickly and with loss of the saline and Dextran™ only 22% insoluble
collagen may remain within the implanted area. This would appear
to be considerably less than the block of insoluble collagen used by
Devore (1977).
It may therefore be expected that the implanted area described
in this thesis would show a greater degree of notching than the
control site and that using this material, total recontour of the
lost bony tissue could not be achieved.
The animal work in this study set out to examine some
fundamental questions concerning the suitability of a specially
formulated collagen paste for use as a bone implant material. The
results obtained have been used to consider the findings in
previously published works. There is little doubt that the collagen
paste is biocompatible and it appears to be resorbed by 28 to 35
days. There is no evidence in this study that collagen induced
calcification directly when implanted into bone. The undecalcified
preparations clearly showed calcification around the matrix but
these areas were localised, sparse and disorganised when compared to
the control areas. The organised pattern shown by Devore e_t_ al
(1977) has not been demonstrated in this work nor confirmed by any
other reports. The number of animals showing organised
calcification is not mentioned by Devore et_ al (1977) and no control
areas were shown; thus the value of this work is in question. An
uncontrolled study using two dogs by Krekler £t^ al (1980) examined
tissue at only two specific points in time, four and five weeks
post-implantation. Their conclusion of a direct calcification of
the collagen matrix in the periodontal pockets in these two dogs is
again limited by the number of animals observed and the period of
observation. If control lesions were disregarded in this thesis, a
case could be made for collagen calcification but the impression in
this research is that healing was retarded by the presence of the
implant and mineralisation of the implanted area was delayed. The
collagen matrix is shown to act as a barrier to osteogenic
granulation tissue and must be removed before the area heals. In
considering other authors' results, the number of animals used, the
characteristics of the collagen matrix, the times and frequency of
observations and the use of controls, must all be considered before
any valid conclusion can be drawn.
This study has also demonstrated the immunological effects of
bovine collagen in the rabbit. The material acts as an immunogen
and levels of antibody were detected by an ELISA. They showed that
an initial antibody response is later suppressed and there seemed to
be no clinical sequelae to the immune response.
The physical properties of the material were satisfactory and
it was easily moulded into the desired shape. There was lack of
complete restoration of the bony contour which may have been due to
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a loss of initial volume of the implant material after fluid and
soluble collagen were resorbed.
Thus the animal work showed, biocompatibility, bio-
degradability, a slower rate of healing compared to a control, an
immune response and lack of full restoration of the bony matrix.
The human implantation study will be discussed in the light of these
findings.
One hundred consecutive patients who required a bony defect in
the maxilla or mandible to be treated were studied clinically and
radiologically. It was assumed that changes in radiological
density in radiographs of these healing areas would be comparable
to those seen in the animal study, and that a similar healing
process would be taking place in both studies.
In this human study no adverse reactions which could be
attributed to the implanted collagen were shown locally by the
appearance of granulomas or other pathological tissue at the site
of the implantation. No patient complained of generalised
symptoms.
The sample used was, however, small in comparison to the 9000
patients used for the Zyderm™ trial by the Collagen Corporation.
Their figures showed that 3% of this sample developed a local
reaction to the implant material when given a subdermal test
aliquot. Using this figure of 3% in the 50 patients who were
implanted with collagen only one or two patients would be expected
to react; none, however, showed any untoward reaction. This lack
of local effect when collagen is placed into bone would require
further examination on a much larger study. The progress of the
two groups used for the human study has by comparison and
182.
inference from the animal study, shown the effect of the material.
Each of the 100 patients was given a standard post-operative
instruction sheet which indicated the minor complications, usually
pain and swelling, which might occur immediately post-operatively,
the recommended analgesic preparations and instruction on local
wound cleanliness. They were asked to return immediately if the
pain became persistent, the swelling did not resolve or there was
any local tissue damage at the site of operation. In all, 12
patients returned before their first review appointment at two
weeks. Only four of the 12 were from the implanted group, of whom
three required reassurance only; an antibiotic was prescribed to
treat a localised cellulitis in the fourth. In the control group,
eight patients returned, four requiring reassurance and an
antibiotic was prescribed in four cases, again for persistent local
infect ion.
At two weeks, 89 patients returned for review. Clinically, the
areas had healed well, although four patients still complained of
some minor discomfort.
There was no evidence in the implanted group that the presence
of collagen had caused a severe and extensive acute inflammatory
reaction as described by Hunt & Benoit (1976) when evaluating
TM
...
Avitene . The clinical impression was that the material was safe
and as no adverse reactions were seen, it was not acceptable to the
patients to test for antibodies. Venepuncture was discussed with
patients but they declined to enter the trial if this was a
condition. They did agree that if a local reaction to collagen was
evident, then their serum could be examined for anti-collagen
antibodies.
183.
Each patient was given a review appointment for three months
after their surgery. At this appointment, seven patients in the
control group and nine patients in the implant group failed to
return (Tables 6.2 and 6.5). Patients who failed to return are not
considered in the discussion. Unfortunately this reduced the
number in each group which then made statistical data more
difficult to interpret. The total figures for failed attendance at
six and 12 months were 20% and 28% respectively (Tables 6.3, 6.4,
6.6 & 6.7).
The progress of individual patients is shown in Appendices 1
to 4 and Tables 6.2 to 6.11 are a compilation of this data. A
change in radiological density at three months was considered to be
indicative of healing within the bony cavity provided the patients
were totally symptom free. A similar criterion was used at six
months so that the degree of healing could be directly compared
with that at three months. At one year it was seen that there
could be radiological variation within each group. Complete bony
regeneration in areas where both cortical plates had been
fenestrated was not usually seen. If collagen had had
osteoinductive potential, a difference between control and
implanted areas when both cortices were fenestrated would have been
evident. The degree of healing shown on radiograph at 12 months
was divided into three categories, instead of the two used at the
three and six month intervals, in order to demonstrate this point.
In Appendix 2, it will be seen that two female patients, S.R.
and N.S., both in the control group, required the operative site to
be re-explored due to persisting local infection. Both areas were
in the maxilla, one was small and one greater than 2 cm. It is not
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uncommon for some apical areas to require re-exploration and this
probably results from failure to remove all infected tissue
initially. A re-exploration rate of 2% was considered acceptable.
The study served as satisfactory comparison between the
implanted and the control groups; the numbers of patients were equal
in each group and the number of defects of comparable size in each
group was similar. The number of patients absent from review
increased with the duration of the study and this made the
interpretation of the results more difficult. At three months, in
the implanted group, 58% of the original total showed no change in
radiological density and 28% showed an increase in opacity. In
Appendix 1 it is seen that the majority of the lesions showing this
increased opacity were originally <1 cm in diameter. By
comparison, 64% of the control group showed evidence of bony
healing by three months and only 18% showed no change in
radiolucency. By six months, however, comparable figures of 76% in
the implant group and 66% of the control showed evidence of bony
deposition in both the implanted and control groups.
After one year the figures showed that 44% of the implanted
group and 54% of the control group showed the areas to be fully
healed by bone deposition. Partial filling of the original area was
shown by 28% of the implanted group and 10% of the control with no
radiological evidence of repair being demonstrated by only 2% of
the patients in the implanted group and 6% in the control.
Tables 6.8 to 6.11 compare control and implanted groups. At
three months similar numbers of patients returned in each group, 41
in the control group and 43 in the implanted group. If the healing
of lesions in each group is assessed, dividing them into small,
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medium and large categories, then statistically there is no
difference in healing with respect to the size of the original bony
defect. In the control group, P = 0.2259 and in the implanted
group, P = 0.4591. This would indicate that the size of the lesion
treated had no effect on the progress of healing taking place. In
the control group, three of the six figures used in the statistical,
analysis were less than 5 in total, and in the implanted group, two
figures are below 5; statistical interpretation of such low numbers
may be misleading.
Bone deposition in control and implant groups at 3 months is
compared in Table 6.11a; 32 patients show bone deposition in the
contol groups and 14 in the implant group. No radiological change
was seen in nine of the control group and 29 of the implant group.
If these figures are directly compared, then a significant
difference is seen between these groups (P = 0.0001). The
radiological evidence at three months in the human study thus
favours the opinion that healing is retarded in the implant group
by comparison with the control group. This view directly parallels
the animal work showing that until the implant material is
resorbed, healing is retarded. There is a difference in the time
scale between the animal model and man; traces of the implant
material in the rabbit are present until between four and five
weeks, and the implanted area is healed by three months, shown
radiologically and microscopically. This is not so in the human
situation and most implanted areas are still radiolucent at three
months, becoming radiopaque by six months.
The radiological evidence at six months compares similar
numbers of patients, 39 and 41 (Fig. 6.9) and it would appear that
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the size of the lesion has little effect upon healing. It is again
seen that many of the numbers used in these tables are less than 5,
and therefore for statistical purposes they are unsatisfactory.
Comparing healing between control and implant groups at six months
(Table 6.11b) there is no significant difference (P = 0.2717) and
the majority of patients in both groups demonstrate evidence of
healing by this time.
Tables 6.10 a&b comparing healing at one year with respect to
the original size of the defect, have too many values below 5 for
statistical evaluation. Figures for control and implant groups at
this time show that similar numbers of patients returned for
review, 70% and 74%. In the implant group, 28% showed partial bony
replacement and 44% full bony healing. The comparable figures in
the control group were 10% and 54%. No radiological evidence of
bone deposition was found in three control and one implanted
patient. Comparing these figures, there would appear to be no
difference (P = 0.0572). Unfortunately, using this data, an
osteoinductive role for collagen cannot be supported or refuted.
The early phase of bone healing seen radiographically in the
human implantation study was considerably delayed when compared to
the control sites. This is comparable with the findings in the
animal study which showed a similar delay radiographically in the
collagen treated areas. This finding parallels the slower
replacement by osteogenic granulation tissue seen microscopically at
the implanted areas. The inference from this work is that the delay
in healing seen in the human study was caused by the presence of the
material. If the healing seen radiographically is considered at
one year, then 44% of the implanted group showed the area to be
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totally replaced by bone and 28% showed only partial replacement.
This may reflect a delay in bony replacement or that the healing
process had stopped at a specific time and the lucent area was
replaced by fibrous tissue only. All patients were symptom free.
When these findings are considered, it is difficult to accept
the very positive report of the similar implantation study and
Zetzmann £t_ a_l (1982). A success rate of 92.5% in cases of third
molar removal, cyst implantation and partial mandibular resection
was reported. These cases were treated with a new collagen material
and the results were assessed radiographically at 14 months. In
translation there are linguistic difficulties, but the report does
not comment on the variations seen in healing shown by this
research. With equal confidence, the author's study could report a
similar figure. At review after one year, 74% of patients with the
collagen implant in this research, returned and 72% showed bony
healing - a success rate of 97%. The interpretation of any results
must therefore be circumspect.
2
Cooperman & Michaeli (1984 ) have shown in a prospective human
implantation study that two patients (3%) developed a local
reaction to subdermally injected Zyderm™. One of these areas was
biopsied and showed a mixed inflammatory infiltrate around foci of
the implanted material. They stated that the response was
self-limiting in the other patient. Their study also found
increased antibody levels, measured by radioimmunoassay to
injected collagen in one patient at six months and the other at one
year.
An interpretation of these findings may be made with reference
to the animal work of this thesis. A hypothesis has been made that T
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cell suppression becomes dominant after an initial helper T cell
response to implanted collagen. Antibody levels after a rapid
initial rise will quickly fall. Soft tissue recontour is achieved
by repeated injections of Zyderm™ and with individual variation in
the immune response, suppression of a helper T cell response may be
delayed. Antibody levels after repeated injections may therefore
increase and remain at an elevated level.
An alternative explanation may be that denatured collagen, in
the form of gelatin, which is used extensively in food preparation,
may cause susceptible individuals to develop and maintain
antibodies to parts of the collagen molecule (Swarbuck e^_ al^ 1979).
No pre-exposure level of antibody was obtained in either of the
subjects in Cooperman & Michaeli's report.
The materials used in all the studies discussed was type I
collagen and if there is a connection between auto-immune disease
and collagen antibodies, then so far type I has not been
implicated. Reaction to type II collagen only has been reported in
the experimental animal work on arthritis (Trentham £t_ al_ 1978;
Cremer et^ a_l 1983).
In the present state of knowledge, it would still be unwise to
continue with collagen implantation in patients who have shown an
adverse clinical response.
A study of the immunology of collagen in man with direct
measurement of the specific T cell response should clarify the
situation further.
This thesis was designed to investigate the properties of a
specially formulated heterologous collagen paste both in^ vivo and _in
vitro and then to use this information to predict and interpret its
behaviour when used in the human subject.
It has shown there is no cytopathic effect on human fibroblast
tissue culture and no adverse effects seen histologically when
placed into a prepared bony cavity in the rabbit. Elimination of
the material was considered to be by local collagenase digestion
probably by the local fibroblast and macrophage population. The
material fulfilled the criteria set for biocompatibility and
biodegradability. The material was specially formulated to enhance
wound healing and clearly this has not been demonstrated. It has
been shown that the material delayed wound healing by preventing
the ingrowth of osteogenic granulation tissue. Repair of bony
lesions in the experimental animal and in man, shown histologically
in the rabbit and radiologically in animal and man, have shown that
healing is retarded.
In the experimental animal, the material was shown to induce an
antibody response but as the material is structurally similar to
host collagen, the response appears to have been suppressed after an
initial response.
Direct calcification of collagen was not shown and the material
did not appear to have an osteoinductive capacity. It was shown to
be safe for human use but offered no advantage, such as accelerated
healing, with its use.
It is disappointing to show that a material which theoretically
had such a useful potential has, as most of the other materials
investigated for this purpose, not totally fulfilled the criteria
set. A suitable material to replace areas of lost bone has yet to
be found. There are now reports of the use of a combination of
collagen with hydroxyapatite as a more suitable material. Several
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authors (Gross £t_ a^L 1980; Hayashi £t_ al_ 1982; Mettelmeier &
Katthagen 1983) suggest that hydroxyapatite may have osteoinductive
properties which have been found lacking in the collagen material
of this research. They also suggest that this osteoinductive
capacity may produce an early increase in strength in bone healing.
If this can be substantiated, then the collagen paste used in this
thesis, which is shown to be biocompatible and biodegradable, may
provide a suitable vehicle for the hydroxyapatite.
In conclusion, the work in this research has provided answers
to some of the questions concerning the suitability of collagen as a
bioimplant material for bone. Much work is still required to
produce an ideal allograft material, but it is hoped the data
presented will be useful as a guide in understanding the effects of
other biological materials on bone healing.
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APPENDIX 1
RADIOGRAPHIC ASSESSMENT OF PATIENT PROGRESS
CONTROL GROUP (MALES)
Patient Site Size 3 months 6 months 12 months
M.B. Mand. M Margins less distinct
increased opacity.
Reduction in radiolucent area.




A.B. Max. S Increased opacity.
Peripheral early
trabeculation.
Bony replacement in outer half
of original area.
Complete bony replacement.
C.C. Mand. M Increased opacity
in bony cavity.
Bony replacement in periphery
of original area.
Complete bony replacement.
J.D. Max. S Increased opacif¬
ication in bony
cavity.
Bony replacement in outer half




S.F. Max. M Increasing opacif¬
ication in bony
cavity.
Reduction of lucent area and
replacement with bone.
D.N.R.
K.F. Max. S No change in lucent
area.
No increase in opacification of
lucent area.
D.N.R.
C.F. Max. S D.N.R. D.N.R. No change in lucent area -
no symptoms.





G.H. Max. M No change in lucent
area.
Margins less distinct increased
opacification.
Bone of replacement in
peripheral half of
original area.
R.L. Max. M Lucent area replaced
by mottled opacity.
Bony replacement at periphery
of lucent area.
D.N.R.
J.M. Mand. L Increasing opacity Whole area now replaced with Complete bony infilling.
early peripheral bony trabeculation.
bony replacement.
P.M. Max. S Increase opacity in Bony trabeculation in periphery Complete bony replacement
bony cavity. of bony cavity. in cavity.
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Patient Site Size 3 months 6 months 12 months
G.M. Max. M Increased opacity in
bony cavity.
D.N.R. Complete bony replacement
in cavity-
G.N. Max. S Early peripheral
bony replacement.
Died.
G.O. Max. S D.N.R. D.N.R. Area reinfected.
G.R. Max. S Increased opacity
early bony replace¬
ment peripherally.
Whole of cavity replaced by bony
trabeculation.
D.N.R.
A.R. Max. S D.N.R. Original lucent area reduced in
size but central area still
radiolucent.
D.N.R.
S.R. Max. M Lucent area replaced
at periphery by
opacity.
Lucent area now replaced by
radiating trabeculated bone.
Bony replacement in all
but small central zone.
P.T. Mand. S No change in lucent
area.
D.N.R. D.N.R.
R.T. Max. S D.N.R. Bony trabeculation in peripheral
half of bony cavity.
D.N.R.
B.T. Max. S Increasing opacif¬
ication in bony
D.N.R. Complete bony replacement
of lucent area.
cavity.





RADIOGRAPHIC ASSESSMENT OF PATIENT PROGRESS
CONTROL GROUP (FEMALES)
Patient Site Size 3 months 6 months 12 months






A.A. Mand. S D.N.R. Whole area of operation shows
increased opacity.
Complete bony healing.
C.8. Max. M Minimal increase in
radio-opacity.
D.N.R. Complete bony replacement
P.8. Max. L Whole area shows no
change in lucency.
Peripherally some increase in
opacity of area margin
indistinct.
Half of original area
shows trabeculated bone.
Central area still lucent.
P.C. Max. M Reduction in size of
lucent area.
Whole area shows good opacific¬
ation with peripheral
trabeculation.
Whole area filled with
trabeculated bone.
C.C. Max. S Increased opacity
of whole defect.




T.C. Mand. L Area filled with
amorphous opacities.
Whole area completely opacified
with trabeculated bone in
periphery.
Bone in whole of defect
except adjacent to teeth.
N.C. Mand. S Margins indistinct
loss of lucency.
D.N.R. D.N.R.
K.C. Max. S No change in lucency. Area reguired re-exploration. Whole area shows
increased opacity.
J.D. Max. M Increased opacity at
operation site.
Margins indistinct peripherally
replaced with trabeculated bone.
Whole area shows bony
replacement.
P.D. Mand. M Area shows increased
opacity with
indistinct margin.
Peripheral trabeculated bone of
replacement.
Area healed with coarsely
trabeculated bone of
repair.
M.E. Max. M •Decreased opacity at
periphery clearly
demarcated from






central lucent area- bone.
219.
Patient Site Size 3 months 6 months 12 months
E.G. Max. M Margin of peripheral
opacification only.




D.G. Hand. M D.N.R. D.N.R. Original area replaced
by bone except for small
lucency at root apex.
I.H. Max. S Peripheral opacific¬
ation of lucent area.
Area now completely replaced
by radiating trabeculated bone.
Area replaced by normal
bone.






E.McG. Max. s Whole area shows
increased
opacification.
Area fully replaced by bone. D.N.R.
L.M. Max. M Replacement of lucent
area by peripheral
opacification.
Peripherally area replaced by
bone. A small central area shows
increased lucency.
Whole area replaced by
bone except small lucent
area adjacent to root
apex.
M.P. Max. S D.N.R. D.N.R. D.N.R.
M.P. Max. s Increased opacity
with a mottled
appearance.
Trabeculated bone at periphery
of original area.
Area replaced by bone
except small lucent area
at apex of root.




S.R. Max. s No change in
radiolucent area.
No change in lucency. Area re-explored due to
recurrent symptoms




Bony replacement at peripheral
half of original lesion.
Area replaced by bone
except for residual
lucency at root apex.
N.S. Max. L Area replaced by
opacity showing a
mottled appearance.
No change from 3 months. Area re-explored and
infected granulation
tissue removed.
K.V. Mand. M No change in lucent
area.




Patient Site Size 3 months 6 months 12 months
J.W. Max. Lucent area replaced
by mottled
opacification.





J.W. Mand. M D.N.R. Central lucent area surrounded
by radiating trabeculated bone.
Bony replacement of area
except around root
apices.










RADIOGRAPHIC ASSESSMENT OF PATIENT PROGRESS
COLLAGEN IMPLANT GROUP (MALES)
Patient Site Size 3 months 6 months 12 months
A.8. Max. S D.N.R. Margins indistinct.
Opacity increased.
D.N.R.
D.B. Mand. M No change in lucent
area.
Reduction in size of lucent area
with indistinct margin.
Whole area shows opacific¬
ation with peripheral
trabeculated bone.
J.B. Max. S No change in lucency
but periphery less
well defined.
Area now shows increased opacity.





M.B. Max. s D.N.R. Margins indistinct. Area shows
increased opacification.
D.N.R.
J.C. Max. s No change in lucency
of original area.
Opacification of area with coarse
trabeculation at periphery.
Area replaced by normal
bone.
C.D. Max. s No radiological
changes.
D.N.R. D.N.R.








A.G. Mand. L D.N.R. Trabeculated bone replacing
whole of original defect.
Bony replacement with
some areas of sclerosis.






W.McC. Max. S No radiological
changes.
Increased opacity in whole area. Opacity shows peripheral
bony replacement.
J.McD. Mand. L No radiological
changes.
D.N.R. Increasd opacity with
marked reduction of
radiolucent area with
deposition of bone of
repair.
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Patient Site Size 3 months 6 months 12 months
T.McK. Max. S No change in
radiolucency.
Area now shows increased opacity. D.N.R.
F.M. Max. M D.N.R. Trabeculated bone in periphery
of lesion with central opacity.
D.N.R.




D.N.R. Whole area replaced by
bone of repair.
U.S. Max. L Peripheral opacity
around central
lucency.
Area now shows opacification
with indistinct margins.
Periphery shows trabecul¬
ated bone of repair.
Central area mottled
opacity.
G.S. Max. M No change in
radiolucent area.
Peripheral opacity with coarse
bony trabeculation.
Area replaced with bone
of repair with lucent bone
around root apices.
J.T. Mand. M D.N.R. Area shows increased opacity with
peripheral bony replacement.
D.N.R.
M.W. Mand. M Area shows increased
opacification with
Area replaced by trabeculated
bone at periphery.
Whole area replaced by
trabeculated bone.
indistinct margins.
S.Y. Max. M No change in
radiolucent area.
Margins indistinct. Increased
opacity at periphery. Central




RADIOGRAPHIC ASSESSMENT OF PATIENT PROGRESS
COLLAGEN IMPLANT GROUP (FEMALES)
Patient Site Size 3 months 6 months 12 months
C.B. Max. M No change in radio-
lucent area.
Increased opacity at periphery
of lucent area.
D.N.R.
J.8. Max. S Increased opacific¬
ation of radiolucent
area.
Trabeculated bone in peripheral




G.B. Mand. M Radiolucent area
shows peripheral
opacification.
Increase in density of
peripheral opacity but lucent
area remains around root
apices.
Bone of repair in lesion
except around root
apices - still shows
lucency.
A.B. Mand. M No change in
radiolucent area.





C.D. Mand. S No radiological
change.
D.N.R. Complete replacement of
lucent area with bone
of repair.
M.D. Max. S No radiological
change.
Margins indistinct. No bone
in area. Central area still
radiolucent.
D.N.R.




repair except small lucent
area around root apices.
C.F. Mand. M No radiological
change in density.





M.F. Max. S No change in
radiological density.
Margins indistinct. Minimal




A.H. Max. S No radiological
. change in density.
Peripheral bony deposition with
lucent area remaining around
root apices.
Area replaced by bone of
repair except lucent area
at root apices.
224.
Patient Site Size 3 months 6 months 12 months




Marked reduction in size of
original area with trabeculated
bone of repair.
Area replaced by bone
except around root
apices - still lucent.
E.H. Max. No change in
radiological density.
Margins indistinct but little




M.K. Max. Increase opacity
over whole area.
D.N.R. Area replaced by bone of
repair except small lucent
area at root apices.
M.K. Max. No change in
radiological density.
Margins indistinct. Central
opacifity of area now seen.
Area now replaced with
trabeculated bone of
repair.
C.L. Max. No radiological
change.
D.N.R. Area infected - required
re-exploration.
A.L. Max. No radiological
change in density.
Margins indistinct. Central
opacity of original lucent area.
More dense opacity with
peripherally bone of
repair noted.
A.L. Max. No change in
radiological density.
D.N.R. Area replaced by bone
except small lucency at
root apices.
I.McC. Max. M No change in
radiolucency.
Central lucent area with
peripheral opacity with early
trabeculation.
Increased bony trabecul¬
ation but central lucent
area remains.
S.McG. Max. No change in
radiolucent area.
Increased opacity in whole of
area.
Peripheral replacement
with bone of repair.
M.McK. Max. No radiological Margins indistinct. Minimal








J.M. Max. S Increased opacity
'in bony defect.
Peripherally area now shows
trabeculated bone of repair.
Area replaced by bone
with small residual
lucency at root apices. >
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Patient Site Size 3 months 6 months 12 months
H.N. Max. S Increased opacity
in bony defect.
D.N.R. D.N.R.
U.O. Max. S No change in
radiological density.




area of bone of repair.
J.P. Max. M Mottled opacities
throughout lucent
area.
Whole area now markedly radio-
opaque. Small lucency around
root apices.
Trabeculated bone of
repair in all but small
area at root apices.
I.T. Max. M Increased opacity
in whole of original
area.





M.T. Mand. M D.N.R. Increased opacity in central
zone with coarsely trabeculated
bone of repair peripherally.
D.N.R.
J.W. Mand. S Margins indistinct.
Area radio-opaque.




M.W. Max. S No change in
radiological density.
D.N.R. D.N.R.
E.W. Mand. M Margins indistinct.
Area shows increased
Trabeculated bone of repair
well established.
Bony repair of original
area.
opacity.
L.W. Max. S No change in lucent
area.
Peripherally trabeculated bone
towards central opacity.
Area healed with
trabeculated bone of
repair.
